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GENERAL INTRODUCTION 
Communication between cells is required to 
coordinate their diverse activities and must have 
been a prerequisite for the evolution of multicellu-
lar organisms. Cells which are not in direct physi-
cal contact in that they do not form gap junctions 
allowing the cytoplasms of the interacting cells to 
join directly, communicate by means of signaling 
molecules. These signaling molecules are either 
released by the cell or displayed on the outer sur-
face of the cell and they are recognized by other 
cells and sometimes also by the signaling cell 
itself. In multicellular organisms, the extracellular 
medium contains a wide variety of signaling 
molecules. Some of these signaling molecules are 
released in the immediate vicinity of the target 
cell(s) where they are rapidly taken up or degraded 
so that they act only on a limited group of cells 
(local chemical mediators) or even only on one sin-
gle cell (neurotransmitters). Others are released 
into the bloodstream and transported to essentially 
all parts of the body (hormones). 
Intercellular communication by means of sig-
naling molecules implies the presence of a cell-
specific set of receptors enabling a particular cell to 
select those signaling molecules which are released 
to control its activity. The fact that most, if not all, 
cells possess more than one type of receptor indi-
cates already that various signaling molecules 
apparently act in concert to regulate the activity of 
a particular cell. As a consequence, the cell has an 
important integrative function in that it translates 
all the information it receives into the most appro-
priate response. 
Basically, by virtue of localization of the 
ligand-binding domain, two different kind of recep-
tors are recognized: (1) cytosolic receptors and (2) 
cell surface receptors. 
Cytosolic receptors interact with ligands such 
as steroid hormones, which, because of their 
lipophilic nature, can easily pass the plasma mem-
brane. On the other hand, cell surface receptors 
expose their ligand-binding site into the extracellu-
lar space. Agonist-binding leads to receptor activa-
tion and depending on the pathway employed to 
convey information across the plasma membrane, 
cell surface receptors which do not need interven-
tion of other membrane-associated molecules are 
differentiated from those who do. 
Recently, molecular cloning of some of the 
receptors, which require other membrane-
associated molecules to pass information to the cell 
interior, has allowed to predict the topographical 
orientation of such receptor proteins with respect to 
the plasma membrane (Nathans and Hogness, 
1984; Zuker et al., 1985; Yarden et al., 1986; Hall, 
1987). The receptors in question are the 
ß-adrenergic receptor, the muscarinic cholinergic 
receptor and the light receptor. Several regions are 
present, which because of their hydrophobicity, are 
potentially membrane spanning. These presumptive 
membrane spanning regions, or transmembrane 
segments, are linked by hydrophilic regions, form-
ing extracellular and intracellular loops. Although 
it is obvious that ligands which can not pass the 
plasma membrane bind to the hydrophilic extracel-
lular domains, preliminary evidence suggests that 
agonist-binding may also occur in the hydrophobic 
domains (Yarden et al., 1986; Ratnam et al., 1986). 
Receptor activation is thought to promote the bind-
ing between hydrophilic intracellular domains and 
a membrane-associated molecule functioning as a 
transducer. As a consequence, the transducer 
becomes activated and, in turn, acts to regulate sec-
ond messenger generating enzymes (Rodbell, 1985; 
Gilman, 1987; Litosch, 1987; Levitzki, 1987) or, in 
some cases, acts to regulate ion channels directly 
(Pfaffmger et al., 1985; Logothetis et al., 1987; 
Bourne, 1987). 
Cell surface receptors which do not need inter-
vention of a transducer and a second messenger 
generating enzyme, are receptors whose intracellu-
lar hydrophilic domains possess tyrosine kinase 
activity. Profoundly studied are the insulin receptor 
and the epidermal growth factor receptor. Upon 
receptor activation, tyrosine kinase activity increas-
es and a specific set of substrate proteins will be 
phosphorylated. 
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In addition, an autophosphorylation site is 
present as well as sites which can be phosphorylat-
ed by protein kinases present in the cytosol 
(Takayama et al., 1984; Hunter et al., 1984; Moon 
et al., 1984; Bollag et al., 1986; Nishizuka, 1986). 
Cell surface receptors which act through transducer 
molecules, can also be phosphorylated (Kelleber et 
al., 1984; Nishizuka, 1986; Lefkowitz et al., 1986). 
The presence of these phosphorylation sites is 
indicative for the existence of devices enabling the 
cell to adjust the activity of a particular receptor to 
the overall information it receives. 
This thesis deals with cell surface receptors 
which are thought to interact with transducer 
molecules. There is good evidence now for the 
existence of such functional transducing molecules 
which, after being activated by the receptor, pass 
the signal to a second membrane- associated 
molecule functioning as an amplifier. The latter 
molecule is an enzyme which generates intracellu­
lar signaling molecules or second messengers. 
These second messengers either remain associated 
with the plasma membrane or are released into the 
cytosol. A wide variety of intracellular events often 
influencing each other and leading thereby to the 
roost appropriate response, is then initiated by these 
messenger molecules. 
With regard to the amplifier molecule which is 
switched on, stimuli which bind to cell surface 
receptors can be devided into two groups: (1) stim­
uli which activate the phosphatidylinositol 
4,5-specific phosphodiesterase (PIP2 phosphodi­
esterase) and, (2) stimuli which either activate or 
inhibit adenylate cyclase. Activation of the PIP2 
phosphodiesterase results in the formation of the 
intracellular messenger molecules 
1,2-diacylglycerol and inositol 1,4,5-trisphosphate 
((1,4,5-)ІРз). Activation of adenylate cyclase leads 
to the formation of adenosine (cyclic) 
3':S'-monophosphate (cAMP). Since stimuli which 
activate the PIP2 phosphodiesterase increase also 
the free cytosolic calcium concentration, they are 
said to activate the calcium messenger system, 
whereas stimuli which increase the intracellular 
cAMP concentration activate the cAMP messenger 
system. Both messenger systems will be discussed 
in more detail and with particular interest in the 
pancreatic acinar cell, in the following sections. 
THE cAMP MESSENGER SYSTEM 
As outlined in the above section, the cAMP 
messenger system is build up of cell surface recep­
tors, a transducing system and an effector. The 
effector is the enzyme adenylate cyclase and stimu­
lation of its activity results in the conversion of 
adenosine triphosphate into adenosine (cyclic) 
3':5'-monophosphate (cAMP). In 1958 Sutherland 
and Rail were the first to discover cyclic AMP and 
in 1968 the role of cAMP as an intracellular signal­
ing molecule had been established in a number of 
honnonally-regulated physiological functions 
(Robison et al., 1968). 
The involvement of a transducing molecule in 
transmembrane signaling was first suggested by 
Rodbell et al. (1971) to explain the requirement for 
guanosine triphosphate (GTP) for hormonal activa­
tion of adenylate cyclase and because of its affinity 
for GTP the membrane-bound transducer was 
called G protein (guanine nucleotide-binding regu­
latory protein). In subsequent years, it was found 
that the requirement for GTP for hormonal regula­
tion of adenylate cyclase activity was paralleled by 
GTP-induced decreases in affinity of the hormones 
for their receptors (Maguire et al., 1976). In 
1976-1977 Cassel and Selinger demonstrated for 
the first time that hormonal stimulation increased 
GTPase activity in isolated membranes. Based on 
these and similar observations, the following model 
for hormonal regulation of adenylate cyclase activi­
ty involving G proteins has evolved. Binding of a 
ligand to its receptor induces a conformational 
change in the receptor. This change is transmitted 
through the cell membrane to the G protein, 
increasing its susceptibility to GTP. The binding of 
GTP induces another conformational change of the 
G protein enabling it to activate the catalytic sub-
unit of adenylate cyclase. Activation of the cyclase 
is terminated by the hydrolysis of GTP to GDP 
which is catalyzed by the enzyme GTPase. Dissoci­
ation of GDP occurs as a result of the rate-limiting 
process which is accelerated by interaction between 
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G protein and receptor (Gilman, 1987). Dissocia­
tion of GTP is followed by binding of GTP (GDP-
to-GTP exchange) (Levitzki, 1987). 
The activity of the catalytic subunit of adeny­
late cyclase is controlled by two different G pro­
teins, a stimulatory one (G
s
) and an inhibitory one 
(Gj). An extracellular signaling molecule which 
activates adenylate cyclase binds to a receptor 
whose action is mediated by G
s
. The stimulatory 
effect of such a stimulus can be inhibited by an 
extracellular signaling molecule which binds to a 
receptor whose action is mediated by Gj (Gilman, 
1984). 
G proteins are heterotrimers, with subunits des­
ignated α, β and γ in order of decreasing mass. The 
subunit defining the G protein appears to be the α 
subunit. The α subunits of some G proteins have 
been shown to be substrate for certain bacteria] tox­
ins. The α subunit of G
s
 is ADP-ribosylated by 
cholera toxin (Moss and Vaughan, 1977; Gill and 
Meren, 1978), whereas the α subunit of Gj is ADP-
ribosylated by pertussis toxin (Katada and Ui, 
1982a,b). Toxin-induced ADP-ribosylation of the 
α subunit of a G protein has been shown to block 
the flow of information from receptor to amplifier. 
In case of cholera toxin, in one way or another, the 
off-reaction which terminates adenylate cyclase 
activation is blocked, leading to continuous activa­
tion of the cyclase. On the other hand, pertussis 
toxin-induced modification of the α subunit of G¡ 
blocks the on-reaction, in one way or another, thus 
preventing inhibitory extracellular signaling 
molecules from exerting their inhibitory action on 
the activity of adenylate cyclase. 
Hormonal stimulation of adenylate cyclase 
activity leads to enhanced formation of cAMP. 
Depending on the activity of the enzyme catalyzing 
the hydrolysis of cAMP to AMP, the cellular 
cAMP level will be increased and cAMP-
dependent protein kinases will be activated. Each 
cAMP-dependent kinase or Α-kinase has two parts, 
one acting as a regulatory subunit and one acting as 
a kinase. Binding of cAMP to the regulatory sub-
unit results in the dissociation of both subunits and 
it is the liberated catalytic subunit which is enzy-
matically active and which will catalyze the phos­
phorylation of a specific set of substrate proteins. 
Phosphorylation of these proteins will induce con­
formational changes of these proteins and their bio­
logical activities will change. However, in most 
biological systems, including the pancreatic acinar 
cell, the steps leading from protein phosphorylation 
to the final cellular response are still poorly under­
stood. 
The cAMP messenger system in the pancreatic 
acinar cell 
Originally, the presence of a membrane-bound 
adenylate cyclase in the pancreas was shown in 
particulate fractions of homogenates of the whole 
organ (Rutten et al., 1972; Marois et al., 1972; 
Kempen et al., 1974; Deschodt-Lanckman et al., 
1974; Schulz et al., 1974) and it was not before 
1977 that a hormone-sensitive adenylate cyclase 
was shown to be present in particulate fractions of 
pancreatic acinar cells (Kempen et al., 1977a; Long 
and Gardner, 1977). 
Adenylate cyclase activity in particulate frac­
tions of pancreatic tissue is stimulated by secretin, 
vasoactive intestinal polypeptide (VIP) and the 
C-terminal octapeptide of cholecystokinin 
(CCK-8). 
In all species tested, CCK-8 has been shown to 
stimulate adenylate cyclase activity in a particulate 
fraction of homogenates of the whole pancreas 
(Rutten et al., 1972; Marois el al., 1972; Kempen et 
al., 1974; Deschodt-Lanckman et al., 1974; Schulz 
et al., 1974; Bonting et al., 1977; Sjodin and Gard­
ner, 1977; De Pont et al., 1979). This suggests the 
presence of cholecystokinin receptors able to acti­
vate adenylate cyclase via G
s
 and indeed Lambert 
et al. (198S) were able to solubilize cholecystokinin 
receptors associated with both G
s
 and G¡ from rat 
pancreatic plasma membranes as a reversible com-
plex with 125I-labelled CCK-9. Moreover, they 
showed that the GTP-induced increase in dissocia-
tion rate was preserved in the soluble state, indicat-
ing that the solubilized CCK receptors remained 
functionally coupled with the guanine nucleotide 
binding site modulating the affinity for CCK. 
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In order to account for the action of cholecys-
tokinin on enzyme secretion from pancreatic acini, 
the hypothesis has been developed that pancreatic 
acinar cells possess one single class of cholecys-
tokinin receptors and each receptor has two dis­
tinct, interacting binding sites, one with a high 
affinity for cholecystokinin and one with a low 
affinity for cholecystokinin (Collins et al., 1981a). 
The high affinity binding site has been associated 
with enzyme secretion, whereas the low affinity 
binding site has been associated with activation of 
adenylate cyclase. 
In the early studies mentioned above, it was 
generally found that in particulate fractions of pan­
creatic tissue CCK-8 increased adenylate cyclase 
activity equally well and sometimes even better 
than secretin or VIP. For instance, in a comparative 
study it was found that CCK-8 stimulated adeny­
late cyclase activity in all species tested, whereas 
secretin was active in guinea pig, cat and rat, but 
not in mouse and rabbit (De Pont et al., 1979). 
Studies in which the binding of 125l-VIP and 
125i_Secretm was measured, revealed that the guin­
ea pig pancreatic acinar cell has two functionally 
distinct classes of receptors each of which interact 
with VIP and secretin. One class has a high affinity 
for VIP and a low affinity for secretin (VIP-
preferring receptors); the other class has a high 
affinity for secretin and a low affinity for VIP 
(secretin-prefening receptors) (Gardner and 
Jensen, 1981; Jensen and Gardner, 1981). Using 
isolated pancreatic acinar cells of the guinea pig, it 
has been shown that occupation of VIP-preferring 
receptors by secretin or VIP leads to the formation 
of cAMP and increased enzyme secretion, whereas 
occupation of secretin-prefening receptors by 
secretin or VIP, despite significant increases in 
cAMP does not lead to enhanced enzyme secretion 
(Jensen et al., 1981; Kaufman et al., 1982). These 
observations have been explained by compartimen-
talizalion of cAMP. Only the cAMP that is pro­
duced upon activation of VIP-preferring receptors 
is in the appropriate compartment to cause stimula­
tion of enzyme secretion (Gardner et al., 1982). In 
addition, it has been suggested that the cAMP 
formed in response to occupation of secretin-
prefening receptors is involved in stimulation of 
fluid and electrolyte secretion from pancreatic aci­
nar cells (Hootman et al., 1983). 
In the pancreatic acinar cell of the rat, the pic­
ture is somewhat different and four distinct classes 
of receptors have been recognized. One class has a 
high affinity for VIP and does not interact with 
secretin. Occupation leads to the formation of 
cAMP and to stimulation of enzyme secretion. A 
second class has low affinities for secretin and VIP 
and occupation does not lead to cAMP formation 
or enzyme secretion. A third class has a high affini­
ty for secretin and does not interact with VIP, and 
occupation leads to cAMP formation and enzyme 
secretion. Finally, a fourth class has low affinity for 
secretin and does not interact with VIP. Occupation 
of these secretin receptors leads to enhanced 
enzyme secretion by a mechanism not mediated by 
cAMP (Bisonnette et al., 1984). The latter observa­
tion may be explained by the recent observation of 
Trimble et al. (1987a,b) that in rat pancreatic acinar 
cells secretin, but not VIP, in addition to its stimu­
latory effect on acinar cell adenylate cyclase, stim­
ulates the production of (1,4,5)ІРз and increases 
the free cytosolic calcium concentration. 
In general secretin, VIP and cholecystokinin 
readily stimulate adenylate cyclase activity in par­
ticulate fractions of pancreatic tissue. However, 
increases in pancreatic acinar cell cAMP concen­
tration, evoked by the above secretagogues, are 
much more difficult to measure and whereas slight 
increases are measured in response to secretin or 
VIP (Gardner et al., 1982), no increases are mea­
sured in response to CCK-8. Only when a suitable 
inhibitor of cyclic nucleotide phosphodiesterase 
activity is present, small ССК-8-induced increases 
in cAMP concentration can be observed (Kempen 
et al., 1977a,b; Renckens et al, 1980; Gardner el 
al., 1983). 
As mentioned already, both in guinea pig and 
in rat, secretin and VIP stimulate enzyme secretion 
from pancreatic acinar cells. However, in the guin­
ea pig, VIP already maximally stimulated pancreat­
ic enzyme secretion at concentrations which did 
not lead to measurable increases in cellular cAMP 
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concentration (Gardner et al., 1983). Yet, adenylate 
cyclase activity appeared to be increased since in 
the presence of an inhibitor of cyclic nucleotide 
phosphodiesterase activity, marked increases in 
cAMP were measured as well as marked increases 
in enzyme secretion. On the other hand, secretin 
stimulated enzyme secretion only at concentrations 
at which measurable increases in acinar cell cAMP 
concentration occurred. 
Also in the rat, secretin and VIP stimulate pan­
creatic enzyme secretion, but whereas both secreta-
gogues increase the acinar cell cAMP concentra­
tion to similar levels, secretin is much more 
efficacious than VIP as a secretory agent (Heisler 
et al., 1974; Vandenneers et al., 1984; Bisonnette 
et al., 1984; Dehaye et al., 1985). 
In other species, like dog, cat and mouse, 
secretin has been shown to increase cAMP, without 
having a stimulatory effect on pancreatic enzyme 
secretion (Robberecht et al., 1977), whereas in 
another study, secretin did not stimulate adenylate 
cyclase activity in a particulate fraction of mouse 
and rabbit, but did stimulate enzyme secretion from 
cat pancreatic tissue (De Pont et al., 1979). 
The presence of a hormone-sensitive adenylate 
cyclase in pancreatic acinar cells suggests the 
involvement of cAMP in the mechanism of action 
of the respective hormones. In order to establish a 
second messenger function for cAMP it has to be 
shown, that an increase in cellular cAMP concen­
tration alone is sufficient to lead to the response. 
There are several ways to increase the acinar 
cell cAMP concentration without receptor activa­
tion. For instance inhibitors of cyclic nucleotide 
phosphodiesterase activity such as theophylline, 
3-isobutyl-l-methylxanlhine (ШМХ) or Ro 
20-1724, can be used to prevent enzymatic break­
down of cAMP formed under unstimulated condi­
tions. Another way to increase the intracellular 
cAMP concentration, is the use of lipophilic 
derivatives of cAMP such as dibutyryl cAMP or 
8-bromo с AMP, which easily pass the plasma 
membrane and bypass receptor activation. In 
mouse and rabbit, enzyme secretion increased in 
response to dibutyryl cAMP and inhibitors of 
cyclic nucleotide phosphodiesterase activity (Kulka 
and Steralicht, 1968; Ridderstap and Bonting, 
1969; Malamud, 1972). In guinea pig, IBMX 
increased the acinar cell cAMP concentration and 
stimulated enzyme secretion (Gardner et al., 1982). 
And in the latter species, enzyme secretion was 
also enhanced by dibutyryl cAMP and 8-bromo 
с AMP, which had to be used, however, in relative­
ly high concentrations (Gardner and Jackson, 
1977). Also in the rat, exogenous derivatives of 
cAMP stimulated enzyme secretion (Stock et al., 
1977; Bauduin et al., 1977). 
Increases in acinar cell cAMP concentration 
can also be obtained by activating post-receptor 
elements of the cellular adenylate cyclase system. 
As has been discussed already, cholera toxin modi­
fies the stimulatory G protein of the adenylate 
cyclase system in such a way that it will perma­
nently activate the cyclase. In the rat, pretreatment 
of pancreatic slices with cholera toxin resulted in 
an increase in adenylate cyclase activity when 
assayed in a particulate fraction prepared from 
toxin-treated slices (Kempen et al., 1975). How­
ever, cholera toxin topically applied to the cannu-
lated rat pancreas, neither affected basal enzyme 
secretion nor cholecystokinin-stimulated enzyme 
secretion (Kempen et al., 1975; Smith and Case, 
1975). Similar observations were reached for the 
perfused cat pancreas (Smith and Case, 1975). 
However, using acini isolated from the rat pan­
creas, it was found that pretreatment with cholera 
toxin besides increasing the acinar cell cAMP lev­
el, significantly potentiated CCK-8-induced 
enzyme secretion (Pan et al., 1982). 
In the guinea pig, pretreatment of pancreatic 
acini with cholera toxin increased both the cellular 
cAMP concentration and enzyme secretion, where­
as the cAMP response to secretin or VIP was 
markedly augmented in toxin-treated acini (Gard­
ner and Rottman, 1979). 
Forskolin, a diterpene extracted from the roots 
of Coleus forskohlii interacts directly and/or indi­
rectly (through a G protein) with the catalytic sub-
unit of adenylate cyclase, thereby increasing its 
activity and thus providing another powerful tool to 
activate the cyclase at a level beyond receptor acti­
vation (Seamon and Daly, 1981,1983; Ross, 1982; 
Wong and Martin, 1983). In the rat, forskolin 
slightly increased enzyme secretion, whereas it 
markedly potentiated the secretory response to 
CCK-8 (Heisler, 1983). 
Summary 
(1) The pancreatic acinar cell contains a 
membrane-bound adenylate cyclase which, in a 
particulate fraction, is stimulated by cholecys-
tokinin, by VIP and apparently with some excep-
tions (mouse and rabbit) by secretin. 
(2) In guinea pig and rat, cholera toxin increased 
the acinar cell cAMP level, indicating that Gs is 
present. 
(3) In intact acinar cells, secretin and VIP, but not 
cholecystokinin, increase cAMP when measured in 
the absence of suitable inhibitors of cyclic 
nucleotide phosphodiesterase activity. 
(4) Similar increases in cAMP concentration 
induced by secretin or VIP do not lead to similar 
secretory responses and species differences are 
observed. 
Aims of this part of the investigation 
Using rabbit pancreatic acini we have studied 
whether forskolin-induced increases in acinar cell 
cAMP concentration lead to enhanced enzyme 
secretion (Chapter 2). 
Despite large increases in cellular cAMP con-
centration, enzyme secretion was not stimulated. 
However, the stimulatory effect of the C-terminal 
octapeptide of cholecystokinin was markedly 
potentiated and we concluded that the role of 
cAMP in pancreatic enzyme secretion is rather a 
modulatory one. 
In a previous study it was found that secretin 
did not stimulate adenylate cyclase activity in a 
particulate fraction of the rabbit pancreas. This has 
led us to investigate whether secretin is able to 
increase cAMP in intact rabbit pancreatic acinar 
cells (chapter 9). 
It was found that secretin, both in the absence 
and in the presence of an inhibitor of cyclic 
nucleotide phosphodiesterase activity, increased 
the the acinar cell cAMP level. However, enzyme 
secretion, even in the presence of the phosphodi-
esterase inhibitor, when the cAMP level in 
response to secretin was markedly increased, was 
not enhanced. We showed also that VIP increased 
the acinar cell cAMP level and again no stimulato-
ry effect on enzyme secretion was observed. It is 
not clear yet why in the earlier study secretin did 
not stimulate adenylate cyclase activity in a partic-
ulate fraction of the rabbit pancreas. 
Evidence for the presence of G¡ was sought by 
treating pancreatic acini with pertussis toxin and 
measuring cAMP production both under unstimu-
lated and stimulated conditions (chapter 3). 
Pretreatment of rabbit pancreatic acinar cells 
with pertussis toxin facilitated ССК-8-induced 
activation of adenylate cyclase. This observation 
led to the hypothesis that CCK-8, by activating the 
calcium messenger system, activates Gj. Activation 
of G¡ then leads to inhibition of ССК-8-induced 
activation of the cyclase via G
s
. Experiments were 
developed to test this hypothesis (chapter 9). 
THE CALCIUM MESSENGER SYSTEM 
Back in 19S3, Hokin and Hokin were the first 
to demonstrate stimulus-induced changes in phos­
pholipid metabolism (phospholipid effect). How­
ever, it was not before methods became available 
to separate individual phospholipids, that the phos­
pholipids showing the phospholipid effect were 
determined. It was found that in pigeon pancreas 
slices, cholinergic stimulation enhanced incorpora­
tion of 32p. i
n
 phosphalidic acid and phos-
phatidylinositol (phosphatidylinositol effect) 
(Hokin and Hokin, 1955,1958). Subsequently, it 
was found that cholinergic stimulation of avian salt 
gland tissue, prelabelled with [^CJglycerol, did 
not result in increased incorporation of label into 
phosphatidic acid and it was concluded that the 
increased incorporation of 32pj ц^о phosphatidic 
acid was not due to de novo synthesis of this phos­
pholipid but to increased phosphorylation of dia-
cylglycerol (Hokin and Hokin, 1965). The hypothe-
- a -
sis was developed that upon cholinergic stimulation 
phosphatidylinosilol was hydrolysed in a phospho-
lipase C-like manner, yielding diacylglycerol and 
inositol monophosphate and that the diacylglycerol 
produced was rapidly phosphorylated by the 
enzyme diacylglycerol kinase. Finally, phospha-
tidic acid was converted back to phosphatidylinosi­
lol by the sequential actions of CTP-phosphatidic 
acid cytidyl transferase and phosphatidylinosilol 
synthase. The scheme was called the 
phosphatidylinositol-phosphatidic acid cycle. 
As to the physiological relevance of the 
phosphatidylinosilol- phosphatidic acid cycle, it 
was not before 1975 that Micheli presented an 
exhaustive list of tissues which showed the phos­
phatidylinosilol effect in response to a wide variety 
of stimuli, showing that it were the very same 
receptors which mediated changes in free cytosolic 
calcium concentration and phosphatidylinositol 
metabolism. Micheli then postulated (1975) that 
agonist-induced breakdown of phosphatidylinosilol 
might play a key role in the reactions that couple 
receptor activation to changes in free cytosolic cal­
cium concentration. 
Next, it was found that in most tissues, includ­
ing the exocrine pancreas (Hokin-Neaverson, 1974; 
Parese et al., 1980; 1981a,b; 1982a,b), stimulation 
resulted in a substantial decrease in mass of phos­
phatidylinositol. This decrease in mass of phos­
phatidylinositol was shown to be calcium-
dependent and to be mimicked by calcium 
ionophores, which finding was apparently in con­
flict with the hypothesis put forward by Micheli 
(1975). On (he other hand, the increased labelling 
of phosphatidic acid and phosphatidylinositol were 
found to occur also in the absence of extracellular 
calcium. 
Finally, in a wide variety of tissues, including 
iris smooth muscle (Abdel-Latif et al., 1977; 
Akhtar and Abdel-Latif, 1980), liver (Kirk, 1982, 
Creba et al., 1983), parotid gland (Putney, 1982; 
Weiss et al., 1982; Downes and Wusteman, 1983), 
platelets (Billah and Lapetina, 1982), exocrine pan­
creas (Putney el al., 1983; Orchard et al., 1984) and 
insect salivary gland (Berridge, 1983; Litosch et 
al., 1984), agonist-induced increases in 
32p-labelling of phosphatidic acid and phos­
phatidylinositol were shown to be preceded by 
stimulated breakdown of ^f-preUbelled phos­
phatidylinositol 4,5-bisphosphate (ΡΙΡ2) rather 
than of phosphatidylinositiol. Receptor-mediated 
hydrolysis of PIP2 was independent of calcium and 
a second messenger function for the products 
formed, diacylglycerol (Nishizuka, 1984) and inos­
itol trisphosphate (Berridge el al., 1983; Downes 
and Wusteman, 1983), is generally accepted now 
(Benidge, 1984,1985,1987a,b; Berridge and Irvine, 
1984; Nishizuka, 1986). 
For a long, time it was poorly understood how 
receptors were coupled to the PIP2 specific phos­
phodiesterase. In 1982 (Goodhardt et al.), prelimi­
nary evidence was provided that a G protein may 
also function in signal transduction for calcium-
mobilizing receptors. Analogous to observations 
with the adenylate cyclase system, il was found 
that GTP reduced the affinity of noradrenaline for 
the α,-adrenergic receptor. Somewhat later, it was 
found that in several cell types pretreatment with 
pertussis toxin, known to modify the G proteins G¡, 
G0 and transducin (Gilman, 1984; Ui, 1984), inhib-
ited subsequent stimulation with calcium-
mobilizing stimuli, suggesting the involvement of a 
G protein sensitive to pertussis toxin (Molski et al., 
1984; Nakamura and Ui, 1985; Brandt et al., 1985; 
Bradford and Rubin, 1985). However, in other tis-
sues no such effect of pertussis toxin was found 
(Masters et al., 1985; Lynch et al., 1986; Schimmel 
and Elliott, 1986). Stimulatory effects of GTP (or 
non-hydrolysable analogues of GTP) on secretion 
in peimeabilized mast cells (Gomperts, 1983) and 
diacylglycerol formation in peimeabilized platelets 
(Haslam and Davidson, 1984) are also in line with 
the hypothesis that a G protein mediates between 
receptor and PIP2 phosphodiesterase. Finally, it 
has been shown that in isolated membranes of sev-
eral cell types (summarized by Cockcroft, 1987), 
guanine analogues alone and in combination with 
agonists stimulate the phospholipase C-like hydrol-
ysis of PIP2. However, the G protein of the 
phosphatidylinositol/calcium system, termed Gp, 
has not been purified and sequenced yet. 
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The (J ,4¿-)1P¡Icalcium pathway 
In 1983, Streb et al., using permeabilized pan-
creatic acinar cells, were the first to show that one 
of the breakdown products of receptor-mediated 
cleavage of PIP2, inositol 1,4,5-trisphosphate 
((1,4,5-)ІРз), released calcium from the intracellu­
lar store they had characterized before as vesicular, 
ATP-dependent and non-mitochondrial. Similar 
observations have now been reported for many oth­
er cell types (Berridge, 1987a: Table 1) and it is 
generally accepted now that this intracellular 
agonist-sensitive calcium pool is the endoplasmic 
reticulum, or at least part of these internal mem­
brane systems that actively sequester calcium 
(Streb et al., 1984; Taylor and Putney, 1985; Biden 
et al., 1986). 
Only shortly thereafter, it was found that much 
of the inositol trisphosphate that accumulated upon 
cholinergic stimulation of parotid glands, prela-
belled with [^HJinosilol, was inosítol 
1,3,4-trisphosphate ((1,3,4-)ІРз) rather than 
(1,4,5-)ІРз (Irvine et al., 1984). However, whereas 
the 1,4,5-isomer increased within seconds after 
stimulation, a time lag was observed in the forma­
tion of the l,3,4-isomer (Irvine et al., 1985; 
Burgess et al., 1985). In addition to both inositol 
trisphosphates, inositol 1,3,4,5- tetrakisphosphate 
((1,3,4,5-)IP4) was found to be formed nearly as 
rapidly as (1,4,5-)ІРз (Batty et al., 1985). Finally, 
in GH4 cells prelabelled with [3H]inositol, also the 
presence of inositol pentaphosphate and inositol 
hexaphosphate was shown (Heslop et al., 1985). 
However, the concentrations of the latter inositol 
polyphosphates did not markedly change upon 
stimulation. 
In addition to the inositol phosphates men­
tioned above, cyclic inositol phosphates have also 
been found to be increased after stimulation with 
calcium-mobilizing stimuli (Wilson et al., 1985). 
However, whether these compounds are involved 
in signal transduction remains an open question 
(Micheli, 1986a). 
Recently, it has been suggested that inositol 
tetrakisphosphate, which does not release calcium 
from intracellular stores (Irvine et al., 1986a), may 
function to control calcium entry across the plasma 
membrane (Hansen et al., 1986; Irvine and Moor, 
1986,1987; Micheli, 1986b). Moreover, Petersen 
recently provided evidence that in the lacrimal 
gland acinar cell only in combination, (1,4,5-ІР)з 
and(l,3,4,5-)IP4 mimicked the acelylcholine-
induced increase in plasma membrane permeability 
for calcium (Morris et al., 1987). However, it has 
also been suggested that the (lAS-JIP^-induced 
discharge of the intracellular calcium pool is the 
trigger for the entry of external calcium (Putney, 
1986). In addion, it has been suggested that the 
receptor-mediated decrease in PIP2 leads to inhibi­
tion of the plasma membrane calcium pump, which 
seems to require phosphoinositides for optimal 
functioning (Charest et al., 1985). As a conse­
quence, passive influx of calcium exceeds active 
extrusion. 
With respect to the (1,4,5-)ІРз/саІсіит path­
way it is the current working hypothesis that 
receptor-mediated phospholipase C-like hydrolysis 
of PIP2 yields (1,4,5-)ІРз. The 1,4,5-isomer of IP3 
releases calcium from the endoplasmic reticulum 
and is rapidly converted to (1,3,4,5-)IP4 (Irvine el 
al., 1986b), a process which is enhanced by calci­
um (Rossier et al., 1986,1987). Inositol 
1,3,4,5-tetrakisphosphate, in tum, may act as the 
intracellular messenger coupling receptor activa­
tion to increased plasma membrane permeability 
for calcium. Inositol tetrakisphosphate is either 
phosphorylated to inositol pentaphosphate, or 
dephosphorylated to (1,3,4-)ІРз. Next, the 
1,3,4-isomer is dephosphorylated, leading to the 
formation of mositol 1,4-bisphosphosphate 
((1,4-)IP2). However, it has to be taken into 
account that part of the 1,4,5-isomer appears to be 
dephosphorylated directly. Further breakdown of 
inositol 1,4-bisphosphate occurs both via inositol 
1- and inositol 4- monophosphate. Finally, the 
monophosphates are dephosphorylated to yield 
inositol, which is then used for the resynthesis of 
phosphatidylinositol, 
phosphatidylinositolmonophosphate and 
phosphatidylinositolbisphosphate. 
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The diacylglycerollprotein kinase С pathway 
As mentioned already, the receptor-mediated 
breakdown of PIP2 yields both the hydrophilic 
(1,4,5-)ІРз molecule, which is rapidly released into 
the cylosol, and the lipophilic diacylglycerol 
molecule, which remains within the membrane 
where it is biologically active and where it is 
metabolized. Diacylglycerol can be metabolized 
either by a kinase, yielding phosphatidic acid 
(Hokin, 1985), or by a lipase, yielding arachidonic 
acid and monoacylglycerol (Hasegawa-Sasaki, 
198S). Phosphatidic acid is converted via CMP-
phosphatidate to phosphatidylinositol. Arachidonic 
acid is precursor in the formation of leukotrienes 
and prostaglandins, which may also have second 
messenger functions (Macphee et al., 1984). 
In 1977 Inoue et al. isolated a protein kinase, 
which could only be activated by the calcium-
dependent thiol protease. In mostjf not all, mam­
malian tissues the enzyme is present, where it is 
recovered mainly from the soluble fraction in its 
inactive form. To prevent proteolytic activation by 
calpain (a calcium-dependent protease), the 
enzyme is usually extracted in the presence of high 
concentrations of calcium-chelating agents. As a 
consequence, the exact intracellular localization of 
the enzyme is unknown. However, recent immuno-
cytochemical studies, using monoclonal antibodies, 
have revealed that the localization of the enzyme 
varies with cell types, but that the enzyme is poorly 
represented in the cell nucleus (Nishizuka, 1986). 
In 1979 it was found by Takai et al. that the 
enzyme, isolated in the presence of calcium chela­
tors, could be activated, other than proteolytically, 
by phospholipids, especially phosphatidylserine 
(Nishizuka, 1983,1986; Takai et al., 1984), in the 
presence of calcium (Takai et al., 1979a). Of major 
importance was the observation (Takai et al., 
1979b), that diacylglycerol dramatically increased 
the affinity of the calciumlphospholipid-dependent 
protein kinase (C) for calcium. A second major 
breakthrough was the observation that the above 
action of diacylglycerol was completely mimicked 
by the tumor promoting phorbol esters, present in 
oil expressed from the seeds of the tree Croton 
tiglium (Castagna et al., 1982). In subsequent 
years, these phorbol esters proved to be powerful 
tools in investigating the role of protein kinase С in 
signal transduction, since they enabled activation 
of the kinase in intact cells without receptor activa­
tion. Recently, Nishizuka (1986) presented an 
exhaustive list of proposed substrate proteins of 
protein kinase С and of possible roles of protein 
kinase С in cellular responses. 
By inducing the hydrolysis of PIP2, calcium-
mobilizing agonists stimulate the generation of two 
different intracellular signaling molecules, each 
activating a specific sequence of intracellular 
events. Recently, evidence is accumulating (hat 
activation of protein kinase С both positively and 
negatively influences cellular processes induced by 
calcium-mobilizing agonists as well as by agonists 
which stimulate the formation of cAMP (Berridge, 
1987a). Some of these effects will be discussed in 
more detail in the next section, which deals with 
the calcium messenger system in pancreatic acinar 
cells. 
The calcium messenger system in the pancreatic 
acinar cell 
The most studied stimulants for pancreatic 
enzyme secretion are the neurotransmitter acetyl­
choline and the peptide hormone cholecystokinin 
(formerly: pancreozymin). Both secretagogues are 
of the calcium- mobilizing type. In addition, pan­
creatic enzyme secretion can be stimulated by other 
calcium-mobilizing stimulants. The calcium- mobi­
lizing secretagogues gastrin and caerulein (a 
decapeptide isolated from the skin of the amphib­
ian Hyla caerulea ), have structural analogies with 
cholecystokinin. The calcium- mobilizing stimu­
lants bombesin (amphibian skin), litorin (amphib­
ian skin), physalaemin (amphibian skin) and ele-
doisin (isolated from the posterior salivary gland of 
the octopod Eledone moschata ), are dissimilar to 
cholecystokinin (Schulz and Stolze, 1980; Jensen 
and Gardner, 1981). 
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Normally, when pancreatic exocrine tissue is 
incubated and enzyme secretion is measured, there 
is a certain rate of basal enzyme secretion (Beau-
doin and Grondin, 1987; Arvan and Castle, 1987). 
When one of the above stimulants is added, and 
medium amylase activity is measured, a rapid 
increase is observed within minutes. During the 
first 5 to 10 min, the rate of enzyme secretion is 
high (initial rapid phase of enzyme secretion), 
thereafter, it rapidly declines but remains elevated 
for the time the secretagogue remains present (sus-
tained phase of enzyme secretion) (Gardner and 
Jensen, 1981; Pandol et al, 1985a,b). 
A role for intracellular calcium ions in the 
mechanism of action of the above-mentioned 
calcium-mobilizing pancreatic secretagogues is 
deduced from several observations. 
First, upon preincubation of pancreatic acini in 
calcium-free medium, the rate of enzyme secretion 
in response to these secretagogues is increased for 
some minutes (initial phase) but then rapidly 
declines to preslimulatory levels, indicating that 
long-term secretion (sustained phase) is lost 
(Scheele and Haymovits, 1979; Williams, 1980; 
Pandol et al., 1985b). Similar observations were 
reached with the isolated rabbit pancreas (Schreurs 
et al., 1976). Moreover, the latter study showed that 
upon readdition of calcium to the incubation medi-
um, enzyme secretion of the isolated pancreas, 
stimulated in the absence of extracellular calcium, 
markedly increased, indicating that the sustained 
response was restored. 
Second, secretion can be stimulated by calcium 
ionophores, like A23187 and ionomycin. These 
calcium ionophores not only cause a large influx of 
extracellular calcium (Gardner et al., 1980) but also 
cause mobilization of cellular calcium (Gardner 
and Jensen, 1980). The latter ability of these 
ionophores explains their stimulatory effect during 
the fust 5-10 min in the absence of extracellular 
calcium (Gardner et al., 1979, 1980; Pandol et al., 
1985b). 
Third, the secretagogues mentioned above 
cause a rapid efflux of ^Ca^+ from prelabelled 
pancreatic acinar cells, even in the absence of 
extracellular calcium (Case and Clausen, 1973; 
Matthews et aL, 1973; Kondo and Schulz, 1976a; 
Schreurs et al., 1976), suggesting that intracellular-
ly accumulated calcium is released (Williams, 
1980; Schulz, 1980). Stimulation in the presence of 
radioactive calcium showed an increased influx, 
indicating that in addition to the release of intracel-
lularly stored calcium, the permeability of the plas-
ma membrane for calcium is increased (Kondo and 
Schulz, 1976a,b; Renckens et al., 1978; Dormer et 
al., 1981). 
Fourth, using calcium-selective microelec-
trodes (Stark and ODoherty, 1982), the calcium-
activated photoprotein, aequorin (Dormer, 1983) 
and the calcium-selective fluorescent indicator, 
quin2 (Ochs et al., 1983,1985; Pandol et al, 1985a; 
Bnizzone et al., 1986; Ansah et al., 1986), rapid 
increases in the free cytosolic calcium concentra-
tion in response to the above secretagogues could 
be directly visualized. Measurements with quin2 
showed a rapid, but transient (2-3 min), increase in 
free cytosolic calcium concentration. During this 
initial period, calcium is thought to mediate the 
rapid and extracellular calcium-independent phase 
of enzyme secretion (Pandol et al., 1985a). 
Fifth, using permeabilized pancreatic acinar 
cells. Knight and Koh (1984) showed that enzyme 
secretion increased dose-dependently with the 
medium calcium concentration. 
The above experiments strongly suggest the 
involvement of calcium in the mechanism of action 
of calcium-mobilizing pancreatic secretagogues. 
Calcium-mobilizing secretagogues dose-
dependently stimulate enzyme secretion. However, 
once the maximally stimulatory concentration is 
reached the magnitude of the secretory response 
decreases again as the concentration of secreta-
gogue increases further. This phenomenon is 
termed restricted stimulation. In case of cholecys-
tokinin as a stimulant, the hypothesis has been 
developed that this submaximal stimulation by 
supramaximal concentrations of secretagogue is 
mediated by a receptor with a low affinity for the 
secretagogue (Collins et al., 1981a). On the other 
hand, (sub)maximal stimulation by (sub)maximal 
concentrations of cholecystokinin is thought to be 
mediated by a receptor with a high affinity for the 
secretagogue. According to this hypothesis, occu-
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pation of the high affinity site is a prerequisite for 
occupation of (he low affinity site. 
When pancreatic acini are first incubated in the 
presence of a supramaximal concentration of a 
calcium-mobilizing secretagogue, washed to 
remove free secretagogue, and then reincubated, 
two phenomena occur. First, enzyme secretion is 
still stimulated and this phenomenon has been 
termed residual stimulation (Collins et al., 
1981a,b). In case of cholecystokinin, residual stim­
ulation is thought to be mediated by the low affini­
ty site. Second, subsequent stimulation by the same 
or any other calcium-mobilizing secretagogue, but 
not by secretagogues which increase cAMP, is 
inhibited (Abdelmoumene and Gardner, 1980). 
This phenomenon has been termed desensitization. 
Recently, Pandol et al. (1985a) showed that 
when the cholinergic receptor antagonist, atropine, 
and the secretagogue cholecystokinin were added 
simultaneously to acini preincubated in the pres­
ence of a supramaximal concentration of the 
cholinergic agonist, carbachol, both the initial rapid 
phase of cholecystokinin-induced enzyme secretion 
and the cholecystokinin-induced increase in free 
cytosolic calcium concentration were abolished. 
They concluded that calcium did not increase as a 
result of carbachol-induced depletion of the intra­
cellular calcium store and they suggested that this 
might be the cause for agonist-induced desensitiza­
tion. 
As discussed already, the ability of pancreatic 
secretagogues of (he calcium-mobilizing type to 
stimulate the breakdown of PIP2 l e d t 0 ^e discov­
ery of the phospholipid effect by Hokin and Hokin 
(1953). More recently, these decreases in PIP2 
have been shown to take place within seconds after 
the onset of stimulation (Putney et al., 1983; 
Orchard et al., 1984; Pandol et al., 1985b) and are 
generally accepted now to preceed the 
secretagogue-induced increase in free cytosolic cal­
cium concentration. In addition, secretagogue-
induced increases in (1,4,5-)ІРз and (1,3,4,5-)IP4 
have also been shown to be fast enough to preceed 
the increase in cytosolic calcium concentration 
(Streb et al., 1985; Menitt et al., 1986a; Trimble et 
al., 1987a; Doughney et al., 1987). And finally, 
using permeabilized pancreatic acinar cells. Streb 
et al. (1983) were the first to show that (1,4,5-)ІРз 
releases actively stored calcium. 
Concerning the involvement of a G protein in 
secretagogue-induced PIP2 hydrolysis, Merritt et 
al. recently described that a non-hydrolysable GTP 
analogen stimulated the formation of inositol 
trisphosphate in electrically permeabilized pancre­
atic acinar cells prelabelled with [^H] inositol (Mer­
ritt et al., 1986b). In addition, Williams and 
McChesney reported that cholecystokinin induced 
the interaction of its receptor with a G protein 
(Williams and McChesney, 1987). 
Phorbol esters, thought to activate protein 
kinase С in a diacylglycerol-like manner, have 
been used in a wide variety of cell types to investi­
gate the role of protein kinase С in stimulus 
response coupling (Nishizuka, 1986). The presence 
of the calcium-activated, phospholipid-dependent 
protein kinase (C) in the pancreatic acinar cell has 
recently been shown by Noguchi el al. (1985). 
Using an enriched preparation of protein kinase C, 
which contained no cyclic nucleotide- dependent or 
calcium-dependent kinase activity, they showed an 
absolute requirement for calcium and phospholipid 
for its activation, and the phorbol ester, 
12-O-tetradecanoylphorbol 13-acetate (TPA), 
markedly increased its affinity for calcium. In the 
presence of TPA, the enzyme was active at submi-
cromolar calcium concentrations. When applied to 
intact pancreatic acini the phorbol esters TPA and 
phorbol dibutyrate significantly stimulate pancreat­
ic enzyme secretion, without affecting the free 
cytosolic calcium concentration (Merritt and 
Rubin, 1985; Pandol et al., 1985a), suggesting an 
important role for protein kinase С in the mecha­
nism of action of calcium-mobilizing pancreatic 
secretagogues (De Pont and Fleuren-Jakobs, 1984; 
Menitt and Rubin, 1985; Nogochi et al., 1985; 
Pandol et al., 1985a). 
Receptor-mediated breakdown of PIP2 leads to 
the formation of two second messenger molecules, 
diacylglycerol and (1,4,5-)ІРз, which has led to the 
dual signal hypothesis of cell activation (Nishizu­
ka, 1984:1986; Kikkawa and Nishizuka, 1986; 
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Berridge, 1985,1987a,b). In the pancreatic acinar 
cell, activation of either of both limbs of the path­
way, bifurcating at the level of receptor-mediated 
PIP2 breakdown, leads to an increase in enzyme 
secretion. This is concluded from experimental 
data obtained with calcium ionophores and phorbol 
esters, which activate the (1,4,5-)ІРз/са1сіит limb 
and the diacylglycerol/protein kinase С limb, 
respectively, without receptor activation. 
In the guinea pig, maximal phorbol ester-
induced enzyme secretion is comparable to maxi­
mal secrelagogue-induced secretion (Pandol et al., 
1985a). On the other hand, in rat (Merritt and 
Rubin, 1985) and rabbit (De Pont and Fleuren-
Jakobs, 1984), maximal phorbol ester-induced 
secretion is significantly less. Moreover, in all 
three species, although less obvious in rat, 
ionophore-induced secretion is less than maximal 
secretagogue-induced secretion. In combination, 
the stimulatory effects of calcium ionophores and 
phorbol esters are additive, indicating that both 
limbs of the bifurcating calcium messenger system 
act synergistically in generating the final response. 
This synergistic role of the two routes has been 
shown for many biological systems (Nishizuka, 
1986; Kikkawa and Nishizuka (1986) Berridge, 
1987a). 
Recently, activation of the С kinase route has 
been shown to lead to inhibition of agonist-induced 
PIP2 breakdown, calcium mobilization and cellular 
responses (Zavoico et al., 1985; Drummond, 1985; 
Brock et al., 1985; Watson and Lapetina, 1985; 
Kojima et al., 1986; Tohmatsu et al., 1986). In hep-
alocytes, this effect of phorbol esters was found to 
be paralleled by inhibition of agonist-binding, 
which suggests an effect at the level of the receptor 
(Lynch et al., 1985). Cholinergic stimulation of rat 
pancreatic acini prelreated with phorbol ester 
resulted also in an impaired calcium response 
(Ansah et al., 1986), whereas secretagogue-induced 
inositol Irisphosphate production was unimpaired 
by phorbol ester treatment (Merritt et al., 1986a). 
Similar observations as those described above, 
summarized by Nishizuka (1986), Kikkawa and 
Nishizuka (1986) and Berridge (1987a,b), lay 
emphasis on the important role for protein kinase С 
in regulation of cellular activities. 
Summary 
(1) It is well established now that the pancreatic 
secretagogues acetylcholine and -cholecystokinin 
are of the calcium-mobilizing type. 
Preliminary evidence suggests the presence of a G 
protein (Gp), coupling calcium-mobilizing recep­
tors to the effector enzyme PIP2 phosphodi­
esterase. 
(3) Both secretagogue-induced decreases in radio-
labelled PIP2 a n d increases in radiolabelled 
(1,4,5-)ІРз occur fast enough to preceed 
secretagogue-induced calcium mobilization. Inosi­
tol 1,4,5-trisphosphate releases calcium accumulat­
ed actively in peimeabilized acinar cells. In addi­
tion, calcium-mobilizing secretagogues increase 
the permeability of the plasma membrane for calci­
um, leading to influx of calcium. 
(4) Protein kinase С is present in the pancreatic aci­
nar cell and the partially purified enzyme is activat­
ed in the presence of phosphatidylserine and syn­
thetic diacylglycerols or phorbol esters by 
submicromolar concentrations of calcium. 
(5) Calcium ionophores and phorbol esters bypass 
receptor activation and stimulate enzyme secretion, 
indicating that activation of either of the two routes 
is suffícient to induce the response. The effects of 
ionophores and phorbol esters are additive which 
shows that both routes act synergistically in gener-
ating the final response. 
(6) In addition to its stimulatory effect on enzyme 
secretion, protein kinase С inhibits secretagogue-
induced calcium mobilization. Therefore, (he 
diacylglycerol/protein kinase С pathway also func­
tions as an internal feedback system. 
Aims of this part of the investigation 
Using rabbit pancreatic acini we have investi­
gated whether the G protein, thought to mediate 
between calcium-mobilizing receptors and PIP2 
phosphodiesterase, is sensitive to pertussis toxin 
(chapter 3). 
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Pretreatment of pancreatic acini with the toxin 
did not alter rapid increases in free cylosolic calci-
um concentration ([Ca2+]¡) induced by the 
C-tenninal octapeptide of cholecyslokinin 
(CCK-8), as judged from changes in fluorescence 
obtained from quin2-loaded acini. On the other 
hand, toxin treatment markedly potentiated 
ССК-8-mduced enzyme secretion and cAMP for­
mation, especially when measured in the presence 
of an inhibitor of cyclic nucleotide phosphodi­
esterase activity. These observations suggest that in 
the pancreatic acinar cell G¡, but not Gp, is modi-
fied by pertussis toxin. Again, increases in cAMP 
concentration alone did not lead to enhanced 
enzyme secretion and the potentiating effect on 
ССК-8-mduced secretion is in line with a modula­
tory role for the cyclic nucleotide in pancreatic 
enzyme secretion. 
The involvement of extracellular calcium in 
secretagogue-induced changes in [Ca2+]¡ was 
investigated by means of the fluorescent calcium 
indicator, quin2 (chapter 4). 
It was shown that the initial and rapid 
secretagogue-induced increase in [Ca^+Jj was 
independent of extracellular calcium. In the pres-
ence of extracellular calcium, [Ca2+]¡ did not 
decline to prestimulatory levels, but remained ele-
vated in the presence of the secretogogue. In the 
absence of extracellular calcium, the [Ca2+]¡ rapid-
ly declined to prestimulatory levels, but increased 
again upon readdition of calcium to the medium. 
The putative intracellular calcium antagonist 
3,4,5-trimelhoxybenzoate 8-(diethylainino)-octyl 
ester (TMB-8), did not affect the secretagogue-
induced extracellular calcium-independent increase 
in [Ca2+]j. However, the secretagogue-induced 
extracellular calcium-dependent increase in 
[Ca2+]¡ was inhibited by the drug. Our results indi-
cate that TMB-8 does not inhibit the stimulated 
release of intracellularly stored calcium, but rather 
prevents the occurrence of long-term elevated cal-
cium levels in the stimulated acinar cell. 
The putative intracellular calcium antagonist 
3,4,5-trimethoxybenzoale 8-(diethylamino)-octyl 
ester (TMB-8) was used in an effort to ascertain the 
role of the secretagogue-induced increase in free 
cylosolic calcium concentration in pancreatic 
enzyme secretion (chapter 5). 
At concentrations between 10 and 100 μΜ, the 
drug inhibited carbachol-, but not CCK-8-, induced 
increases in [Ca2+]¡ and enzyme secretion. Inhibi-
tion is apparently due to its action as a cholinergic 
receptor antagonist. Our results show that the drug 
does not impair secretagogue- induced calcium 
mobilization. However, at concentrations between 
SO and 100 μΜ, TMB-8 potentiated the stimulatory 
effect of submaximal concentrations of secreta­
gogue as well as the stimulatory effects of the cal­
cium ionophore, A23187, and the phorbol ester, 
TPA. At concentrations beyond 100 μΜ, the poten­
tiating effect of the drug declined and at a concen­
tration of 500 μΜ the stimulatory effect of CCK-8 
was abolished completely. However, severe cyto­
toxic effects were observed at this relatively high 
concentration. 
The phorbol ester 12-O-tetradecanoylphorbol 
13-acetate (TPA), thought to activate protein 
kinase С in a diacylglycerol-like manner, was used 
to investigate whether activation of the 
diacylglycerol/protein kinase С pathway may 
underly secretagogue- induced desensitization 
(chapter 6). 
Rabbit pancreatic acini were incubated in the 
presence of TPA, washed and reincubaled. Enzyme 
secretion was still enhanced in phorbol ester- treat­
ed acini, indicating that the С kinase is still active. 
However, the dose-response curves for 
ССК-8-stimulated enzyme secretion and calcium 
mobilization were shifted to the right, suggesting 
an inhibitory effect of protein kinase С on 
secretagogue- induced calcium mobilization. This 
inhibitory effect was not paralleled by inhibition of 
ССК-8-induced PIP2 hydrolysis. From these obser­
vations the conclusion was drawn that protein 
kinase С acts at a level beyond receptor-mediated 
PIP2 breakdown. 
In a subsequent study it was investigated 
whether phorbol ester pretreatment impaired 
(l,4,S-)IP3-induced calcium release in permeabi-
lized pancreatic acinar cells (chapter 7). 
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It was found, that at a free calcium concentra­
tion of 0.1 μΜ and in the presence of an inhibitor 
of mitochondrial calcium uptake, pretreatment with 
TP A significanlly inhibited (1,4,5-)ІРз- induced 
calcium release in permeabilízed pancreatic acinar 
cells. No effect was observed on ATP-dependent 
calcium accumulation. This observation indicates 
(hat protein kinase С is able to modulate the activi­
ty of the (1,4,5-)ІРз/са1сіит route, without impair­
ing the formation of its own stimulant diacylglyc-
erol. 
In addition to its effect on secretagogue-
induced calcium mobilization, the effect of phorbol 
ester pretreatment on secrelagogue-induced cAMP 
formation was investigated (chapter 9). 
In a previous study, it was found that pretreat­
ment with pertussis toxin facilitated 
ССК-8-mduced activation of adenylate cyclase in 
intact acinar cells. Since, the toxin is thought to act 
by inactivating G¡, it was proposed that the relative 
inability of CCK.-8 to stimulate cyclase activity in 
the intact cell might be due to activation of G¡ by 
some component of the calcium messenger system, 
thus preventing the secretagogue from activating 
the cyclase via Gs. The observation that in the rab-
bit pancreatic acinar cell, neither secretin nor VIP 
stimulated the breakdown of 32p.iabelled PIP2. is 
in line with the above proposal. Pretreatment with 
phorbol ester did not significantly affect basal 
adenylate cyclase activity, but inhibited both 
CCK-8- and VIP- induced increases in acinar cell 
cAMP concentration. These results indicate that 
protein kinase С modulates also secretagogue-
induced cAMP formation. However, only the 
cAMP response to relatively low concentrations of 
secretagogue was inhibited. Therefore, 
CCK-8-induced activation of protein kinase С does 
not explain the relative inability of this secreta­
gogue to stimulate adenylate cyclase in the intact 
acinar cell. 
Phospholipids, phosphoinositides in particular, 
play a crucial role in signal transduction. In this 
study (chapter 8) , we investigated both the effect 
of the secretagogue CCK-8 and of the phorbol ester 
TPA on the incorporation of ortho[32p]phosphate 
in acinar cell phospholipids. 
Only in the presence of CCK-8, labelling of 
PIP2 reached equilibrium within 60 min. Com­
pared to control acini or acini labelled in the pres­
ence of TPA, the amounts of labelled PIP2. extract­
ed from cells labelled in the presence of CCK-8, 
were significantly reduced and subsequent stimula­
tion with carbachol did not lead to any further 
decrease in the amount of 32p.i
a
(j
e
i]
e(j pjpj, 
These observations suggest that the amount of PIP2 
is markedly decreased in stimulated cells and that 
this may be the reason for the lack of effect of oth­
er stimuli of the calcium-mobilizing type. In the 
presence of TPA, labelling of PIP2 appeared to be 
increased. Compared to acini labelled in the pres­
ence of CCK-8, no increased labelling of phospha-
tidic acid and phosphatidylinositol was observed. 
However, labelling of phosphatidylcholine was sig­
nificantly enhanced. The latter observations indi­
cate that phorbol esters seriously affect phospho­
lipid metabolism in a manner different from 
calcium-mobilizing secretagogues. 
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The role of cyclic AMP in the regulation of enzyme secretion by the rabbit pancreas has been investigated by 
means of forskolin, an activator of the catalytic subunit of adenylate cyclase. Forskoiin increases the cyclic 
AMP level in isolated pancreatic acini in a dose-dependent way. Basal amylase release, however, remains 
unchanged. Forskolln potentiates the increase in amylase release induced by the C-terminal octapeptide of 
cbolecystokinin (CCK-8). Potentiation is already apparent at honnone concentrations which are only 
marginally effective in stimulating amylase secretion. CCK-8 alone does not raise the cellular cAMP level, 
but it potentiates the forskolin-induced increase. In relative terms, potentiation is higher with decreasing 
concentration of forskolin. These results indicate that cAMP alone does not play a direct role in 
CCK-stfamdated pancreatic enzyme secretion in the rabbit, but it potentiates enzyme secretion already 
stimulated through a cAMP-independent process. 
Introduction 
Considerable evidence has accumulated suggest-
ing that an increase in cytosolic Ca2+ may mediate 
the action of CCK on pancreatic enzyme secretion 
[1-3]. However, it is still uncertain whether and, if 
so, how cyclic AMP is involved in the mechanism 
of action of this hormone. 
In all species studied, the acinar cell contains an 
adenylate cyclase, which is stimulated by CCK 
[4-6]. However, a detectable increase in the acinar 
cAMP level is only found in the presence of a 
suitable inhibitor of cAMP phosphodiesterase ac-
tivity [7-9]. Species differences in the effects of 
cholera toxin and the hormone secretin further 
complicate the picture. Cholera toxin increases the 
cAMP level in guinea pig and rat acini, but only in 
Abbreviations CCK, cholecystolumn-pancreozymin, CCK-8, 
C-temunal octapepude of cholecystolunin-pancreozymin; VIP, 
vasoactive ш testina] peptide. 
the guinea pig does it stimulate the enzyme secre­
tion [10-12]. In both species, cholera toxin 
potentiates the CCK-stimulated enzyme secretion 
[10,13]. Secretin increases the acinar cAMP level 
as well as the enzyme secretion in guinea pig and 
rat [14,15], while the hormone also stimulates the 
adenylate cyclase [14]. However, in the rabbit 
secretin neither stimulates the adenylate cyclase 
nor enhances enzyme secretion [14]. Hence, we 
have chosen the rabbit pancreas to investigate the 
CCK-stimulated pathway of enzyme secretion. 
Forskolin, a diterpene extracted from the roots 
of Coleus forskohlu, is known to activate the cata­
lytic subunit of nearly all eukaryotic adenylate 
cyclases [16]. This has led us to use this substance 
in a study of the involvement of cAMP in the 
regulation of pancreatic enzyme secretion by CCK. 
We have investigated the effects of forskolin, with 
and without CCK, on amylase release from rabbit 
pancreatic acini, and correlated these with the 
cAMP levels in the acini. 
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The results presented here show that an in­
crease in cellular cAMP, caused by forskolin, does 
not stimulate enzyme secretion by itself, but that it 
potentiates the effect of CCK on enzyme secretion. 
Materials and Methods 
Pancreatic acini 
Rabbit pancreatic acini are prepared essentially 
as described for acinar cells by Amsterdam and 
Jamieson [17], except that the divalent cation 
chelating step is omitted. The method is based on 
two successive incubations with collagenare and 
hyaluronidase in a medium containing 0.1 mM 
C a 2 + . After this digestion, the tissue is incubated 
in a medium containing 1.2 mM Ca 2 + and is 
dispersed by pipetting. The suspension is filtered 
through nylon gauze and purified by centrifuga-
lion through a 4% albumin layer. The intactness of 
the isolated acini has been demonstrated by Trypan 
blue exclusion. 
For secretion studies, a Krebs-Ringer bi­
carbonate medium (pH 7.4) containing 119 mM 
NaCl, 3.5 mM KCl, 1.2 mM K H 2 P 0 4 , 25 mM 
КаНСОз, 2.5 mM CaCl2, 1.2 mM MgCl2, 5.8 
mM glucose, 1% bovine serum albumin and an 
amino acid mixture according to Eagle [18] is used 
at 37°C. The stimulants are added after 20 min, 
and samples of the incubation mixture are re­
moved at appropriate times for determination of 
the amylase activity. At the end of the experiment 
the acini are homogenized in the incubation 
medium. Amylase activity is measured in the sam­
ples after rapid sedimentation of the acini and in 
the acinar homogenate by means of the Phadebas 
test. 
Détermination of с AMP 
cAMP is determined by the method described 
by Kempen et al. [19]. Acini prepared from two 
pancreases are suspended in 20 ml incubation 
medium and incubated in a volume of 1.5 ml. At 
appropriate times, 300-/il samples are removed 
and mixed with 300 μΐ 10% trichloroacetic acid. 
After centrifugation at 10000 x g for 1 min, 500 μ\ 
supernatant is extracted three times with 5 ml of 
water-saturated diethyl ether. After addition of 2 
pmol [3H]cAMP, the supernatant is further puri­
fied on a Dowex-50W column, according to the 
method of Krishna et al. [20]. Standard solutions 
of cAMP in incubation medium are treated in the 
same way. 
The cAMP content of the extract is determined 
by saturation assay with cAMP binding protein, as 
described by Brown et al. [21]. By this method, 
between 0.5 and 100 pmol cAMP per sample can 
be measured. The cAMP content of the acini is 
expressed in pmol/mg protein. Protein concentra­
tions are determined by the Lowry method, using 
bovine serum albumin as a standard. 
Materials 
The cAMP binding protein is isolated from 
bovine adrenal cortex as described by Brown et al. 
[21]. The C-terminal octapeptide of cholecys-
tokinin has been synthesized by Dr. H.M. Rajh in 
the Department of Organic Chemistry, University 
of Nijmegen. [3H]cAMP (15 Ci/mmol) is pur­
chased from ICN, Irvine, CA, U.S.A. Soybean 
trypsin inhibitor and bovine serum albumin are 
obtained from Sigma, St. Louis, MO, USA; cAMP 
from Boehringer, Mannheim, F.R.G.; Dowex 
50W-X8 from Fluka, Buchs, Switzerland; activated 
charcoal (Noril, SX-1) from Norit, Amersfoort, 
The Netherlands. Forskolin is purchased from 
Calbiochem, La Jolla, CA, U.S.A., and the 
Phadebas test kit is from Pharmacia, Uppsala, 
Sweden. All other chemicals are of reagent grade. 
Results 
Effects on amylase release 
Incubation of rabbit pancreatic acini in the 
presence of 1 • 10"" M CCK-8 produces a nearly 
linear increase in amylase release with time during 
the first 20 min (Fig. 1). In the presence of 3 · 10" 5 
M forskolin (without CCK-8), the basal amylase 
release remains virtually unchanged. CCK-8 with 
forskolin, however, gives a more than additive 
effect on amylase secretion. This potentiation of 
the CCK-8 response by forskolin occurs mainly 
during the first 10 min. 
The dose-response curve for the effect of CCK-8 
alone on amylase release shows a maximal effect 
at a concentration of 1 · 10" ' M, beyond which it 
decreases (Fig. 2). In the presence of 3 · 10" 5 M 
forskolin the curve has a similar shape, but at all 
concentrations of CCK-8 the response is signifi-
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Fig. 1 Effects of CCK-8 and forskobn (Fonk ), alone and in 
combination, on amylase release Trom rabbi l pancreatic acini 
Acini are prcincubated for 20 nun at 37 e C and are then 
incubated for 40 nun with 1 ΙΟ*8 M CCK-8, ( O ) 3 M " 5 M 
forskolin (D) от both ( · ) Amylase release is measured al the 
indicated unies, and is expressed as percentage of the total 
amylase content of the acuu at the beginning of incubation 
Basal release from 20 to 60 mm is the same as that m the 
presence of fonkolin (without CCK.-8) This figure is typical 
for seven experiments. 
300-
« 0 -
,00. 
0 ·· 
14, t 
Ъі 
\ 
Ι V 
neg log melar CCK β СОПС ПІГМЮТ 
Fig. 2 Effect of fonkohn (Forsk ) on the dose-responie curve 
for CCK-8 stimulation of amylase secretion by rabbit pan­
creatic acini Acini are incubated for 35 nun at 37°C The 
indicated concentrations of CCK-8. with ( · ) or without ( O ) 
fonkohn (3 1 0 " ' M), are added at 20 mm Amylase release is 
measured at 0, 10, IS and 30 mm and is expressed as per­
centage of total amylase originally present in the earn The 
mercase in amylase release at 30 mm is corrected for the basal 
release at that tune, determined by extrapolation from the 
release values at 0, 10 and IS mm in each expenmenL The 
value obtained with 1 И Г * M CCK-S alone (12 9«, S E 1 S, 
и — 6 of total amylase originally present in the acuu) is set at 
100%, to which all other values are related The number of 
expenments is given m parentheses. 
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Fig. 3 Effect of CCK-8 on the dose-response curve for for­
skobn stimulation of amylase secretion by rabbit pancreatic 
aam Aam are incubated for 35 mm at 37°C The indicated 
concentrauons of forskobn, with ( · ) or without ( O ) CCK-8 
(1 10~B M), are added at 20 nun Details on sampling and 
calculations are given m the legend of Fig. 2 The number of 
expenments is given m parentheses 
cantly higher. The potentiation in absolute terms is 
maximal at a CCK-8 concentration of 1 • IO - 8 M, 
but at lower hormone concentrauons the relative 
potentiation is even higher (700% at 1 • 10~1 0 M, 
170% at 1 • IO"' M. 150% at 1 · IO"' M). 
Fig. 3 shows a dose-response curve for for­
skobn. With forskolin alone the basal amylase 
release remains unchanged at all concentrations 
tested In combination with 1 · 10" ' M CCK-8, 
potentiation is alreay 100% at a fonkohn con­
centration of only 1 · 10" ' M. Potentiation of the 
hormone response increases with increasing con­
centration of forskolin, and at a concentration of 
1 · 10"* M it is almost 200%. 
Effects on cAMP content 
Incubation of rabbit pancreatic acini in the 
presence of 3 • 10* 5 M forskolin produces a steep 
mercase in the cellular cAMP level during the first 
4 mm after addition of the agent (Fig. 4). The 
response is maximal after approx. IS nun, when a 
new steady state level of cAMP is established. 
Addition of CCK-8 alone does virtually not change 
the basal cellular cAMP concentration (see also 
Fig. S, lower line) However, a combination of the 
two agents potentiates the forskobn effect. Poten­
tiation is greatest during the first 8 mm after 
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Fig 4 Effects of forskolin (ForsJc ) and ССК-в, акте and ш 
combination» on the cAMP content of rabbit pancreatic acini 
Acini arc preincubated for 20 nun at 370C and are then 
incubated for 40 nun with 1 10'* M CCK-8 (O), 3 ΙΟ - 5 M 
forskolin (•) or both ( · ) cAMP is determined at the indicated 
tunes This figure represents a single expenmenl 
addition, reaches a maximum at about IS mm, and 
then decreases slightly to a new steady cAMP level 
in about 30 mm 
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Fig S Effect of fonkolui (Forsk ) on the dose-response curve 
for the ССК.-8-induced increase of the cAMP content of rabbit 
pancreatic ваш Acmi are incubated for 35 nun at 37*C The 
indicated concentrations of CCK-8, with ( · ) and without (O) 
forskolin (3 1СГ5 M), are added at 20 nun Samples for cAMP 
determination are taken at 5 nun and 35 mm The increase m 
cAMP is expressed as percentage of that obtamed with 3 10 " 5 
M forskolin measured in the same experunent In unstimulated 
acmi the cAMP level is 3 1 (S E. 0 8, л - 9) pmol/mg prolan 
With 3 10 ' M forskolin. the ulerease m cAMP is 41 (S E. 5 6, 
π — 9) pmol/mg protein The number of expenments is given 
m parentheses. 
n«g log molar forsholin concenlrallon 
Fig. 6 Effect of CCK-S on the dose-response curve of the 
forskolin-induccd increase of the cAMP content of rabbit pan­
creatic aam Aam are incubated for 35 mm at 370C The 
indicated concentrations of forskolin. with ( · ) and without (O) 
CCK-8 (1 10"' M), are added at 20 mm Details on sampling 
and calculations are given in the legend of Fig 5 The number 
of experunents is given in parentheses 
In further expenments, the difference m the 
cAMP level, measured 15 mm before and after 
addition of CCK-8 and/or forskolin, is used for 
expressing the effects of the added compounds 
Fig 5 shows the dose-response curve for CCK-8 
At none of the concentrations tested, the hormone 
increases the cAMP level significantly m the ab­
sence of forskolin In the presence of 3 1 0 _ 5 M 
forskolin, potentiation of the response begins at 
1 10~'M CCK-8, reaches a maximum at 1 1 0 e 
M, and then decreases slightly The maximum 
effect coincides with that on the amylase release, 
which also occurs at 1 10" 8 M CCK-8 (Fig 2) 
The dose-response curve for forskolin (Fig 6) 
shows that its effect on the cAMP level is clearly 
dose-dependent At a concentration of 1 10~4 M, 
the cAMP level is increased about 40-fold CCK-8 
(1 10~8 M) has a small, but significantly positive 
effect on the cAMP level m the presence of for­
skolin, as compared to forskohn alone Only at the 
highest forskohn concentration (1 IO"4 M) tested, 
the effect of CCK-8 is not significant In absolute 
terms, potentiation is maximal at a concentration 
of forskolin of 3 ' 1 0 " s M, whereas m relative 
terms, it is higher at lower concentrations of for­
skohn 
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Discussion 
Our finding that CCK-8 does not increase the 
cellular cAMP level in rabbit pancreatic acini con­
firms the earlier findings of many other investiga­
tors [22]. Only in the presence of a cAMP-phos-
phodiesterase inhibitor in high concentration and 
at high ( > 1 · 10 ~ e M) CCK-8 concentrations is 
there an increase in the cAMP concentration [8,9]. 
This virtual failure of the hormone to increase the 
cellular cAMP level suggests that stimulation of 
pancreatic adenylate cyclase, which has been 
detected in isolated pancreas membranes [4-6] 
and which originates from the acinar cell [6,7] is 
not involved in the mechanism of action of CCK 
in intact cells. 
Forskolin has been used with succes to eluci­
date the role of cAMP in the intracellular control 
mechanisms of several secretory systems [16], and 
most recently also in enzyme secretion by the rat 
pancreas [23]. In contrast to cholera toxin, which 
acts by ADP-ribosylation [24] of the noncatalytic 
G-subunit, forskolin activates the catalytic subunit 
of adenylate cyclase in a direct way [25]. We have 
now demonstrated that forskolin increases the cell­
ular cAMP level in rabbit pancreatic acini. Whereas 
the effect of cholera toxin only becomes visible 
after relatively lengthy incubation periods [10-12], 
the effect of forskolin is already apparent within a 
few minutes after addition. Therefore, forskolin 
appears to be a useful tool in investigating the role 
of cAMP in pancreatic enzyme secretion. 
In the rabbit pancreatic acini the increase in 
cellular cAMP concentration, caused by forskolin, 
is not paralleled by an increase in the secretion of 
amylase. In the guinea pig, however, an increase in 
cAMP, caused by either cholera toxin [10], or 
secretin or VIP [10,14,15], may lead to enzyme 
secretion. In the rat the situation is complicated, 
since secretin and VIP increase cAMP and give a 
minor increase in amylase secretion [7,15], while 
cholera toxin alone increases cAMP without en­
hancing enzyme secretion [11-13]. In the rabbit 
pancreas secretin has neither an effect on the 
acinar cell adenylate cyclase activity, nor on the 
pancreatic enzyme secretion [14]. The use of rabbit 
pancreatic acini thus has the advantage that a 
secretin-stimulated cAMP pathway seems to be 
absent. 
In contrast to the findings of Heisler [23] for rat 
acinar cells, we do not find forskolin alone to 
stimulate enzyme secretion by the rabbit pan­
creatic acini. In agreement with his findings, we 
find that forskolin potentiates the stimulatory ef­
fect of CCK-8 on enzyme secretion. The latter 
observation parallels the finding of Pan et al. [13] 
that cholera toxin potentiates the effect of CCK-8 
on enzyme secretion in the rat. It is also in agree­
ment with the report of Gardner et al. [9] that the 
increase in the cellular cAMP concentration, 
caused by CCK-8 in the presence of an inhibitor 
of cAMP phosphodiesterase activity, potentiates 
the effect of this hormone on amylase secretion 
from guinea pig pancreatic acini. For the rabbit 
pancreatic acini we find that marginally effective 
concentrations of CCK-8 greatly stimulate enzyme 
secretion, when the cellular cAMP level is in­
creased by forskolin. These observations suggest 
that whereas in guinea pig a mere increase in 
cellular cAMP concentration already results in an 
enhanced enzyme secretion, in rabbit another in­
tracellular factor seems to be additionally re­
quired. This intracellular factor may well be an 
increase in cytosolic Ca2*, since Heisler [23] has 
found that forskolin potentiates the ionophore 
A23187-induced enzyme secretion from rat pan­
creatic acinar cells. For the rabbit pancreatic acini 
we find that forskolin (3 · 10 " 5 M) increases en­
zyme secretion induced by ionophore A23187 (1 • 
IO"« M) by 180% (S.E. 66; л - 3). 
The mechanism by which the forskolin-induced 
increase in cAMP leads to stimulation of amylase 
secretion is not yet understood. The molecular 
details of the stimulus-secretion coupling process 
are still insufficiently known. Hence, an explana­
tion for the effect of cAMP in this process can 
only be speculative. One possibility could be that 
cAMP has an effect on the cytosolic calcium con­
centration, and thus may indirectly stimulate en­
zyme secretion. Another possibility could be that 
cAMP would affect the phosphatidylinositol 
metabolism, which is stimulated by CCK. It could 
also be that the phosphorylation of a protein in­
volved in one of the final steps of the stimulus-
secretion coupling process could be induced by 
cAMP and Ca2 +, acting on different sites. In the 
rabbit pancreas, phosphorylation on a cAMP-de-
pendent site alone would not be sufficient to in-
- 27 -
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duce secretion. However, it would potentiate secre­
tion induced by phosphorylation on a Ca2+ -de­
pendent site. Further studies are needed to dis­
tinguish between these various possibilities. 
Another observation made in our study is that 
the forskolin-induced increase of the cellular cAMP 
concentration is potentiated by CCK-8. It is not 
clear whether this increase is due to a direct activa­
tion of the adenylate cyclase by the hormone or to 
an indirect effect of the hormone through the 
increased cytosolic Ca1+ level, e.g., by inhibition 
of cAMP phosphodiesterase activity. 
In conclusion, we can say that although cAMP 
is not directly involved in the mechanism of action 
of CCK, it may potentiate the stimulatory effect of 
the hormone on the secretion of enzymes by the 
rabbit pancreatic acinar cell. However, it cannot 
be stated at this moment whether it would do this 
directly or indirectly. 
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Pertussis toxin stimulates cholecystokinin-induced cyclic AMP formation 
but is without effect on secretagogue-induced calcium mobilization 
in exocrine pancreas 
P.H.G.M. Willems, R.H.J. Tilly and J.J.H.H.M. de Pont 
Department of Biochemistry, University of Nijmegen, Nijmegen (The Netherlands) 
(Received 13 November 1986) 
Key wordt Pertussis loxin, Cholecyslokmm, cyclic AMP, Calcium ion mobilizaüon, (Pancreas) 
The role of a pertussis toxin sensitive GTP-binding protein in mediating between cholecystokinin receptors 
and pbosphatidylinositol 4,5-bisphosphate phosphodiesterase as well as in preventing cholecystokinin from 
increasing cellular cyclic AMP has been investigated using dispersed acini from rabbit pancreas. Pertussis 
toxin pretreatment (500 ng/ml, 2 h) did not affect cliolecystokinin(octapeptide) (CCK-8) -induced increases 
in cytosolic free Ca1* as judged from changes in fluorescence obtained from quinl-loaded adni. Although 
pretreatment with pertussis toxin was also without effect on resting acinar cell cyclic AMP levels, adenylate 
cyclase activity was increased, since inhibition of cyclic AMP phosphodiesterase activity by isobutylmethyl· 
xanthine (ШМХ) resulted in an additional increase in cyclic AMP levels in toxin-treated adni, indicating 
that acinar cell adenylate cyclase activity is under some tonic inhibitory control by the pertussis toxin-sensi­
tive inhibitory GTP-binding protein (G,) of the adenylate cyclase system. CCK-8 gave an increase in cydk 
AMP levels in both control (1.6-fold) and toxin-treated (2Л-ГоМ) acini, leading to cyclic AMP levels in the 
toxin-treated acini 2-tiines as high as those in control acini. In the presence of IBMX, the cyclic AMP 
response to CCK-8 was again markedly enhanced in acini pretreated with the toxin (3.2- vs. 1.8-fold), 
resulting in cAMP levels in die toxin-treated adni 3.7-times those in the absence of IBMX, 2.5-tlmes those 
In control adni in the presence of ШМХ and 7.0-tfmes those in control adni in the absence of IBMX 
Neither the pretreatment with pertussis toxin, nor the presence of IBMX alone, nor the combination had an 
effect on basal amylase secretion. However, all three treatments potentiated the stimulatory effect of CCK-8 
on amylase secretion and the amount of potentiation was proportional to the cydic AMP levels reached. Our 
findings suggest that in the intact pancreatic acinar cell G, inhibition of the catalytic subunit of the 
adenylate cyclase may largely be responsible for preventing cholecystokinin from increasing cellular cyclic 
AMP. They moreover show that cydic AMP is a modulatory agent in rabbit pancreatic enzyme secretion, 
not able to stimulate secretion Itself, but potentiating effects mediated by the phosphatidylinositol-caldiBn 
pathway. 
Abbreviations CCK-8, cholecystokinin (octapeptide) CTP, 
guanosmetnphosphate, G
a
, stunulalory GTP-bmding protein 
of the adenylate cyclase system, G,, inhibitory GTP-binding 
protein of the adenylate cyclase system, P l^, phosphati-
dylinositol 4,5-bisphospbate, ІЯ3, inositol 1,4,5-lmphosphale, 
TPA, 12-O-letradecanoylphorbol 13-acetate, IBMX, 3-iso-
butyl-l-methybunthme, Hepcs, 4-<2-hydraxyethyl>l-piper-
azineethanesulfonic acid 
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Introduction 
It is the current working hypothesis that 
calcium-mobilizing hormones exert their actions 
on target cells by stimulating phosphodiestenc 
cleavage of phosphatidylinositol 4,5-bisphosphate 
(PI/2), yielding the intracellular messengers in­
ositol 1,4,5-tnsphosphate (1P}) and 1,2-diacylglyc-
erol, mediating intracellular Ca 2 + mobilization and 
protein kinase С activation, respectively [1,2] 
Recent studies have revealed that in the exoc-
nne pancreas receptors for the secretagogue 
cholecystokimn are coupled to PI ^ -phosphodies­
terase, since within seconds the hormone decreases 
membrane-bound PI/2 and increases the cytosohc 
concentrations of IP 3 and C a
2 +
 [3-8] 
In broken cell preparations, however, cholecys­
tokimn has also been shown to be able to stimu­
late acinar cell adenylate cyclase activity [9-11] 
Yet, in intact acinar cells no cholecystokimn-in-
duced increases in cellular cyclic AMP have been 
observed [12-14] This suggests that m acinar cells 
one or more of the following possibilities occur (1) 
cholecystokimn-induced coupling of its receptors 
to adenylate cyclase may be blocked, (u) the en­
zyme may be under inhibitory control or (ui) 
cyclic AMP formed m response to the hormone 
may rapidly be eliminated 
It is well established that hormonal stimulation 
of adenylate cyclase activity is mediated by a 
stimulatory GTP-binding protein (G
s
), whereas an 
inhibitory one (G,) mediates hormonal inhibition 
[15-17] Pertussis toxin, an exotoxin of Bordetella 
pertussis, has been shown to inactivate G, 
[16,18,19] This has led us to use this substance 
alone and in combination with isobutylmethyl-
xanthine (IBMX), a well-known inhibitor of cyclic 
AMP phosphodiesterase activity, to investigate 
whether G, and cyclic AMP phosphodiesterase 
are involved in preventing cholecystokimn from 
increasing acinar cell cyclic AMP 
In addition we investigated whether the GTP-
binding protein postulated to mediate between 
calcium-mobilizing receptors and PI/^-phosphodi­
esterase [20-24], as already described in some 
tissues [25-32], is also sensitive to pertussis toxin 
in the exocrine pancreas 
Materials and Methods 
Dispersed acim from rabbit pancreas were pre­
pared using the method reported previously [8,14] 
and were suspended m a Krebs-Ringer bi­
carbonate medium (pH 7 4), containing 119 mM 
NaCl, 3 5 mM KCl, 12 mM K H 2 P 0 4 , 25 mM 
КаНСОз, 1 2 mM CaCl 2, 1 2 mM MgCl2, 5 8 
mM glucose, 1% bovine serum albumin, 0 2 mg/ml 
soybean trypsin inhibitor and an amino acid mix­
ture according to Eagle [33] Acini were incubated 
in the absence or presence of 500 ng/ml pertussis 
toxin for 2 h at 37° С Pertussis toxin was removed 
by centnfugation and the acini were resuspended 
in Krebs-Ringer bicarbonate medium to which 0 
or 10" 4 M isobutylmethylxanthine (IBMX) was 
added for enzyme secretion and cAMP formation 
studies and to which quin2/AM was added for 
measurement of cytosohc free calcium as de­
scribed below Acini were then incubated for 
another 65 nun and samples were removed at 0, 
15, 30, 45 and 60 mm for measuring amylase 
activity and at 35 and 65 mm for determination of 
the cyclic AMP concentration At the beginning of 
the experiment an aliquot of the acini suspension 
was removed and the acim were homogenized in 
the medium Amylase activity was measured in the 
samples after rapid sedimentation of the acim and 
in the acinar cell homogenale by means of the 
Phadebas test [34] Amylase activity was expressed 
as a percentage of total amylase present in the 
acim at the beginning of the experiment Cyclic 
AMP was measured as described previously [14] 
and the cyclic AMP content in the acini was 
expressed as pmol cyclic AMP per mg protein 
Quin2 loading of control and pertussis toxin-
treated acini and measurement of quin2 fluores­
cence was essentially the same as reported before 
[8], with the exception that fluorescence measure­
ment was performed in a Hepes/Tns medium 
medium (pH 7 4) containing 133 mM NaCl, 4 2 
mM KCl, 10 mM CaCl 2, 10 mM MgCl2 v 5 8 
mM glucose, 0 2 mg/ml soybean trypsin inhibitor 
and 10 mM Hepes, adjusted with Tns to pH 7 4 
and thoroughly gassed with 100% 0 2 Maximal 
fluorescence was obtained using the calcium lono-
phore lonomycin at a concentration of 10 " 5 M 
and [Ca 2*], was calculated according to Tsien et 
al [35] 
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Materials 
Purified pertussis toxin (batch 91) was pur­
chased from PHLS Centre for Applied Microbi­
ology and Research, Sabsbury, U К The C-termi-
nal octapeptide of cholecystokimn has been 
synthesized by Dr H M Rajh in the Department 
of Organic Chemistry, University of Nijmegen 
The cAMP binding protein was isolated from 
bovine adrenal cortex as described by Brown et al 
[36) lonomycin was obtained from Behring Di­
agnostics, La Jolla, CA, U S A , 3-isobutyl-l-meth-
ylxanthine (IBMX) from Aldnch Chemical Com­
pany, Ine, Milwaukee, WI, U S A , [3HlcAMP (15 
Ci/mmol) from ICN, Irvine, CA, U S A , 12-0-
tetradecanoylphorbol 13-acetate (TPA), soybean 
trypsin inhibitor, bovine serum albumin and 
qum2/AM from Sigma, St Louis, MO, U S A , 
cAMP and hyaluronidase from Boehnnger, Man­
nheim, F R G , collagenase from Cooper Biomedi­
cal Inc. Malvern, PA, U S A , Dowex 50W-X8 
from Пика, Buchs, Switzerland and activated 
charcoal (Nont, SX-1) from Nont, Amersfoort, 
The Netherlands The Phadebas test kit was 
purchased from Pharmacia, Uppsala, Sweden AU 
other chemicals were of reagent grade 
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Fig. 1 The effect of CCK-8 on cytosohc free Ca 2* level« in 
qum2 loaded rabbit pancreatic acini pretreated with pertussis 
toxin Rabbit pancreatic acuu were incubated for 2 h either in 
the absence or m the presence of pertussis toxin (500 ng/ml) 
Dunng the last 20 mm of this premcubation qiiin2/AM was 
added at a concentration of SO μΜ Excess quin2/AM was 
removed by centnfugation and the acuu were resuspended m 
fresh Krebs-Ringer bicarbonate medium. Samples removed for 
fluorescence measurements were centnfuged and the acini were 
resuspended m a Hepes/Tns medium (pH 74) thoroughly 
gassed with 100% Oj CCK-8 ( Ι Ο - 1 0 3 IO" 1 0 and 3 ΙΟ"» M) 
was added at the indicated times This figtue is typical for five 
experunenls 
Results 
Effects on cytosohc free calcium 
In acmi pretreated with pertussis toxin (500 
ng/ml, 2 h), the effect of CCK.-8 on cytosohc free 
C a 2 + had been measured with the quin2 tech­
nique 
Basal cytosohc free calcium concentrations, 
calculated to be 137 nM (S E 21, π - 5) in pertus­
sis toxin-treated acini, were not significantly dif­
ferent from those in control acini (150 nM, S E 9, 
η - 5) Fig 1 shows that in toxin-treated acini (B) 
and in control aam (A) CCK-8 at a concentration 
of 10" 1 0 M was without effect on cytosohc-free 
C a 2 + At a concentration of 3 10" 1 0 M, however, 
CCK-8 increased [Ca 2 *], in both toxin-treated 
and control acini to the same extent (338 nM, S E 
43; л = 5 and 431 nM, S E 55, л = 5, respec-
üvely) as did 3 IO" ' M CCK-8 (745 nM, S E 118, 
л - 5 and 635 nM, S E 99, л = 5, respectively) 
The fact that the dose-response curve for the 
ССК-8-induced initial increase in [Ca 2 *], is not 
shifted to the right excludes the possibility that in 
the exoenne pancreas a pertussis toxin-sensitive 
GTP-binding protein mediates between the 
cholecystokimn receptor and PI ^-phosphodies­
terase 
Effects on basal amylase release and resting cellular 
cyclic AMP levels 
From Table I it is clear that both basal amylase 
release (First line) and resting cyclic AMP levels 
(fourth Ime) remained virtually unchanged upon 
pretreatment with pertussis toxin However, acinar 
cell cyclic AMP levels, measured after 25 mm, 
were substantially mcreased m control as well as 
m toxin-treated acini, when 10~4 M IBMX was 
included m the medium The levels reached ш the 
presence of IBMX were significantly higher (14-
tunes) ш the toxin-treated acuu than those in 
control acini Neither IBMX alone nor the combi­
nation pertussis toxin/IBMX had a clear effect 
on basal amylase secretion 
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TABLE I 
EFFECTS OF PERTUSSIS TOXIN ON AMYLASE RELEASE AND cAMP LEVELS IN CONTROL ACINI AND IN ACINI 
STIMULAI LD WITH CCK 8 OR TPA 
Rabbit pancreatic acini incubated in the absence or presence of pertussis toxin (500 ng/ml) for 2 h at 37 0 С were resuspended in 
fresh incubation solution contammg 0 or 10"* M IBMX After 30 mm either CCK-8 (10"' M), TPA (10" ' M) or no stimulant was 
added Samples for measurement of amylase activity in the medium were removed at 0, IS 30, 45 and 60 mm and amylase activity is 
expressed as percentage of total amylase onginaJly present in the acini The increase m amylase activity m the incubation medium at 
60 min was calculated from the amylase activity values at 30, 45 and 60 nun and was corrected for the basal release at that time, 
determined by extrapolation from the amylase activity values at 0, 15 and 30 mm in each experiment Samples for cAMP 
measurement were removed at 25 and 65 nun and cAMP levels are expressed m pmol/mg protem Results shown are the 
means ± S E of the amount of expenmenls given m parentheses 
Basal amylase 
secretion (% of total) 
Stimulated amylase 
secretion (% of total) 
CCK 8 
TPA 
cAMP before stimu­
lation (pmol/mg 
protem) 
cAMP after 
stimulation 
(pmol/mg protein) 
-
CCK В 
TPA 
Acini not treated with 
pertussis toxin 
-IBMX 
1 6 ± 0 1 (14) 
1 1 9 ± 1 7 b (8) 
3 7±0 8 ' (6) 
2 9±0 3 (14) 
-
4 7±0 7 , , (8) 
3 5±07 (6) 
+ IBMX 
1 8 ± 0 1 
232±2Sbi 
69±0T: 
63±04^^ 
7 4 ± 0 9 
І З І і З О
1 
5 9 ± 1 2 c 
(28) 
(9) 
(6) 
(28) 
(13) 
(9) 
(6) 
Acmi treated with pertussis 
toxin (500 ng/ml) 
-IBMX 
15 ±0.2 (14) 
18 3 ± 3 1 ъ (8) 
5 2 ± 1 1 (6) 
3 8 ±0 6 (14) 
-
8 9±2 3 (8) 
3 4±0 5 (6) 
+ IBMX 
2 3 ± 0 1 d 
4 0 0 ± 4 4 b d 
9 1 ± 1 2 e 
9 1 ± 0 7 4 ' 
W9±09d' 
32 8±4 7 b ' ' 1 ' 
8 6 ± 1 0 d 
(28) 
(9) 
(6) 
(28) 
(13) 
(9) 
(6) 
a
 Compared with control without stimulus ( ? < 0 05) 
" The same as * (P < 0 01) 
c
 Compared with same conditions m the absence of IBMX (P < 0 05) 
* The same as * (P < 0 01) 
e
 Compared with same conditions but not treated with pertussis toxin ( Ρ < 0 05) 
' The same a s ' (P < 0 01) 
After 65 mm of incubation ω the presence of 
IBMX, the intracellular cyclic AMP concentration 
in toxin-treated acini was still significantly higher 
than that in control acini (Table I, fifth line) 
However, compared to the levels after 25 mm, m 
both control and toxin-treated acini, the 65 nun 
levels were not statistically different (P > 010) 
Effects on CCK-8- and TPA-induced amylase secre­
tion 
30 mm after the incubation was started, either 
CCK-8 (IO"8 M), TPA (10" ' M) or no stimulant 
was added The mcrease in amylase secretion above 
basal was calculated for the 30 nun period after 
stimulation CCK-8 stimulated amylase secretion 
m control and in pertussis toxin-treated acini with 
and without IBMX present (Table I, second Une) 
Although the stimulatory effect of CCK-8 ap­
peared to be potentiated m toxin-treated acini 
mcubated in the absence of IBMX, this effect was 
not statistically significant (0 05 < Ρ < 0 10) 
IBMX gave a 2-fold mcrease of the CCK-8 effect 
in both control and toxin-treated acini In the 
presence of IBMX, the potentiating effect of per­
tussis toxin on ССК-8-stimulated amylase release 
was significant (P < 0 01) 
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The stimulatory effect of TPA (IO"* M) on 
amylase secretion, which was much smaller than 
that of CCK.-8 (10 " · M), was also potentiated in 
the presence of IBMX (P < 0.01 and Ρ < 0.05 in 
control and toxin-treated acini, respectively). Per­
tussis toxin itself, however, did not significantly 
affect TPA-induced amylase secretion (P>0.10) 
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Fig. 2. The potentiating effect of iocreaied cellular cyclic AMP 
levels on атуіак secretion induced by either CCK-8 or TPA. 
Rabbit pancreatic acini incubated in the abience or presence 
of pertimu toxin (300 ng/ml) for 2 h at 37° С were resus-
pended in fresh incubation solution containing 0 or 10 "* M 
IBMX. After 30 min either IO"' M CCK-8 (A), 10"' M TPA 
(B) or no stimulant was added. Details on sampling and 
calculations are given in the legend of Table I. 
and also the potentiating effect of IBMX on the 
TPA response in toxin-treated acini was not sig­
nificantly different from that in control acini ( Ρ > 
0.10). 
Effects on cellular cyclic AMP levels in CCK-8 and 
TPA'Stimulated acini 
Acinar cell cyclic AMP levels were measured 35 
min after stimulation. Upon stimulation with 
CCK-8, cyclic AMP levels were slightly but sig­
nificantly increased above control levels in both 
control and toxin-treated acini (Table I, sixth line). 
The acinar cell cyclic AMP concentration in 
toxin-treated acini was about 2-times as high as in 
control acini. 
In the presence of IBMX, 1 0 ' ' M cholecys-
tokinin increased the cellular cAMP concentration 
1.8-times that in control acini and 3.2-ümes that 
in toxin-treated acini, resulting in final cyclic AMP 
concentrations in toxin-treated acini 2.5-times 
those in control acini. 
The effects of IBMX and/or pertussis toxin 
pretreatment on cyclic AMP levels remained virtu-
ally unchanged in the presence of 10"6 M TPA, 
indicating that TPA does not directly or indirectly 
influence acinar cell cyclic AMP levels. 
In Fig. 2 acinar cell cyclic AMP levels are 
plotted against amylase secretion. This figure 
shows that the increase in cyclic AMP concentra-
tion alone did not lead to enhanced amylase secre-
tion, but dose-dependently potentiated the secre-
tory response to CCK-8 (A) as well as to TPA (B). 
Discussion 
The main observation in this paper is that 
cholecystokinin, one of the calcium-mobilizing 
pancreatic secretagogues, is able to significantly 
activate rabbit pancreatic acinar cell adenylate 
cyclase provided that the inhibitory guanine 
nucleotide-binding regulatory protein of the 
adenylate cyclase system (Gj) is inactivated. 
Inactivation of Gj was achieved by incubating 
pancreatic acini with pertussis toxin under the 
conditions (500 ng/ml, 2 h) described in the liter-
ature as being appropriate for the toxin to exhibit 
its modifying effect on the α-subunit of Gj 
[29-30,37]. The results obtained indicate that the 
acinar cell GÌ was indeed inactivated by pretreat-
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ment with pertussis toxin since, as in other toxin-
treated tissues (for a review, see Ref 38), the 
cyclic AMP response to an agent which stimulates 
adenylate cyclase activity was found to be en­
hanced 
Our data show that the basal adenylate cyclase 
activity is normally slightly inhibited by G, since, 
provided that IBMX is present, the increase in 
cellular cyclic AMP concentration in acini pre-
treated with pertussis toxin is about 1 6-times as 
high as in control acim This observation is m 
agreement with the finding by Cenone et al [39], 
ι e, that reconstitution of G, purified from human 
erythrocytes together with the adenylate cyclase 
catalytic subunit purified from bovine caudate 
nucleus markedly reduced basal adenylate cyclase 
activity In the absence of IBMX pertussis toxin 
pretreatment does not significantly affect acmar 
cell cyclic AMP levels This indicates that the 
relatively slightly increased cyclic AMP produc­
tion is fully counteracted by the activity of cyclic 
AMP phosphodiesterase 
Both in the absence and in the presence of 
IBMX, in control as well as m pertussis loxin-pre-
treated acini, basal amylase secretion is hardly or 
not affected Therefore, there is no indication that 
pertussis toxin interferes with pancreatic enzyme 
secretion other than by altering adenylate cyclase 
activity 
The fact that pertussis toxin was found to 
increase the ability of hormones to stimulate 
adenylate cyclase activity and cyclic AMP accu­
mulation has also been described for a variety of 
tissues [38] It suggests that in the intact pan­
creatic acinar cell the abihty of cholecystokimn to 
activate adenylate cyclase greatly depends upon 
the activity of G, and m fact is largely suppressed 
by G, This is further supported by our observa-
tion that CCK-8, even in the absence of IBMX, 
substantially mcreases cellular cyclic AMP in ac­
inar cells pretreated with pertussis toxin Ap­
parently cyclic AMP phosphodiesterase activity is 
too low to fully eliminate the amount of cyclic 
AMP then produced 
Our observation that cholecystokimn is able to 
increase cAMP levels in intact acini is in Ime with 
earher reports that the hormone stimulates adeny­
late cyclase in broken cell preparations [9-11] It 
suggests the presence of cholecystokimn receptors 
able to couple with the stimulatory guanine 
nucleotide-bmdmg regulatory protem (G
s
) of the 
acinar cell adenylate cyclase system The presence 
of both a cholera toxin-sensitive α,-subunit of G, 
and a pertussis toxin-sensitive α,-subumt of G, 
coupled to the adenylate cyclase system in rat 
pancreatic membranes has already been reported 
by Lambert et al [40] 
Now that we have shown that inactivation of 
G, enables CCK-8 to substantially stimulate ac­
inar cell adenylate cyclase activity, it remains to 
be elucidated whether the inhibitory action of G, 
on ССК-8-induced activation of the adenylate 
cyclase is due to (i) the inability of the secreta-
gogue, when used at concentrations which opti­
mally stimulate enzyme secretion, to overcome 
some tome inhibitory control exerted by G, over 
the activity of the adenylate cyclase (u) direct 
activation of G, by CCK-8 bindmg to an inhibi­
tory receptor, or (ш) indirected activation of G, 
by CCK-8 activating the calcium messenger sys­
tem In the latter case it may be speculated that 
one of the crucial enzymes of this messenger sys­
tem, protem kinase C, is involved The fact that 
pancreatic secretagogues such as vasoactive in­
testinal peptide or secretin, which do not activate 
the calcium messenger system, substantially 
activate the acinar cell adenylate cyclase and in­
crease the acinar cell cAMP concentration in the 
absence of pertussis toxin and/or IBMX may be 
in favour of the third explanation Coupling of G, 
to the catalytic subunit of the adenylate cyclase as 
a consequence of the activation of the calcium 
messenger system may also explain the fact that m 
broken cell preparations the adenylate cyclase sys­
tem is much better activated by cholecystokimn 
than in intact cells It also may explain the inhibi­
tory effect of CCK-8 on cAMP levels increased by 
secretin and vasoactive intestinal polypeptide in 
guinea pig acmar cells [10] 
The present results demonstrate that a positive 
correlation exists between cellular cyclic AMP 
levels and the extent of potentiation of the secre­
tory response to an agent (cholecystokimn) 
activating the calcium messenger system and an 
agent (TPA) activating the C-kmase part of this 
system This is in Ime with our earher observation 
that forskohn-mduced increases in acmar cell 
cyclic AMP potentiate the secretory response to 
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CCK-8 as well as to the calaum tonophore 
A23187, without affectmg basal amylase secretion 
[14] Therefore, the role for cyclic AMP in pan­
creatic enzyme secretion stimulated by cholecys-
tokumn seems rather to be a modulatory one 
Finally, the fact that pertussis toxin pretreat­
ment of pancreatic acinar cells does not result in 
inhibition of ССК.-8-induced increases m [Ca2 +] l 
or amylase secretion clearly demonstrates that, as 
m some [41-45], but not all [25-32] Ussues, the 
GTP-binding protein postulated to mediate be­
tween calcium-mobilizing receptors and Pl/y 
phosphodiesterase in the pancreatic acinar cell is 
not sensitive to pertussis toxin. The same conclu­
sions were drawn by Memtt et al. [46] who re­
cently showed that in permeabilized rat pancreatic 
асшаг cells GTPTS-induced mositol tnsphosphate 
formation was not inhibited by pertussis toxin. 
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Chapter 4 
Inhibitory effect of TMB-8 on cholecystokinin-induced long-term elevated 
free cytosolic calcium levels in rabbit pancreatic acinar cells. 
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SUMMARY 
The effects of the potent muscle relaxant 8 (N,N-diethylamino)-octyl 
3,4,5-trimethoxybenzoate (TMB-8) on secretagogue-induced changes in free cytosolic cal-
cium levels ([Ca2+]j) ¡n rabbit pancreatic acinar cells were investigated using the calcium 
selective indicator, quin2. 
Both the C-terminal ocUpeptide of cholecystokinin (CCK-8) and the cholinergic 
receptor agonist, carbachol, increased [Ca2+]¡ from a resting level of 150 nM to a peak 
value of about 700 nM, independent of the presence of extracellular calcium. In the 
absence of extracellular calcium, however, [Ca^+Jj then rapidly decreased to the resting 
level, whereas in the presence of extracellular calcium, this decrease was more slowly and 
a post-stimulatory [Ca2+]¡ of approximately 200 nM, which was significantly higher than 
before stimulation, was maintained for longer periods of time, The higher steady-state 
level, reached within 2 min after the onset of stimulation, is probably due to a stimulus-
induced increase in plasma membrane permeability for calcium, since both the presence 
of a receptor antagonist and the absence of extracellular calcium prevented stimuli from 
maintaining [Ca2+]¡ elevated for longer periods of time. 
TMB-8 only slightly and transiently decreased [Ca2*]; in unstimulated acinar cells. 
The drug did not affect the ССК-8-induced increase in [Ca2+]¡. The ССК-8-ïnduced, 
extracellular calcium dependent long-term elevated [Ca2"*"];, however, was blocked by 
TMB-8. Furthermore, in acinar cells stimulated in the absence of extracellular calcium, 
TMB-8 decreased [Ca2+]¡ to below the resting level. However, resting levels were 
restored upon the readdition of calcium to the medium. 
Our results suggest that in rabbit pancreatic acinar cells, TMB-8 lowers the free 
cytosolic calcium concentration by stimulating the calcium extrusion mechanism rather 
than by blocking the secretagogue-induced increase in plasma membrane permeability 
for calcium. 
INTRODUCTION 
Enzyme secretion studies have shown that in 
pancreatic exocrine tissue stimulated with either 
cholecystokinin (CCK) or acetylcholine the rate of 
enzyme secretion is initially relatively high but 
then rapidly declines to a much lower level, which 
is maintained, however, for prolonged periods of 
lime [1-3]. It has also been shown that the initial 
phase of the secretory response is independent of 
the presence of extracellular calcium [1,2], whereas 
the sustained response is blocked completely in its 
absence [4,5]. In the latter case, stimulated enzyme 
secretion was shown to be restored upon readdition 
of calcium to the medium. 
Experiments in which 4'Ca2+ ^ \)een u se (] [0 
measure calcium fluxes also show a biphasic pat-
tern in that a stimulated calcium efflux is followed 
by a stimulated influx [6-8]. In these studies the 
secretagogue-induced calcium influx was interpret-
ed to be due to a secretagogue-induced increase in 
the plasma membrane penneability for calcium 
[9,10], resulting in a net accumulation of calcium 
[7]. 
Finally, experiments in which changes in free 
cytosolic calcium concentration ([Ca2+]j) were 
measured by means of the fluorescent calcium indi-
cator, quin2, have shown that the secretagogues 
CCK and acetylcholine induce an almost instanta-
neous increase in [Ca2+]¡ followed by a more grad-
ual decrease to near resting levels [11-14]. The 
secretagogue-induced initial increase in [Ca^+Jj is 
independent of the presence of extracellular calci-
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um, suggesting that it represents the inositol 
1,4,5-trisphosphate (IP3) stimulated release of cal-
cium from an intracellular store [11,12,15]. On the 
other hand, after stimulation with CCK or a cholin-
ergic receptor agonist, [Ca2+]¡ does not return to 
prestimulatory levels but remains elevated for pro-
longed periods of time [11,13]. This sustained cal-
cium response, however, is not observed in the 
absence of extracellular calcium [11]. Therefore, 
there are good indications that intracellularly stored 
calcium plays a role in the initial secretory 
response, whereas extracellular calcium is involved 
in sustained secretion. 
The potent muscle relaxant 8-(N,N-diethyl-
amino)octyl 3,4,5-lrimethoxybenzoate (TMB-8) 
has been postulated to act as an intracellular calci-
um antagonist [16-18]. Inhibitory effects of this 
drug on stimulus-evoked processes have therefore 
frequently been used to support other evidence that 
release of calcium from an intracellular pool is 
involved in the mechanism of action of calcium 
mobilizing stimuli (for a review, see Ref.19). 
Recently, however, we [20] and others [21] have 
shown that TMB-8 does not affect stimulus-evoked 
initial increases in [Ca^+Jj, but has several other 
effects among which a potentiating effect 
[20,22-24] and an antimuscarinic effect [20,25]. 
In this study we investigated whether (part of) 
the effects of TMB-8 could be due to inhibition of 
the sustained calcium influx which is essential for 
prolonged enzyme secretion. We therefore applied 
the quin2 technique on rabbit pancreatic acinar 
cells and demonstrated indeed the presence of a 
secretagogue-induced permeability increase for cal-
cium. TMB-8 was shown to be able to block the 
increase in cytosolic calcium, but the results indi-
cate that TMB-8 activates the calcium extrusion 
mechanism rather than that it inhibits the perme-
ability increase. 
MATERIALS AMD METHODS 
Preparation of rabbit pancreatic acinar cells, 
loading of the acinar cells with the calcium selec-
tive fluorescent indicator, quin2 and fluorescence 
measurements were carried out as previously 
described [15,20]. Cytosolic free calcium concen-
trations were calculated according to Tsien et 
al.[26]. 
The C-tenninal octapeptide of cholecystokinin 
has been synthesized by Dr. H.M. Rajh in the 
Department of Organic Chemistry, University of 
Nijmegen. Carbachol was ptnchased from ACF 
Chemiefarma, Maarsen, The Netherlands. 
Atropine was obtained from Merck, Dannstadt, 
F.R.G.; TMB-8 from Aldrich Chem. Co., Milwau-
kee, WI, U.S.A.; soybean trypsin inhibitor and 
quin2/AM from Sigma, St. Louis, MO, U.S.A.; col-
lagenase from Cooper Biomedical Inc., Malvern, 
PA, U.S.A. and hyaluronidase from Boehringer, 
Mannheim, F.R.G. All other chemicals were of 
reagent grade. 
RESULTS 
Rabbit pancreatic acinar cells loaded with the 
fluorescent calcium indicator, quin!, were used to 
calculate the free cytosolic calcium concentration 
both under stimulated and unstimulated conditions. 
In unstimulated acinar cells [Ca^+Jj was calcu-
lated to be 150 nM (S.E. 9; 5 different cell prepara-
tions). When acinar cells were resuspended in 
medium to which no calcium was added and the 
extracellular calcium concentration was reduced 
further by adding 0.2 mM of the calcium chelating 
agent, EGTA, no decrease in [Ca^+Jj was 
observed. [Ca2*]; did also not increase in those 
experiments in which, after a 1 min incubation in 
the presence of EGTA, the medium calcium con-
centration was increased to 1.0 mM. 
Both CCK-8 (ЗЛО"8 M) and carbachol (IO"5 
M) increased [Ca2 +]j within seconds to about 800 
nM. Figure 1 shows that this initial increase was 
independent of the presence of extracellular calci­
um. In the absence of extracellular calcium, how­
ever, [Ca2+]j more rapidly declined and returned to 
prestimulatory levels, whereas in its presence, 
[Ca2+]¡ remained elevated at approx. 200 nM for 
prolonged periods of time. Readdition of calcium 
to the medium, after stimulation in the absence of 
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Figure 1. Effects of extracellular calcium on CCK-8- and caibachol-induced changes in [Ca2+]j 
in quinl-loaded rabbit pancreatic acinar cells. Immediately before use, acinar cells loaded with 
quin2 were resuspended in a HEPES/TRIS medium (pH 7.4) to which no calcium was added and 
which was thoroughly gassed with O2· The cells were transferred to a cuvet placed in a spectroflu-
orometer and preincubated for 3 min at З ? ^ . Stining of the cell suspension was start«! and 0.2 
mM EGTA was added (-Ca). In those experiments in which extracellular calcium was present 
(+Ca), after 1 min the medium calcium concentration was increased to 1.0 mM. CCK-8 (3.10"° 
M), Carbachol (CCh; 10 - 5 M), atropine (3.10"5 M) and calcium (final concentration 1.0 mM) 
were added at the times indicated. In the recordings shown, corrections were made for the effects 
of EGTA and calcium, due to the presence of extracellular quin2. This figure is typical for three 
different acinar cell preparations. 
- 42 -
Figure 2, Effects of TMB-8 on ССК-8-induced changes in [Ca2+]¡ in quin2-loaded rabbit pancre-
atic acinar cells. After 3 min of preincubation in the spectrofluorometer (see legends to figure 1), 
stirring of the cell suspension was started and 0.2 mM EGTA was added (-Ca). In those experi-
ments in which extracellular calcium was present (+Ca), after 1 min the medium calcium concen-
tiation was increased to 1.0 mM. CCK-8 (3.10~9 M), TMB-8 (250 μΜ) and caldum (final con­
centration 1.0 mM) were added at the times indicated. In the recordings shown, corrections were 
made for the effects of EGTA and calcium, due to the presence of extracellular quin!. This figure 
is typical for five different acinar cell preparations. 
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extracellular calcium, resulted in a rapid increase in 
[Ca2+]j to the same elevated levels as observed in 
cells stimulated in the presence of extracellular cal-
cium. The latter increase in [Ca2+]¡ was blocked 
when the cholinergic receptor antagonist atropine 
was added prior to calcium (Fig. lb). In the pres-
ence of extracellular calcium, the carbachol-
induced long-term elevated [Ca2+]j decreased 
immediately to prestimulalory levels when atropine 
was added (Fig. 1 b,c). 
Figure 2 shows that addition of 2S0 μΜ 
TMB-8 to unstimulated acinar cells resulted m a 
small but transient decrease in [Ca2+]j (Fig. 2 c,d). 
As shown before [20], the CCK-S-induced initial 
increase in [Ca^+jj was not affected by the drug. 
However, after stimulation with CCK-8 in the pres­
ence of extracellular calcium and TMB-8, [Ca2+]j 
did not return to the sustained elevated levels but 
decreased to the prestimulalory level (Fig. 2c), 
whereas in the absence of extracellular calcium, 
[Ca2+]¡ decreased even to below the resting level 
(Fig. 2d). In the latter case prestimulalory free 
cytosolic calcium levels were restored upon readdi-
tion of calcium to the medium. Figure 2a shows 
that, in the presence of extracellular calcium, 
TMB-8 almost immediately decreased the 
CCK-8-induced long-term elevated [Ca2+]¡ to 
below the resting level followed by a more gradual-
ly increase to prestimulatory levels. Addition of 
TMB-8 to acinar cells, stimulated in the absence of 
extracellular calcium, at the time [Ca2+]¡ had 
reached resting levels again, resulted in an almost 
immediate, but not a transient, decrease in [Ca2+]¡ 
(Fig. 2b). In the latter case, [Ca2+]¡ did not return 
to prestimulatory levels unless calcium was 
readded to the medium. 
TMB-8, at a concentration of 250 μΜ did not 
affect the intactness of the acinar cells as was dem­
onstrated by Trypan blue exclusion immediately 
after measurement of fluorescence. 
DISCUSSION 
At least three structures are involved in regulat­
ing the free cytosolic calcium concentration: plas­
ma membrane [27], mitochondria [28] and a non­
mitochondrial pool probably the endoplasmic 
reticulum [6,29,30]. In the resting cell, calcium 
pumps localized in the above structures maintain 
the [Ca2 +]j at about 150 nM. The fact that in the 
absence of extracellular calcium no decrease in 
[Ca2+]¡ is observed, indicates that the passive leak-
age of calcium is very low and/or that a very effi-
cient compensatory mechanism exists. Addition of 
250 μΜ TMB-8 to unstimulated acinar cells slight­
ly but transiently decreased [Ca2+]i, suggesting 
that the calcium balance is temporary disturbed. In 
adrenal glomerulosa cells, TMB-8 was also found 
to decrease the resting [Ca2+]¡ [31]. In these cells, 
however, the ТМВ-8-induced decrease was perma­
nent and it was suggested that the drug affected 
basal calcium influx. 
Upon stimulation with CCK-8 or carbachol an 
almost instantaneous increase in [Ca2+]¡ is 
observed which is independent of the presence of 
extracellular calcium and which is therefore 
thought to represent the inositol 
1,4,5-trisphospbate-mediated release of calcium 
from an intracellular store, most probably the endo-
plasmic reticulum [32]. As we have shown before, 
this initial phase of the calcium response was not 
affected by TMB-8 [20]. 
After having reached its peak value, [Ca2+]¡ 
decreased within 2 min to a plateau level of about 
200 nM, which is maintained for a prolonged peri-
od of time. This sustained phase of the calcium 
response clearly depends on the presence of extra-
cellular calcium and is therefore most likely due to 
an increased influx of calcium. The fact that that 
the sustained phase of the calcium response is 
blocked completely by a receptor antagonist, indi-
cates that receptor occupation is required. Although 
it is not clear yet which mechanism underlies this 
stimulus-induced increase in plasma membrane 
permeability for calcium, there are some indica-
tions that inositol 1,3,4,5-telrakisphosphate, might 
be involved [33]. Most interestingly, TMB-8 
blocks this CCK-S-induced long-term elevated 
[Ca2+]¡. Inhibition was complete at a concentra-
tion of 250 μΜ, whereas at lower concentrations 
(50 - 100 μΜ), the drug markedly but not com­
pletely decreased this long-term elevated [Ca2+]¡ 
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(data not shown). Observations like these strongly 
suggest that TMB-8 inhibits the ССК-8-induced 
increase in plasma membrane permeability for cal­
cium. In fact, in adrenal glomerulosa cells, TMB-8 
is thought to inhibit angiotensin^ stimulated aldos­
terone secretion by inhibiting the influx of extracel­
lular calcium [34], whereas in cultured bovine 
adrenal chromaffin cells it is speculated that the 
drug inhibits calcium uptake by blocking a cholin­
ergic receptor-coupled calcium channel [35]. Our 
observation, however, that in acinar cells stimulat­
ed in the absence of extracellular calcium, TMB-8 
decreases [Ca2+]¡ to below the resting level and 
that the resting level is restored upon readding cal-
cium to the medium, is not in line with the above 
hypothesis. This observation rather suggests that 
the drug activates some kind of calcium extrusion 
mechanism. If this is the case then the transient 
decrease in [Ca2+]¡ observed upon addition of 
TMB-8 to unstimulated cells can be explained by a 
stimulated calcium extrusion process, followed by 
a compensatory release of calcium from an intra-
cellular store. In stimulated cells this intracellular 
store is emptied but in the presence of extracellular 
calcium, the influx of calcium compensates for the 
increased extrusion. In the absence of extracellular 
calcium no compensatory calcium pool is present 
and [Ca2+]j decreases to below the resting level, 
which is restored upon readdion of calcium to the 
medium. 
From the results presented in this study it is 
clear that TMB-8 inhibits secretagogue-induced 
long-term elevated free cytosolic calcium levels in 
rabbit pancreatic acini and that this inhibitory 
action of TMB-8 is rather due to a stimulatory 
effect on the process of calcium extrusion than to 
an inhibitory effect on the receptor-mediated 
increase in plasma membrane permeability for cal-
cium. More detailed investigations are needed, 
however, to clarify the exact mechanism of action 
of this drug. 
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The putative intracellular calcium antagonist 3,4,5-triinethoxybenzoate 8-(diethylamino)-octyl ester (TMB-8) 
affects carbachol-induced enzyme secretion from rabbit pancreatic acini in a different way than it does that 
induced by either the C-terminal octapeptide of cholecystokinin (CCK-8), the phorbol ester, 12-O-tetrade-
canoylphorbol 13-acetate (TPA) or the calcium ionophore, A23187. In the presence of TMB-8 the 
dose-response curve for carbachol-induced amylase release shifts to the right, suggesting competitive 
antagonism at the muscarinic receptor. The hypothesis that TMB-8 acts as a muscarinic receptor antagonist 
Is supported by the observation that TMB-8 dose-dependently inhibits the carbachol-, but not ССК-8-in-
duced increases in cytosolic free calcium, measured in acinar cells by means of the fluorescent calcium 
indicator quin2. At a concentration of 100 μΜ, TMB-8 maximally potentiates the secretory response to 
suboptimal, but not (supra)optimal, concentrations of CCK-8. At the same concentration the drug also 
potentiates TPA- and A23187-induced enzyme secretion. Cytosolic free calcium levels and ССК-8-induced 
Increases in cytosolic free calcium remain unaffected by 100 μΜ TMB-8. The above results strongly suggest 
that potentiation occurs at or beyond the site of interaction between the diacylglycerol- and the Ca1''-activated 
pathways. At concentrations beyond 100 μΜ the potentiating effect of TMB-8 declines and, finally, at a 
concentration of 500 μ M the drug completely abolishes the secretory response to CCK-8 and TPA. Basal 
enzyme secretion, however, remains unaffected. At 500 μΜ severe side effects are observed as is shown by 
Trypan blue uptake, lactic dehydrogenase release and release of trapped quin2. It is concluded that at lower 
concentrations TMB-8 does not act as a specific Intracellular calcium antagonist in pancreatic enzyme 
secretion and that inhibitory effects obtained with rather high concentrations of this drug should be treated 
with caution. 
Introduction 
In the exocrine pancreas both the receptor for 
cholecystokinin (CCK) and for acetylcholine are 
coupled to the calcium messenger system [1-4]. In 
secretion studies, the initial response to the above 
Abbreviations TMB-8, 3,4,5-lnmethoxybenzoic acid 8-(dielh-
ylamino)-octyl ester, CCK(-8), cholecystokimn(ociapeptide), 
TPA, 12-O-tetradecanoylphorbol П-acítate, quin2, 2-|(2-bis-
(carboxyniethy])amino-5-meltiylphenoxy)meihyl]-6-ineihoxy-
quinoline, quin2/AM, quin2-tetra-(acetoxymethyl)ester 
Correspondence address Dr JJ H H M de Pont. Department 
of Biochemistry, PO Box 9101, 6500 HB Nijmegen, The 
Netherlands 
secretagogues has been shown to be independent 
of the presence of extracellular calcium, whereas 
ш its absence the sustained response is abolished 
[1,5,6] Moreover, upon preincubation with calcium 
chelating agents the secretory response in the ab­
sence of extracellular calcium has been shown to 
diminish with time [1,5,7,8] Observations of the 
kind described above have led to the hypothesis 
that during the initial phase of the response, 
calcium is mobilized from intracellular stores, 
whereas the influx of extracellular calcium is 
needed to maintain the response [1,3,9,10] 
The drug TMB-8 has been postulated to act as 
0167-4889/86/ЮЗ 50 О 1986 Elsevier Science Pubhshers В V (Biomedical Division) 
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an intracellular calcium antagonist [11-13] It 
could, therefore, be a useful tool to assess the 
relative requirement for calcium of intracellular 
and extracellular origin in pancreatic enzyme 
secretion 
In preliminary experiments, however, a slight 
stimulatory effect of TMB-8 on the secretory re­
sponse to the octapeptide of cholecystokmin 
(CCK.-8) was observed This has led us to study 
the mechanism of action of this drug in pancreatic 
enzyme secretion in more detail 
We conclude that TMB-8 has several effects in 
exocrine pancreatic secretion but is not a specific 
intracellular calcium antagonist in this system 
Materials and Methods 
Rabbit pancreatic acini were prepared essen­
tially as described for acinar cells by Amsterdam 
and Jaimeson [14], except that the divalent cation 
chelating step was omitted The method is based 
on two successive incubations with collagenase 
and hyaluromdase in a medium containing 0 1 
mM C a 2 + After this digestion the tissue was 
dispersed by pipetting The suspension was filtered 
through nylon gauze and punfied by centrifuga­
tion through a 4% albumin layer For the prepara­
tion of acinar cells the procedure of Amsterdam 
and Jamieson [14] including the calcium chelating 
step has been applied The intactness of the iso­
lated acini and acinar cells has been demonstrated 
by Trypan blue exclusion 
For secretion studies, acim were incubated in a 
Krebs-Ringer bicarbonate medium (pH 7 4) con­
taining 119 mM NaCl, 3 5 mM KCl, 12 mM 
КНзРО,,, 25 mM NaHC0 3 , 1 2 mM CaCl2, 1 2 
mM MgCl2, 5 8 mM glucose, 1% bovine serum 
albumin, 0 2 mg/ml soybean trypsin inhibitor 
and an amino acid mixture according to Eagle [15] 
and 37° С The stimulants were added as indicated 
in the legends to the figures, and samples of the 
incubation mixture were removed at appropriate 
times for determination of both the amylase and 
lactic dehydrogenase activities At the end of the 
experiment, the acini were homogenized in the 
incubation medium Amylase activity was mea­
sured in the samples after rapid sedimentation of 
the acini and in the acinar homogenate by means 
of the Phadebas test [16] Lactic dehydrogenase 
activity was assayed with the technique of Kubo-
witz and Ott [17] 
Intracellular calcium measurements have been 
earned out in acinar cells loaded with the fluo­
rescent calcium indicator, quin2, as described by 
Ochs et al [18] After a 20 min incubation in the 
presence of 50 μΜ quin2/AM at 37 0C, the 
medium was diluted 8-times and the cells were 
incubated for another 45 mm Excess quin2/AM 
was then removed by two centrifugation steps for 
5 mm at 100 x g Quin2-loaded acinar cells were 
resuspended m the above medium and kept at 
room temperature Samples removed for fluores­
cence measurements were centnfuged and the cells 
were resuspended in the above medium containing 
1 0 mM CaClj, 1 0 mM MgClj and 0 1% bovine 
serum albumin Fluorescence measurements were 
earned out at 37 "C, using a Shimadzu RF-510 
spectrofluorometer equipped with a magnetic 
stirrer and a thermostated cuvet holder For 
calibration of the quin2 signals digitonin (15 pg/ 
ml, maximal fluorescence), Tns base (10 mM) and 
EGTA (2 mM, minimum fluorescence) were ad 
ded sequentially In each expenment the same 
amount of unloaded acinar cells was treated in 
exactly the same way and corrections were made 
for the effects of the compounds added Calcium 
concentrations were calculated according to Tsien 
et al [19] 
Materials 
The C-termmal octapeptide of cholecystokmin 
was synthesized by Dr H M Rajh in the Depart­
ment of Organic Chemistry, University of Nijme­
gen Carbachol was purchased from ACF Chemie-
farma, Maarsen, The Netherlands A23187 was 
obtained from Calbiochem, La Jolla, CA, U S A , 
TMB-8 was from Aldnch Chem Co, Milwaukee 
WI, U S A , TPA, soybean trypsin inhibitor, 
bovine serum albumin and quin2/AM were from 
Sigma, St Louis, MO, U S A , collagenase was 
from Cooper Biomedical Ine, Malvern, PA, U S A 
and hyaluromdase was from Boehnnger, Mann­
heim, F R G The Phadebas test kit for determina­
tion of amylase activity was purchased from 
Pharmacia, Uppsala, Sweden All other chemicals 
were commercial preparations of the highest ob­
tainable punty 
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Results 
Effects on CCK-8 induced amylase release 
The increase in amylase release from rabbit 
pancreatic acini stimulated by the secretagogue 
CCK-8 is nearly linear with time during the first 
30 mm (Fig 1) But, whereas in the presence of 
100 fiM TMB-8 basal amylase release remains 
virtually unchanged, the secretory response to 10 "* 
M CCK-8 is potentiated. On the other hand, 
enzyme secretion induced by CCK-8 at a con­
centration of 10"* M is not potentiated but slightly 
inhibited To investigate the effects of TMB-8 on 
ССК-8-induced amylase release in more detail, 
dose-response curves for TMB-8 in the presence of 
subopümal (10"' M and 10"' M), optimal ( Ю - 7 
M) and supraoptimal (IO"6 M) concenntrations of 
CCK-8 were produced. 
60 80 
time (mm ) 
Fig. 1 Effects of CCK-8 and TMB-8, alone and in combina­
tion, on amylase release from rabbil pancreauc acini After 
pmncubauon for 20 mm at 37°C TMB-8 (100 jiM clued 
symbols) is added CCK-8 ( 1 0 - ' M, v,», and IO" 6 M, OM) 
was added 20 nun later Amylase release was measured at the 
indicated limes, and is expressed as a percentage of the total 
amylase content of the acini at the beginning of incubation 
Basal release from 20 to 70 nun is the same as that m the 
presence of TMB-8 (without CCK-8) This figure is typical of 
four experiments 
Fig 2 shows that the effect of TMB-8 on 
CCK-8 stimulated amylase release depends both 
on its own concentration and that of the secreta­
gogue At TMB-8 concentrations above 100 μΜ 
the secretory response to CCK-8 is inhibited dose 
dependently leading to complete abolishment at 
500 μΜ. Basal amylase secretion, however, re­
mains unaffected, even with TMB-8 concentra­
tions as high as 300 μΜ. At concentrations be­
tween 50 and 100 μΜ, TMB-8 potentiates the 
secretory response to suboptimal (10 ~' M and 
10 "* M) concentrations of CCK-8, whereas the 
stimulatory effect of optimal (IO - 7 M) and 
supraoptimal (ΙΟ-* M) concentrations of the 
hormone is slightly inhibited. 
· " 5 4 3 
nag log molar TMB-8 concentration 
Fig. 2 Dose-mhibition curve for TMB-8 on CCK-8 stimulated 
amylase secretion from rabbit pancreauc acuu Acini were 
incubated for 70 mm at 37°C TMB-8, at the indicated con­
centrations, and CCK-8 ( I O " ' M, O. IO" 1 M, · , IO"' M, D; 
and 1 0 " ' M, •) were added after 20 nun and 40 mm, respec-
Uvely Amylase release was measured at 0, 20, 40 and 70 nun 
and is expressed as percentage of total amylase originally 
present in the acmi The increase ш amylase release at 70 mm 
was corrected for the basal release at that tune, determined by 
extrapolation from the release values al 0, 20 and 40 nun in 
each expenment The values presented are the means ± S E. of 
3-4 expenments 
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Effects on carbachol-induced amylase release 
The dose-response curve for the effect of 
carbachol alone on amylase release from rabbit 
pancreatic acini shows a maximal effect at a con­
centration of 3 10" 5 M (Fig 3). As with CCK-8 
the stimulatory effect of carbachol is completely 
abolished at 500 μΜ TMB-8 At concentrations 
between 10 and 100 μΜ, however, TMB-8 affects 
carbachol-induced amylase release differently from 
the response to CCK-8. The stimulatory effect of 
suboptimal (3·10~* M and ΙΟ"5 M) concentra­
tions of carbachol is effectively inhibited by TMB-
8 at concentrations ranging from 10 to about 100 
μΜ The secretory response to optimal ( 3 · 1 0 " 5 
M) and supraoptimal (ΙΟ - 4 M) concentrations of 
carbachol, however, is slightly inhibited at low 
(10-25 μΜ) and potentiated at intermediate 
(25-50 μΜ) concentrations of the drug Therefore, 
the potentiating effect of TMB-8 seems to overrule 
an inhibitory effect which is not seen upon stimu-
0 0
 5 4 3 
neg log molar ΤΜΒ-Θ concentration 
Fig. 3 Dose-mhibiuon curve for TMB-8 on carbachol stimu­
lated amylase release from rabbit pancreatic acini Acini were 
incubated for 70 min TMB-8, al the indicated concentrations, 
and carbachol (3 Н Г ' Μ, Ο, ΙΟ" 5 M, · . 3 IO" 5 M, D, and 
10"* M, •) were added after 20 mm and 40 mm, respectively 
Details on sampling and calculations are given in the legend of 
Fig. 2 The values presented are the means±SE. of 3-4 
experiments. 
lation with CCK-8. This observation would be in 
line with a competitive action of TMB-8 on the 
cholinergic receptor The latter is more apparent 
by the nght-hand shift of the dose-response curve 
for carbachol in the presence of TMB-8 (Fig 4) 
One interesting feature of potentiation by 
TMB-8 is that m the presence of the drug, amylase 
release does not exceed that induced by the maxi­
mally stimulating concentration of secretagogue 
alone (Figs 2 and 3) 
Effects on TPA- and A23187-mduced amylase re­
lease 
The mechanism of action of TMB-8 on pan­
creatic enzyme secretion was examined further by 
investigating the effect of 100 μΜ TMB-8, shown 
to maximally potentiate the response to CCK-8, 
on amylase release induced by the phorbol ester, 
« 7 6 5 4 
neg log molar carbachol concentration 
Fig 4 Effect of TMB-8 on the dose-response curve for 
carbachol stimulation of amylase secretion from rabbit pan­
creatic acini Acini were incubated for 70 mm TMB-8 (0 μΜ. 
О, 10 μ M, · . 23 μΜ, О, SO μΜ. •, 100 μΜ, ν, 200 μΜ, Τ, 
300 μΜ, Δ , and 500 μΜ, A) and carbachol, at the indicated 
concentrations, were added after 20 nun and 40 mm, respec-
uvely Details on sampling and calculations are given in the 
legend of Fig. 2 The values presented are the means of 3-4 
ex penmen Is, 
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TPA. known to activate protein kinase С [20], and 
the calcium ionophore A23187. 
Fig. 5 shows that 100 μΜ TMB-8 potentiates 
the slight stimulatory effect of TPA at all con­
centrations (1 nM to 10 μΜ) tested. At the same 
concentration TMB-8 also potentiates the secre­
tory response to 10" ' M A23187 (Fig. 6). As with 
CCK.-8 and carbachol, TPA-induced amylase 
secretion is completely inhibited at 300 μΜ TMB-
8. However, at a concentration of 500 μΜ, TMB-8 
neither potentiates nor inhibits the response to 
10"* M A23187 (data not shown). 
Effects on cytosolic free calcium 
In order to investigate more directly the possi­
bility that intracellular calcium levels are affected 
by TMB-8, pancreatic acinar cells were loaded 
with the fluorescent calcium indicator quin2. In 
unstimulated acinar cells cytosolic free calcium, 
[Ca2+]„ is calculated to be 149 nM (S.E 10 nM; 5 
different cell preparations). Fig. 7 shows that the 
os 9 8 7 6 5 
neg log molar TPA concentration 
Fig. 5. Effect of TMB-B on the dote-response curve for TPA 
stimulation of amylase release from rabbit pancreatic acini. 
Acini were incubated for 70 mm at 37"С TMB-8 (100 μΜ) 
and TPA, al the indicated concenlrations, were added after 20 
nun and 40 mm, respectively Details on sampling and calcula­
tions are given in the legend of Fig. 2. The values presented are 
the incans±S.E. of 3-4 experiments. 
80 100 
t im· (mm) 
Fig. 6. Effects of A23U7 and TMB-8, alone and in combina­
tion, on amylase release from rabbit pancreatic acini. After 
preincubation for 40 mm at ]7°C, TMB-8 (100 μΜ, closed 
symbols) was added. A23187 (10"' M, O, •) was added 20 mm 
later. Details on sampling and calculations are given in the 
legend of Fig. 1. Basal release from 40 to 90 mm was the same 
as that in the presence of TMB-8 alone. This ñgure is typical of 
three expenments. 
addition of TPA (10~s M) does not lead to any 
change in [Ca2*],. Upon stimulation with 10"' M 
CCK-8, however, an almost immediate increase in 
[Ca1*], up to about 800 nM is observed, followed 
by a relatively slow decay (Fig. 8, top). When 
pancreatic acinar cells are preincubated with 100 
μΜ TMB-8, shown before to maximally potentiate 
thesecrelory response to either CCK-8, TPA or 
A23187, for 20 min, neither the basal [Ca2*], nor 
the CCK.-8 ( 1 0 - 9 M)-induced initial increase in 
[Ca2*], is altered (Fig. 8, top). 
Fig. 8 (bottom) shows that the addition of Ю - 5 
M carbachol results in an almost immediate in­
crease in [Ca2*], up to about 800 nM. This figure 
also shows that upon subsequent stimulation with 
ΙΟ
- 1
 M CCK-8, there is no further increase in 
[Ca2*],. However, when 50 μΜ TMB-8 is added 
just before carbachol, the effect of carbachol on 
[Ca2*], is almost abolished, whereas the effect of 
CCK-8 remains unchanged (Fig. 8, bottom). A 
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Fig. 7. The effect of TPA on [Ca 1* ), in quin2-loade<i rabbi! 
pancreatic acinar cells. Quin2-loaded cells were incubated entier 
in the absence (a) or in the presence (b) of TPA ( 1 0 " ' M). This 
figure is typcial of five expenments. 
dose-response curve for the inhibitory effect of 
TMB-8 on the initial increase in [Ca2 + ] 1 induced 
by 10 5 M carbachol (Fig. 9) indicates again that 
Caf 
(nM) 
760 
150 
(nM) 
8 0 0 -
130 
CCK-8 
I 
сск-в 
I 
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. I m í n . 
CCh CCK-β 
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им 
H 
мм« ' 
CCh сск-
ІЛІЫЧ/*** 
/WW 
, 1 min 
Fig 8 The effect of TMB-8 on the carbachol- and ССК.-8-in-
duced increase in [Ca 2* I, in quin 2-loaded rabbit pancreatic 
acinar cells. Top: quin2-loaded cells were preincubated for 20 
nun either in the absence (a) or presence (b) of TMB-8 (100 
μΜ) Fluorescent measurement was starled and CCK-8 ( 1 0 " ' 
M) was added Bottom: quin2-loaded cells were incubated 
either in the absence (a) or presence (b) of TMB-8 (SO μΜ). 
Carbachol (CCh; IO" 5 M) and CCK-8 (ΙΟ" ' M) were added 
at the indicated times. This figure is typical of four experi­
ments. 
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Fig. 9. Dose-inhibition curve for TMB-8 on the carbachol-in-
duced initial increase in [ C a 2 * ] , in quin2-loaded rabbit pan­
creatic acinar cells. Quin2-loaded cells were incubated for 1 
mm in the presence of TMB-8, at the indicated concentrations. 
After 1 mm carbachol (CCh, 10 5 m) is added 
TMB-8 is a cholinergic receptor antagonist. The 
inhibitory action of 50 μΜ TMB-8 is relieved 
when the drug is removed. TMB-8, at concentra­
tions up to 250 μΜ, has no effect on [Ca 2 *], (data 
not shown). At the relatively high concentration of 
500 μΜ, however, TMB-8 increases the fluores­
cence obtained from unloaded as well as quin2-
loaded cells. Similar observations with relatively 
high concentrations of TMB-8 are reported by 
Simpson et al. [21]. 
Effects on lactic dehydrogenase retention and Trypan 
blue exclusion 
The viability of the acinar cells is routinely 
checked during the incubation period using the 
vital stain Trypan blue. The addition of carbachol, 
CCK-8, TPA (dissolved in dimethylsulfoxide) or 
A23187 (dissolved in ethanol) does not effect the 
viability of the acinar cells. Also TMB-8 alone, at 
concentrations as high as 500 μΜ, has no effect 
on Trypan blue exclusion over a period of at least 
50 min. However, pancreatic acinar cells prein­
cubated with 500 μ M TMB-8 lose their capability 
to exclude Trypan blue within 20 min after the 
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addition of either 10"' M A23187 or CCK-8 at 
concentrations at or above 10"' M 
The suggestion that TMB-8 in combination with 
a stimulant has a cytotoxic effect on pancreatic 
acinar cells is supported by the fact that, whereas 
no lactic dehydrogenase is released in the presence 
of TMB-8 (500 /iM) alone, addition of either 
CCK-8 or A23187 leads to a nearly complete 
release of lactic dehydrogenase within 20-30 mm 
In the presence of 100 μΜ TMB-8, however, none 
of the stimulants used induced the release of lactic 
dehydrogenase 
Discussion 
The mechanism of action of the potent muscle 
relaxant TMB-8 has been investigated by Malagodi 
and Chiou [11-13] Since TMB-8 blocked muscle 
contraction in response to agents which increase 
cytosohc calcium and the more since the drug 
inhibited caffeine-induced calcium release from 
isolated sarcoplasmic reticulum TMB-8 was con­
cluded to act by preventing the release of calcium 
from intracellular stores This finding has led many 
investigators to use TMB-8 in studies on the role 
of intracellular calcium pools in stimulus-response 
coupling (for a review, see Ref 22) 
Pancreatic enzyme secretion is stimulated by 
the neurotransmitter acetylcholine and the peptide 
hormone cholecystokinin Since both secreta-
gogues are thought to activate the same intracellu­
lar pathways [1-4], it was quite surprising to us 
that in rabbit pancreatic acini, TMB-8 affected 
carbachol-induced amylase release in a signifi­
cantly different way than the secretory response to 
CCK-8, TMB-8 inhibition of enzyme secretion 
stimulated by carbachol was more effective, 
whereas amylase release induced by CCK-8 was 
even potentiated under certain circumstances 
The experimental data obtained strongly sug­
gest that m the exocrine pancreas TMB-8 acts as a 
cholinergic receptor antagonist Our results sup­
port those of Tennes et al [23], who reported that 
in mouse, [3H]quinuclidinoI benzoate binding was 
inhibited by TMB-8 both in pancreatic acini and 
submandibular glands, indicating that in these 
tissues TMB-8 blocks the muscarinic receptor In­
hibitory effects of TMB-8 on carbachol-induced 
pancreatic enzyme secretion were also reported by 
Ikeda et al [24] An anticholinergic effect of 
TMB-8 was excluded by these authors because the 
drug also inhibited CCK-8 stimulated enzyme 
secretion The type of inhibition, however, was not 
investigated in more detail 
An interesting finding made in this study is 
that under certain conditions TMB-8 potentiated 
the stimulatory effect of the secretagogue used 
Potentiating effects of TMB-8 have been described 
in the literature [25-27] In none of these studies, 
however, is the mechanism of action of TMB-8 
examined in more detail The observation that 
secretagogue-induced enzyme secretion potenti­
ated by TMB-8 did not exceed that induced by the 
optimal concentration of secretagogue, suggests 
that the drug accelerates some important step in 
stimulus-secretion coupling up to the same level as 
is reached with optimal concentrations of 
secretagogue The fact that TMB-8 alone had no 
effect on pancreatic enzyme secretion seems to 
rule out a direct activation by the drug itself of 
crucial steps leading to secretion 
Our results do not support the hypothesis that 
the potentiating effect of TMB-8 is mediated by 
calcium [26,27] This is because the drug neither 
increased [Ca2 +],, nor induced an additional in­
crease in [Ca 2 +], upon stimulation with secreta­
gogue Moreover, TMB-8 also potentiated the 
secretory response to calcium lonophore A23187 
Since TMB-8 potentiated both the response to 
A23187 and TPA, the drug seems to act at or 
distal from the site of interaction between Ca2 + 
and TPA It remains to be elucidated, whether 
potentiation occurs at the level of protein kinase С 
itself, or at some step beyond the activation of this 
enzyme 
At TMB-8 concentrations above 100 μΜ, the 
drug becomes inhibitory to the stimulatory effects 
of CCK-8, carbachol and TPA Although an ex­
planation for the inhibitory effect of 100-500 μΜ 
TMB-8 can hardly be given, it is clear that at 500 
μΜ cytotoxic effects are observed The acinar cells 
rapidly lost their integrity in the presence of 
secretagogue, as has been observed by Di Virgilio 
and Gomperts [28] for TMB-8, m combination 
with monensin, at concentrations at or above 300 
μ M in rabbit neutrophils At relatively high con­
centrations, TMB-8 has been described to de­
crease significantly intracellular ATP levels [22,29] 
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and to act as a general membrane disrupting 
reagent (30]. Therefore, inhibitory effects of rela­
tively high concentrations of TMB-8 found on 
stimulus-evoked processes should be treated with 
caution 
From the results presented in this paper, it is 
concluded that in the exocnne pancreas TMB-8 is 
not a selective inhibitor of secretagogue-induced 
calcium mobilization Inhibitory effects of TMB-8 
are either due to its anticholinergic activity or to 
the cytotoxic activity it has at relatively high con­
centrations. At 100 μΜ, TMB-8 maximally poten­
tiates enzyme secretion induced by suboptimal 
concentrations of CCK-8 It is argued that this 
potentiating effect of TMB-8 is not likely to be 
due to an (additional) increase in [Ca 2*],. Since 
100 μΜ TMB-8 also potentiates the response to 
A23187 and TPA, it is suggested that potentiation 
occurs at or beyond the site of interaction between 
C a 2 + and TPA Detailed investigations are needed, 
however, the clanfy to exact mechanism of the 
stimulatory action of TMB-8 in pancreatic enzyme 
secretion 
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Phorbol ester inhibits cholecystokinin octapeptide-induced 
amylase secretion, but is vithout effect on secretagogne-
induced hydrolysis of phosphatidylinositol 4^-bisphosphate 
in rabbit pancreatic acini. 
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Phorbol ester inhibits cholecystokinin octapeptide-induced amylase secretion 
and calcium mobilization, but is without effect on secretagogue-induced 
hydrolysis of phosphatidylinositol 4,5-bisphosphate in rabbit pancreatic acini 
P.H.G.M. Willems, I.G.P. van Nooij, H.E.M.G. Haenen 
and J.J.H.H.M. de Pont 
Department of Biochemistry, Umuentty of Nijmegen. Nijmegen (The Netherlands) 
(Received 1 Apnl 1987) 
Key wordc: Phorbol ester, Cholecystokinin octapeplide; Amylase secretion; Cakium mobibzation. Inositol phosphate; 
(Rabbit acini) 
The effect of prolonged protein kinase С activation on cholecystokinin octapeptide (CCK-8)-induced 
amylase secretion from rabbit pancreatic acini was studied by means of the phorbol ester, 12-O-tetrade-
canoylphorbol 13-acetate (TPA). The phorbol ester itself increased basal amylase secretion but inhibited 
completely the secretory response to relatively low concentrations of CCK-8. The inhibitory action of TPA 
on ССК-8-induced amylase secretion was paralleled by inhibition of ССК-8-induced calcium mobilization 
but not by inhibition of ССК-8-induced breakdown of "P-labeiled phosphatidylinositol 4,5-bisphosphate. 
The results presented suggest that protein kinase C, or one of its phosphorylated products, inhibits the 
ССК-8-stimulated pathway leading to secretion at a level beyond the secretagogue-induced hydrolysis of 
phosphatidylinositol 4,5-bispbosphate. Inhibition of the initial, inositol 1,4,5-trisphosphate-mediated and 
extracellular calcmm-independent, increase in free cytosolic calcium concentration, together with the 
findings of others, suggests that die efficacy of this inositolphosphate to release calcium is reduced. 
Introduction 
Activation of the calcium messenger system 
implies the receptor-mediated breakdown of phos-
Abbrenations: CCIC-8. cholecystokinin octapeptide, TPA. 12-
O-tetradecanoylphorbol 13-acetate, quin2, 24(2-(bi)((carbon-
yl)methyl)ammo)-5-roelhylphtnoxy)inelhyl-6-mtlhony-8-(bii-
((carbonyl)inethyl)amino)quinoline, quin2/AMl quin2-
teira(ace1oxyniethyl)ester, P1P3, phosphatidylinositol 4,3-bie-
phosphale; ΙΡ3, inositol 1,4,3-tnsphosphale, (Ca1* I,, free cy­
tosolic calcium concentration; DMSO, dimethyl sulfoxide, 
Hepes, 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid. 
Correspondence: Ρ H G M Willems, Department of Biochem­
istry, University of Nijmegen, P.O. Box 9101, 6500 HB 
Nijmegen, The Netherlands. 
phatidylinositol 4,5-bisphosphate (РІРг), yielding 
1,2-diacylglycerol and inositol 1,4,5-tnsphosphate 
((1,4,5)IP]). Both of these products possess im­
portant second messenger functions. Di-
acylglycerol activates the calcium/phosphohpid-
dependent protein kinase (C) and (1,4,5)1?, re­
leases calcium from an intracellular store [1,2]. 
In the exocrine pancreas, the increase in free 
cytosolic calcium concentration in response to the 
calcium-mobilizing secretagogues cholecystokinin 
and acetylcholine has been shown to take place 
within seconds after stimulation, followed by a 
somewhat slower decay to nearly resting levels 
reached within 2 min [3,4]. So far, however, in­
creases in diacylglycerol have only been measured 
upon supramaximal stimulation and were found 
0167-4889/87/S03 JO С 1987 Elsevier Science Publishers B.V. (Biomédical Division) 
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to take place more gradually with time, reaching 
plateau values which were maintained as long as 
the calcium-mobilizing receptor was occupied by 
its agonist [5] 
It is well documented that prolonged stimula­
tion of exocrine pancreatic tissue with a secreta-
gogue of the calcium-mobilizing type reduces the 
secretory response to subsequent stimulation with 
a calcium-mobilizing secretagogue (for a review, 
see Ref 6) More recently, this phenomenon of 
secretagogue-induced desensitization has been ex­
plained by assuming that the intracellular calcium 
pool is emptied by the first stimulus and is not 
refilled before the stimulus is removed [4] In 
vanous biological systems, however, protein kinase 
С activation has also been implicated in the pro­
cess of desensitization (for a review, see Ref 28) 
The experiments described in this paper were 
undertaken to investigate whether activation of 
the protein kinase С pathway of the calcium mes­
senger system can also altnbute to the reduced 
efficacy of the second stimulus To achieve protein 
kinase С activation without receptor activation we 
used the phorbol ester, 12-O-tetradecanoylphorbol 
13-acelate (TPA), known to activate protein kinase 
С in a diacylglycerol-like manner [7] 
The results presented here show that TPA re­
duces the secretory response to cholecystokinm-
octapeptide (CCK-8) by inhibiting ССК-8-in-
duced calcium mobilization The ССК-8-induced 
breakdown of MP-labelled PIP2, however, is not 
affected by TPA This suggests that protein kinase 
С or one of its phosphorylated products exerts a 
negative feed-back control over some step beyond 
the level of PIP2 hydrolysis leading to calcium 
mobilization 
Materials and Methods 
Methods 
Preparation of rabbit pancreatic acini Rabbit 
pancreatic acini were prepared as previously de­
scribed [8,9] 
Amylase secretion experiments For amylase 
secretion expenments rabbit pancreatic acini re-
suspended in a Krebs-Ringer bicarbonate medium 
(pH 7 4) containing 119 mM NaCl, 3 5 mM KCl, 
1 2 mM K H 2 P 0 4 , 25 mM NaHCOj, 1 2 mM 
CaCl j , 1 2 mM MgCl2, 5 8 mM glucose, \% bovine 
serum albumin, an ammo acid mixture according 
to Eagle [10] and 0 2 mg/ml soybean trypsin 
inhibitor, were incubated for 30 mm either in the 
absence or in the presence of 10 " ' M TPA The 
suspension was then centnfuged and the acini 
were resuspended in fresh incubation solution to 
which no additional TPA was added Amylase 
secretion was measured over a penod of SO mm 
Except for the controls, CCK-8 at the indicated 
concentrations was added 20 nun after the incuba­
tion was started At appropriate times, samples 
were removed for determination of medium 
amylase activity At the beginning of the experi­
ment, an aliquot of the suspension was removed 
and the acim were homogenized for determination 
of total amylase activity Amylase activity was 
measured by means of the Phadebas test and 
medium amylase activity was expressed as percent 
of total amylase present in the acini at the begin­
ning of incubation 
Free cytosolic calcium concentration measure­
ments Rabbit pancreatic acmi resuspended in the 
above Krebs-Ringer bicarbonate medium were 
loaded with quin2 by a 20 min incubation m the 
presence of 50 μΜ quin2/AM The suspension 
was then diluted six times and half of the suspen­
sion was incubated further in the presence of W " 6 
M TPA To the remaining part of the suspension 
dimethyl sulfoxide, the solvent for TPA, was ad­
ded After 30 mm the suspensions were centn­
fuged and the acini were resuspended m fresh 
incubation solution Immediately before fluores­
cence measurement, samples were removed, 
rapidly centnfuged (Eppendorf minifuge) and re­
suspended in a Hepes/Tns medium (pH 7 4) con­
taining 133 mM NaCl, 4 2 mM KCl, 5 8 mM 
glucose, 1 0 mM CaCl 2, 1 0 mM MgCl2, 0 2 mg/ 
ml soybean trypsin inhibitor and 10 mM Hepes 
Before use, the medium was thoroughly gassed 
with 100% 0 2 Details on fluorescence measure­
ment and calibration of intracellular calcium con­
centrations are descnbed elsewhere [9,11] 
Phosphatidylmositol 4,5-bisphosphate breakdown 
measurements Rabbit pancreatic acini were resus­
pended in the above Krebs-Ringer bicarbonate 
medium containing 10 μΜ K H 2 P 0 4 , 0 5% bovine 
serum albumin and 25 μ Ο / ι η ! ortho[32P]phos-
phate and were incubated for 60 mm at 37° С 
TPA (10- 6 M) and DMSO (control acim) were 
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present during the last 30 mm of the labelling 
penod After 60 mm of labelling, CCK.-8 at the 
indicated concentrations was added and 400-μΙ 
samples were removed and vigorously mixed with 
18 ml ice-cold extraction medium (dichloro-
methane/methanol/concentrated HCl, 20 40.1) 
immediately before and 8 and 30 s after stimula­
tion :>H-labelled PIP2 was added to the extraction 
medium for recovery measurements. Phase sep­
aration was obtained by adding 400 fil dichloro-
methane and 400 μΐ water followed by centnfuga-
tion (S mm, 700 X g). After collection of the 
organic phase, the aqueous phase was extracted 
again and the combined organic phases were blown 
to dryness with nitrogen. The extracts were then 
dissolved m dichloromethane/ methanol/ water 
(75:25:2) and the phospholipids were separated 
by thin-layer chromatography using potassium 
oxalate-treated high-performance plates (Merck). 
The plates were developed with dichloromethane/ 
methanol/methylamine (20%) (60:36.10) PIP2 
spots were identified by both the tntiated PIP2 
marker and by unlabelled PIP2 and were scraped 
off. Scintillation fluid (Aqualuma) and water (10%, 
v/v) were added and 3 H and 3 Z P radioactivity 
were measured using a Philips PW 4510 liquid 
scintillation analyzer After correction for the 3 H -
labelled PIP2 recovery the amount of
 32P-labelled 
PIP2 present in the CCK-8 stimulated acmi was 
expressed as percent of the amount present im­
mediately before stimulation. 
Moleríais 
The C-terminal octapeplide of cholecystokimn 
has been synthesized by Dr. H.M. Rajh m the 
Department of Organic Chemistry, University of 
Nijmegen, Bovine serum albumin, soybean trypsin 
inhibitor, TPA, phosphatidylmositol 4,5-bis-
phosphate and quin2/AM were obtained from 
Sigma, St. Louis, MO, USA. ; HPTLC plates 
silica gel 60 were from Merck, Darmstadt, F.R G., 
phosphatidyl[2-3H]inositol 4,5-bisphosphate was 
from A m e r s h a m Labora to r i e s , U K., 
ortho[32P]phosphate was from New England 
Nuclear, Boston, MA, U.S.A.; lonomycin was from 
Behring Diagnostics, La Jolla, CA, U S.A ; col-
lagenase was from Cooper Biomedical Inc . 
Malvem, PA, U S.A and hyaluromdase was from 
Boehnnger, Mannheim, F.R G. The Phadebas test 
kit was purchased from Pharmacia, Uppsala, 
Sweden. All other chemicals were of reagent grade 
Results 
Rabbit pancreatic acini were preincubated with 
the phorbol ester, 12-Otetradecanoylphorbol 13-
acetate, at a concentration of 10~6 M for 30 mm 
and then resuspended in fresh incubation solution 
without additional TPA. Amylase secretion was 
measured over the next SO mm of incubation. 
Upon stimulation of DMSO-pretreated acini with 
10"6 M TPA at 20 mm, the amount of amylase 
released during the subsequent 30 mm increased 
from 1 8% (S E , 0.2; л = 13) to 5.7% (S E., 0 6; 
η - 6), which was not significantly different from 
the rate of amylase secretion observed for the 
TPA-pretreated acini over the same penod of time 
(5.5%, S.E., 0 6; и - 12) 
Fig 1 shows that CCK-8 at concentrations of 
3 · 1 0 " 1 0 - 1 0 " ' M did not significantly alter 
amylase secretion from TPA-treated acini, whereas 
in control acini the secretory response dose-depen-
dently increased. At 3·10~'-10~ 8 M, however, 
the amount of amylase released during the subse­
quent 30 mm of incubation was not different from 
that in control acini. 
In order to examine the inability of CCK-8 at 
concentrations of З - Ю ' ^ - Ю - ' M to stimulate 
amylase secretion from TPA-treated acmi m more 
detail, we investigated the effects of TPA pretreat­
ment on ССК-8-induced increases in [Ca2 +J,, 
measured by means of quin! At a concentration 
of 3 1 0 " , 0 M, CCK-8 increased the free cytosolic 
calcium concentration within seconds, to about 
200 nM. Fig. 2 (A, B) shows that this initial 
increase in [Ca24"), in response to the secretagogue 
was independent of the presence of extracellular 
calcium. In the absence of extracellular calcium, 
however, the fluorescence intensity declined more 
rapidly and returned to basal levels within 2 mm 
When the acmi were pretreated with 10~6 M TPA 
and then stimulated with 3 · 10~1 0 M CCK-8, the 
increase in [Ca24"], was completely abolished, even 
in the presence of extracellular calcium (Fig. 2 
( Q ) 
Fig 3 shows that TPA pretreatment inhibited 
completely the ССК-8-induced initial increase in 
[Ca 2*], at the lower concentrations ( l O ' ^ - l O " * 
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s* 
10 9 
- log [CCK-B] (M) 
Fig 1 Effect of TPA on the dose-response curve for CCK-8 
stimulation of amylase secretion from rabbit pancreatic aam 
Rabbit pancreatic acini were incubated for 30 nun either in the 
absence (O) or ш the presence ( · ) of 1<Г6 M TPA The 
suspensions were then centnfuged and the aam were resus­
pended in fresh incubation solution to which no additional 
TPA was added Amylase secretion was measured over a 
penod of SO mm Except for the controls, CCK-8 at the 
indicated concentrations was added at 20 mm Medium amylase 
activity was measured at 0, 20, 30, SO and 60 nun and the 
increase in amylase release over the last 30 nun of incubation is 
expressed as percentage of total amylase originally present in 
the acini The values presented are the mean±SE. of 6-9 
expenments. 
M) of the secrelagogue At or beyond 3 · 10 " ' M, 
CCK-8 also increased [Ca2*], in TPA-treated ac­
ini. The dose-response curve, however, was shifted 
markedly to the right. 
Since the ССК-8-mduced initial increase in free 
[Ca2\ 
т. 
(nM) 
200 
IbO 
-10 я 
2.10 M CCK-8 
3.10~WM CCK-8 
200 
150\- «S»V>t» V >*/»*, 
ISO 
3.10~10M CCK-8 
члдий Μ * Μ * Μ Α * 
1 min 
Fig 2 Effects of extracellular calcium and TPA on CCK-8-m-
duced increases in [Ca2 * ], in quin2-loaded rabbit pancreatic 
acini Rabbit pancreatic acini were incubated with quin2/AM 
and TPA (10 - 6 M) Immediately before use, pancreatic acini 
loaded with quin2 were resuspended in a Hepes/^Tns medium 
(pH 7 4) to which no calcium was added and which was 
thoroughly gassed with 0 2 The acini were transferred to a 
cuvette placed in a spectrofluorometer and preincubated for 3 
nun at 37 е С before measurement was started Stirring of the 
acini suspension was then started and 0 2 mM EGTA was 
added In those expenments in which extracellular calcium was 
present, after 1 mm the medium calcium concentration was 
increased to 1 0 mM DMSO-treated acim were stimulated 
with 3 10' ^ M CCK-8 m the presence (A) and in the absence 
(B) of extracellular calcium TPA-treated aam were stimulated 
with CCK-8 in the presence of extracellular calcium (C) 
cytosohc calcium concentration is thought to rep­
resent the (lASJIPj-mediated release of Ca 2 + from 
an intracellular store [3,4], we investigated the 
effects of the phorbol ester on ССК-8-mduced 
PIP2 breakdown Rabbit pancreatic acini were 
labelled with ortho[32P]phosphate for 1 h During 
the last 30 min of that penod either TPA or 
DMSO was present. Fig 4 shows that subsequent 
stimulation with CCK-8 resulted in a dose- and 
time-dependent decrease in the amounts of radio-
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I 
δ 
200 — 
100 — 
- log [CCK-BÌ f Η) 
Flg. 3 Effecl of TPA on Ihe dose-respon» curve for CCK-8-
mduced imlial incitases ш free cytosohc calcium concentration 
ш rabbit pancreatic acmi A siupauion оГ rabbit pancreatic 
acuii, incubated in the presence of 50 μΜ qiuii2/AM for 20 
mm, was diluted 6 tunes. HaJf of the suspension was then 
incubated m the presence of 10 ' M TPA ( · ) , whereas DMSO 
was added to the remaining half (O) At 30 mm, the suspen­
sions were centnfuged and the acini were resuspended m fresh 
incubation solution to which no additional TPA was added 
Immediately before fluorescence measurement samples were 
removed, rapidly centnfuged (Eppendorf muufuge) and resus­
pended m a Hepes/Tns medium (pH 7 4) Fluorescence mea-
suremenu were earned out at 37 ° С using a spectrofluorome-
ter equipped with a thermostattically controlled cuvette holder 
and a magnetic stirrer After S mm of equilibration, CCK-8 
was added at the indicated concentrations The initial increase 
m [Ca 2 * ] , , observed within seconds, was calculated according 
to the method of Tsien et al [27] using 1 0 " ' M lonomycin to 
determine maximal fluorescence The values presented are the 
mean ± S E. of 3-5 «penments. 
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Fig. 4 Effect of TPA on the dose-response curve for CCK-8-
induced breakdown of ,2P-labelled PIP, Rabbit pancreatic 
aam were incubated in the presence of orthc(32P]phosphatc 
for «0 mm at 37 ° С At 30 mm 10"* M TPA (O) was added to 
one half of the suspension while DMSO ( · ) was added to the 
other half After 60 mm of labelling, the acini were stimulated 
with CCK-β at the indicated concentrations and samples for 
measurement of radiolabelled PIP2 were removed immediately 
before and 8 (A) and 30 (B) s after stimulation 32P-labelled 
PIPj at 8 and 30 s after stimulation was expressed as per­
centage of radiolabelled PIP2 immediately before sumula-
tion The values presented are the mean±S E of 3-7 expen-
ments 
acini No inhibitory effect of TPA (10"' M) was 
observed on PIP2 breakdown induced by 10 ~' M 
CCK-8, at which concentration the stimulatory 
effect on calcium mobilization was completely 
inhibited by pretreatment with TPA (10 " ' M) 
Even at a concentration of 10 ~5 M TPA, the 
stimulatory effect of CCK-8 (10" ' M) on РІР2 
hydrolysis was not attenuated, since the residual 
J2P-labelled PIP2 content, 83 0% (S E., 4 4, η - 3), 
was not significantly different from that in control 
acini (79 7%, S Ε, 1 7, η - 7) when measured 30 s 
after stimulation 
Discussion 
In the intact cell, phorbol esters are generally 
believed to act by mimicking the stimulatory ef-
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feet of endogenous diacylglycerol on the calcium-
and phospholipid dependent-protein kinase С [7] 
In recent years many studies have revealed the 
ability of phorbol esters to stimulate pancreatic 
enzyme secretion [4,9,12-15], thus establishing the 
important role protein kinase С plays in the mech­
anism of action of pancreatic secretagogues that 
initiate phosphatidylmositol turnover 
One of the main observations presented in this 
paper is that the phorbol ester, TPA, in addition 
to its stimulatory effect on pancreatic enzyme 
secretion also inhibits the secretory response to 
submaximal concentrations of the secretagogue 
CCK-8 This suggests that protein kinase С is also 
involved in negative feed-back regulation of pan­
creatic enzyme secretion 
Cholecystokinin stimulates the enzymatic 
breakdown of PIP2 ([16-18] and this study), yield­
ing the intracellular messengers diacylglycerol [5] 
and (1,4,5)ІРз [19], involved in protein kinase С 
activation [7] and intracellular calcium mobili­
zation [20], respectively A rapid but transient 
increase in the free cylosolic calcium concentra­
tion ([Ca2*],) is observed when pancreatic acinar 
cells, loaded with the fluorescent calcium indica­
tor, quin2, are stimulated with CCK-8 ([3-5] and 
this study) This initial increase in [Ca2*], is inde­
pendent of the presence of extracellular calcium 
(Refs 3 and 4 and this study), and is therefore 
thought to be mediated by (1,4,5)IP, 
In order to study the intracellular mechanism 
underlying the inhibitory action of TPA on CCK-
8-induced pancreatic enzyme secretion in more 
detail, we investigated whether ССК-8-mduced 
increases in [Ca2*], were affected by phorbol ester 
treatment From the results obtained it is evident 
that inhibition of ССК-8-slimulated amylase 
secretion is paralleled by the failure of CCK-8 to 
increase [Ca2*], in these cells The observation 
that TPA-stimulated amylase secretion is only then 
increased when the concentration of CCK-8 is 
high enough to overcome the inhibitory action of 
TPA on secretagogue-mduced calcium mobili­
zation supports the important role calcium is 
thought to play in pancreatic enzyme secretion 
and makes it unlikely that the intracellular path­
ways leading to ССК-8-induced enzyme secretion 
are inhibited at or beyond the level of piotein 
kinase С activation Inhibitory effects of TPA on 
carbachol-induced increases in [Ca2*], have re­
cently been described for guinea pig pancreatic 
acini by Ansah et al [13] However, they did not 
investigate whether carbachol-induced amylase 
secretion was also affected by the phorbol ester 
The possibility that in TPA-treated acini CCK-
8-induced increases in [Ca2*], are not observed 
because of protein kinase C-mediated stimulation 
of calcium extrusion and/or sequestration is not 
supported by the observation that when stimu­
lated with 10- 1 0 -10- 9 M CCK-8, no increase m 
[Ca2*], is observed at all Stimulated calcium 
extrusion and/or sequestration has been sug­
gested by Drummond [29] to explain the fact that 
in GH3 cells TPA transiently lowers [Ca2*], 
elevated by high potassium 
The fact that the initial increase in [Ca2*],, 
which is independent of the presence of extracellu­
lar calcium and which is therefore thought to be 
mediated by (1,4,5)ІРз, is inhibited m phorbol 
ester-treated pancreatic acini led us to investigate 
the effect of TPA on the ССК-8-induced hydroly­
sis of PIP2 The results surprisingly demonstrate 
that TPA is without effect on ССК-8-induced 
PIPj breakdown, even then when the secretagogue 
is used at concentrations which fail to increase 
[Ca2*], in phorbol ester-treated acini This ob­
servation strongly suggests that protein kinase С 
or one of its phosphorylated products does not act 
at the level of secretagogue-mduced PIP2 break­
down Our results support those of Memlt et al 
[19], who reported that in rat pancreatic acini the 
phorbol ester, phorbol dibutyrate, is without effect 
on the formation of (1,4,5)ІРз and (1,3,4)ІРз in­
duced by maximal as well as submaximal con­
centrations of caemlein It was concluded by these 
authors that in the exocrine pancreas phorbol 
esters are not involved in desensitization of 
calcium-mobilizing receptors They did not in­
vestigate, however, whether phorbol dibutyrate af­
fected caerulem-induced calcium mobilization 
and/or enzyme secretion 
Comparison of the effect of the higher con­
centrations of CCK-8 (3 lO-'-lO"* M) on 
amylase secretion and calcium mobilization shows 
that pretreatment with TPA has no effect on 
enzyme secretion (Fig 1), whereas the stimulatory 
effect on cytosohc calcium is reduced by at least 
50% (Fig 3) This strongly suggests that in the 
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presence of TP A only a partial increase of the free 
cytosohc calcium concentration is sufficient for 
maximal stimulation of enzyme secretion 
The possibility that in TPA-treated acim the 
synthesis of PIP2 is reduced, thus leading to less 
(1,4,5)IP] formed upon stimulation with CCK.-8, 
seems to be ruled out, since m TPA-treated aciru 
[ J2P]PIP2 amounted to 84 3« (S E, 14 7, л - 7) of 
the control value On the other hand, the amount 
of ['2P]phosphaUdylcholine was 164 656 (S Ε, 24 3, 
π = 11) of the control, indicating an enhanced 
phosphorylation of this phospholipid Effects of 
phorbol esters on the metabolism of phospholipids 
have been described for a vanety of tissues. In 
human platelets TPA was found to increase, not 
to decrease, the labelling of phosphatidylmositol 
and phosphatidyhnositolmonophosphate in the 
presence of ["PJP, [21], whereas an enhanced 
biosynthesis of phosphatidylcholine has been ob­
served m phorbol ester-treated neuroblastoma-
glioma (NG 108-15) cells [22], human leukemic 
cells [23], HeLa cells [24], myoblasts [25] and 
Krebs 11 ascites cells [26] 
Together, our results and those of Ansah et al 
[13] and Memtt et al [19] suggest that protein 
kinase С exerts its negative feed-back control over 
secretagogue-induced pancreatic enzyme secretion, 
not at the level of the secretagogue-induced hy­
drolysis of PIP2 ([19] and this study), nor at the 
level of the (de)phosphorylaüon of (1,4,5)IP, [19], 
but maybe at the level of the (l,4,S)IP,-activated 
release mechanism for calcium from the intracellu-
lar store More detailed investigations are needed, 
however, to test this possibility 
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Chapter 7 
Desensitization of inositol 1,4,5-trísphosphate-induced 
Ca^+ release 
in permeabilized pancreatic acinar cells by phorbol ester pretreatment 
WILLEMS, P.H.G.M.,* 
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Departments of Biochemistry,* Physiology** and 
Statistical Consultation*** 
P.O. Box 9101,6500 HB Nijmegen, The Netherlands. 
Abbreviations: (1,4,5-)ІРз, inositol 1,4,5-trisphosphate; PIP2, phosphatidylinositol 4,5-biq)hosphate; 
TPA, 12-O-tetradecanoylphorbol 13- acetate; EGTA, ethylene glycol bis (ß-aminoethyl eÜier)-N,N'-tetra 
acetic acid; HEEDTA, N-(2-hydroxy ethyl) ethylene diamine-N^'^-triacetic acid; HEPES, 
4-(2-hydroxy ethyl)-l-piperazme ethane sulphonic acid; NTA, nitrilotriacetic acid. 
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SUMMARY 
Stimulus-induced increases in free cytosolic Ca2+ concentration reflect changes in the 
Ca 2 + permeability of plasma membrane and/or intracellular C a 2 + stores. In the pancre­
atic acinar cell the initial secretagogue-induced increase in cytosolic Ca2"·" is independent 
of extracellular Ca 2 + and represents release from intracellular C a 2 + s tores 1 " 3 . 
Receptor-mediated Ca 2+ mobilization is preceded by phosphatidylinositol 
4,5-bisphosphate (PIP2) breakdown4, yielding inositol 1,4,5-trisphosphate ((1,4,5-)ІРз), 
which has originally been shown to be a potent promotor of the release of actively stored 
Ca 2 + in permeabilized pancreatic acinar ce l l s 5 . The kinetics of stimulus-induced 
increases in (1,4,5-)ІРз concentration are compatible with the idea that this compound is 
involved in the receptor-mediated increase in Ca 2 4 " permeabil ity of the intracellular 
Ca 2 + store6"'. Receptor-mediated hydrolysis of PIP2 also results in formation of diacyl-
glycerol and thus in activation of protein kinase C 4 . Using a phorbol ester, which sub­
stance mimicks the stimulatory effect of diacylglycerol on protein kinase СЮ, w e 3 and 
othersll have recently shown that in pancreatic acinar cells, as in other cell types 4 , 
agonist-induced Ca 2 + mobilization can be inhibited. However, unlike in other cell types 
this inhibitory action of the phorbol ester was not paralleled by inhibition of receptor-
mediated breakdown of PIP2 (Ref. 3), suggesting an effect at the level of the 
(l,4,5-)IP3-induced release of C a 2 + from the intracellular store, or at the level of the 
metabolism of (1,4,5-)ІРз. We have now examined the effects of phorbol ester pretreat­
ment on ATP-dependent C a 2 + uptake and (l,4,5-)LP3-induced Ca2"*" release from rabbit 
pancreatic acinar cells, permeabilized by saponin treatment. The (l,4,5-)IP3-induced 
release of actively stored C a 2 + was significantly inhibited in phorbol ester-treated acinar 
cells. This is in support of our earlier hypothesis 3 that activation of protein kinase С 
leads to negative feed-back control on agonist-induced Ca2"*" mobilization at a level 
beyond receptor-mediated formation of (1,4,5-)ІРз. 
RESULTS AND DISCUSSION nanomole Ca 2 + /mg protein, S.D. 0.08, n=7) (Fig. 
1A). At 10 min, a plateau value of 1.34 nanomole 
C a ^ / m g protein (S.D. 0.47, n=7) was reached 
Dispersed rabbit pancreatic acinar cells were which was maintained for the next S min. Phorbol 
incubated in the presence of ester pretreatment neither significantly affected the 
12-O-tetradecanoylphorbol 13-acetate (TPA) initial rate of Ca2"1' uptake, determined at 60 sec 
(ІО-бМ) or dimelhylsulfoxide (0.1 %, v/v) for 30 (0.58 nanomole Ca 2 + /mg protein, S.D. 0.06, n=7), 
min al З ? ^ . Peimeabilization and 4 5 c a 2 + uptake nor the maximum amount of C a 2 + accumulated, 
experiments were performed essentially as determined at IO min (1.36 nanomole Ca2+/mg 
described for enterocytes by van Corven et a l . l 2 , protein, S.D. 0.44, n=7). Therefore, the non-
wilh the exception that 4 5 C a 2 + uptake was mea- mitochondrial C a 2 + uptake system, recently char-
sured at pH 7.1 and at Ύ1<Κ1. acterized as a C a 2 + + K+-stimulated 
At a free Ca2+concentration of 0.1 μΜ and in Mg 2 +-dependent transport ATPase I 3 does not 
the presence of ruthenium red, an inhibitor of mito- seem to be influenced by phorbol ester-
chondrial Ca^+ uptake, Ca^ "1" uptake in permeabi- pretreatment. 
lized pancreatic acinar cells was ATP-dependent When (1,4,5-)ІРз (2 μΜ) was added at 10 min, 
and linear with time during the first 60 sec (0.60 the residual C a 2 + content decreased linear with 
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Time (sec ) 
Figure J. Time-dependence of C a 2 + uptake (A) and (l,4,5-)IP3-induced Ci?+ release (B) in per-
meabilized pancreatic acinar cells. Isolated rabbit pancreatic acinar cells^ were pelleted twice, 
resuspended in a high potassium medium (1 mg protein/ml) containing (mM): 13S KQ; 1.0 
MgCl·»; 1 · 2 KH2PO4; 0.1 phenylmethylsulpbonylfluoride and 10 Hepes (pH 7.4) and penneabi­
lized with saponin (30 μg/ml, 10 min, 250C). After sapooin-ueatment less than 25 % of the cells 
excluded trypan blue. The permeabilized cells were washed twice and resuspended (5-8 mg 
protein/ml) in a "Ca2"1" uptake" medium containing (mM): 120 KCl; 1.0 MgCl2; 1.2 KH2PO4; 5 
pyruvate; 5 succinate; O.S EGTA; 0.5 NT A and 0.5 HEEDTA and adjusted to pH 7.1 with KOH. 
The mitochondrial Ca2"1" uptake inhibitor ruthenium red (10 μΜ) was added and the penneabilized 
cells were kept at C^C for 45 min. Calcium uptake at 370C was started by adding 100 μΐ of penne­
abilized cells to 900 μΐ Ca2"1" uptake medium which contained in addition: 10 mM creatine phos­
phate; 10 Units creatine kinase; 5 цСі/тІ 4 5 C a 2 + and 0 (o) or 10 mM (·) MgATP. The free 
Mg 2 4" and Ca2"*" concentrations were adjusted to 1.45 mM and 0.1 ЦМ, respectively, according to 
Van Heeswijk et a l " . After 10 min, maximal ATP-dependent Ca2"*" accumulation was reached 
(A) and (1,4,5-)ІРз was added (B). At the times indicated, 100 |il aliquote were quenched in 1.0 
ml ice-cold "stop solution" containing (mM): 150 KCl; 5.0 MgC^; 1.0 EGTA and 20 Hepes-KOH 
(pH 7.1) and the suspension was rapidly filtered (Schleicher and ScfaUU, ME 25, 0.45 Цт). The 
filters were washed twice with 2.0 ml ice-cold stop solution, dissolved in scintillation fluid and 
counted. Total Ca2"1" was calculated and expressed as nanomole per mg: protein (A). When 
(l,4,5-)IP3-induced Ca2"*" release was measured, in each experiment the Ca2* content at 10 min 
was set at 100%, to which all other values were related (B). Protein was determined with a com­
mercial Coomassie blue kit (Biorad, Richmond, USA) after treatment of the cells with 0.1 % Tri­
ton X-100. Tbe values presented are the means ± S.E. of 5-7 (A) and 3-4 (B) cell preparations. 
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Figure 2. Effect of TPA-pretreatmenl on (l,4,5-)IP3-induced Ca 2 + release in permeabilized pan-
creajic acinar cells. Isolated rabbit pancreatic acinar cells were incubated in the presence of 
ІО-бм TPA (o) or 0.1% (v.v) dimethylsulfoxide ( · ) for 30 min at 370C. After treatment the cells 
were permeabilized and resuspended in calcium uptake medium as described in the legend to fig­
ure 1. ATP-dependent calcium uptake was started by adding 10 ul of permeabilized cells to 90 μΐ 
Ca z + uptake medium. At 10 min maximal ATP-dependent Ca?+ accumulation was reached and 
(1,4,5-)ІРз was added in the concentrations indicated. After 30 sec 1.0 ml ice-cold stop solution 
was added and the suspension was rapidly filtered. The filters were washed, dissolved in scintilla­
tion fluid and radioactivity was counted. Total Ca 2 + was calculated and expressed as nanomole 
per mg protein. In every experiment, for dimeihylsulfoxide- as well as phorbol ester- treated cells, 
each concentration of (1,4,5-)ІРз was tested in triplicate. In between two concentrations of 
(І,4,5-)ІРз its solvent was added and the mean of the latter triplicate was set at 100%, to which the 
means of the other two triplicates were related. The values presented are the means ± S.E. of three 
different cell preparations. A rather high variation was observed among the three cell preparations 
used in this investigation with respect to the effectiveness of (1Α,5-)ΪΡ^ to release actively accu­
mulated Ca2 +. However, multivariate analysis of variance revealed that over the whole range of 
(1,4,5-)ІРз concentrations tested, the (l,4,5-)IP3-induced decrease in residual Ca 2 + content was 
significantly less in phorbol ester-treated cells (p = 0.0027). It was calculated that in phorbol ester-
treated cells the residual Ca 2 + content was 5.5% (S.E. 1.6%) above the value obtained in control 
cells, indicating that in phorbol ester-treated cells the dose-response curve for (l,4,5-)IP3-induced 
Ca 2 + release is significantly shifted to the right. 
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time during the first IS sec and a maximal effect 
was observed within 30 sec (Fig. IB). No re­
uptake of Ca2+ occurred during the next 60 sec, 
which suggests that the (1,4,5-)1Рз receptor 
remains occupied and (1,4,5-)ІРз breakdown is still 
not completed. In subsequent experiments, in 
which the residual Ca?+ content was measured 30 
sec after the onset of stimulation, (1,4,5-)ІРз 
decreased the residual C a 2 + content dose-
dependently in both dunethylsulfoxide- and phor­
bol ester-treated acinar cells (Fig. 2). However, in 
TPA-treated cells the dose-response curve was sig­
nificantly shifted to the right. Since the 
(l,4,5-)IP3-induced release of Ca2+ at a maximally 
effective concentration of 10 μΜ (Ref. 5) was not 
markedly inhibited in phorbol ester-treated cells, 
the above observation suggests that 
(l,4,5-)IP3-induced Ca2+ release from intracellular 
C a 2 + stores in phorbol ester-treated cells has a 
lower affinity for (1,4,5-)ІРз than in untreated 
cells. 
Since phorbol esters act by mimicking the 
stimulatory effect of diacylglycerol on protein 
kinase C ^ , the data obtained in the present study 
provide evidence for protein kinase C-induced 
desensitization at the level of the (1,4,5-)ІРз recep­
tor, which is in support of the hypothesis that acti­
vation of protein kinase С leads to negative feed­
back control over the stimulus-induced release of 
intracellularly stored C a 2 + at a level beyond the 
receptor-mediated hydrolysis of Р П ^ . 
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Chapter 8 
Differential effects of cholecystokinin octapeptide and 
12-O-tetradecanoylphorboI 13-acetate on 
32P-labelling of phospholipids in rabbit pancreatic acini. 
WILLEMS, P.H-GJVÍ. 
VAN NOOU, LG.P. and 
DE PONT, J J.H.H.M. 
Department of Biochemistry, University of Nijmegen, 
P.O. Box 9101,6S00 HB Nijmegen, The Netherlands. 
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The abbreviations are: CCK-8, C-terminal oclapeptide of cholecystokinui; PI, phosphatidylinositol; PC, 
phosphatidylcholine; PA, phosphatidic acid; PIP, phosphatidylinositol 4-monophosphate; PIP2, phos­
phatidylinositol 4,5-bisphosphate; (1,4,5-)ІРз, inositol 1,4,5-trisphosphate; (13,4-)ІРз, inositol 
1,3,4-lrisphosphate; (1,3,4,5-)IP4, inositol 13.4^4etrakispliosplute. 
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SUMMARY 
We have studied the effects of both the С-terminal octapeptide of cholecystokinin 
(CCK-8) and the phorbol ester, 12-O-tetradecanoylphorbol 13-acetate (TPA), on the 
labelling of pancreatic acinar cell phospholipids by ortho[32P]phosphate. 
CCK-8, but not TPA, markedly enhanced 32P-labelling of phosphatidic acid and 
phosphatidylinositoL Only in the presence of CCK-8, labelling of phosphatidylinositol 
4,5-bisphosphate (PIP2) reached equilibrium within 60 min. Equilibrium was reached at 
40 min and the amount of labelled PIP2 was reduced by some 50% compared to control 
acini or acini labelled in the presence of TPA. This suggests that in the presence of 
CCK-8, but not of TPA, PIP2 levels are significantly decreased. Additional stimulation 
through the cholinergic receptor of acini, labelled in the presence of CCK-8, did not lead 
to a further decrease in the amount of ^^P-labelled PIP2. 
In the presence of TPA, labelling of PIP2 appeared to be increased, suggesting a stim­
ulatory effect on de- and/or rephosphorylation rates. TPA did not inhibit the CCK-8 
induced decrease in ^P-labelled PIP2· 
Finally, labelling of phosphatidylcholine was markedly enhanced in the presence of 
TPA, but not in the presence of CCK-8. It remains to be elucidated whether the lack of 
effect of the secretagogue on the labelling of phosphatidylcholine reflects inhibitory path­
ways not activated by the phorbol ester alone. 
INTRODUCTION 
Stimulation of pancreatic enzyme secretion 
with acetylcholine or cholecystokinin is accompa­
nied by rapid changes in phospholipid metabolism. 
Within seconds after stimulation marked decreases 
in [32p]orüiophosphate- or 
PHjinositol-prelabelled phosphatidylinositol 
4,5-bisphosphate (PIP2) are observed, followed by 
rapid incorporation of label in phosphatidic acid 
and phosphatidylinositol in the presence of these 
radioactive tracers [1-3]. The breakdown products 
of PIP2, diacylglycerol and inositol 
1,4,5-lrisphosphate (IP3) have important second 
messenger functions in that they activate the 
calcium- and phospholipid- dependent protein 
kinase С and release calcium from an intracellular 
store, respectively [4-6]. Phorbol esters, like 
12-O-tetradecanoylphorbol 13-acetate (TPA), are 
able to activate protein kinase C, probably because 
of their structural analogy with diacylglycerol [7]. 
Recently we [8] and others [9] showed that 
activation of protein kinase С also leads to inhibi­
tion of secretagogue-induced calcium mobilization 
and thus may attribute to secretagogue-induced 
desensitization. However, in our experiments the 
ССК-8-induced PIP2 hydrolysis was not impaired 
by pretreatment with TPA [8]. 
In the latter study [8], the effect of TPA on the 
ССК-8-induced breakdown of PIP2 was investigat­
ed in acinar cells prelabelled with 
ortho[32p]phosphate for 60 min, during the last 30 
min of which the phorbol ester was present. We 
found that TPA significantly stimulated the incor­
poration of label into phosphatidylcholine (PC), 
whereas the labelling of PIP2 appeared to be slight­
ly reduced. This has led us to compare the effects 
of TPA on the labelling of phospholipids in rabbit 
pancreatic acinar cells with that of the calcium 
mobilizing secretagogue cholecystokinin. 
MATERIALS AND METHODS 
Preparation of rabbit pancreatic acini. Rabbit 
pancreatic acini were prepared as previously 
described [8,10]. 
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32p-labelling, extraction and analysis of phospho­
lipids. For labelling studies acini were resuspended 
in a Krebs-Ringer bicarbonate medium (pH 7.4) 
containing 119 mM NaCl, 3.5 mM KCl, 10 μΜ 
KH2PO4, 25 mM NaHCOa, 1.2 mM СаСІг, 1.2 
mM MgCl2, 5.8 mM glucose, 0.5% bovine serum 
albumin, an amino acid mixture according to Eagle 
[11.], 0.2 mg/ml soybean trypsin inhibitor and 25 
цСі/т! ortho[32P]phosphate and were incubated 
for 70 min at Э7°С. CCK-8 (10-8 Μ), TPA (IO"5 
M) or the solvent dimethylsulfoxide, were present 
during the entire incubation period. At 60 min, 
10"5 M carbachol was added to the ССК-8-treated 
acini, whereas IO-" M CCK-8 was added to the 
TPA- and dimethylsulfoxide-treated acini. 
At appropriate times 200 μΐ samples were 
removed in duplo and vigorously mixed with 0.9 
ml ice-cold extraction medium (dichloromethane: 
methanol: concentrated HCl, 20:40:1). Phase sepa­
ration was obtained by adding 200 μΐ 
dichloromethane and 200 μΐ water, followed by 
centrifugation (5 min, 700xg). After collection of 
the organic phase, the aqueous phase was re-
extracted and the combined organic phases were 
blown to dryness with nitrogen. The extracts were 
then dissolved in dichloromethane/ methanol/ 
water (75:25:2) and divided over two potassium 
oxalate-treated high performance plates (Merck). 
One was developed with dichloromethane/ 
methanol/ 20% methylamine (60:36:10) and the 
other with dichloromethane/ acetone/ methanol/ 
acetic acid/ water (40:15:13:12:8). The first system 
separates PIP2, PIP, PC and PE, but not PI from 
PA and the second system separates PIPj. PIP, PA 
and PE, but not PI from PC. Radioactive spots 
were visualized by means of autoradiography, 
scraped off and counted. 
Under the above conditions of labelling with 
ortho[32p]ptiosphate, PS was not labelled, whereas 
PE-labelling was very weak. In each experiment, 
for each individual phospholipid, the amount of 
labelling reached in the dimethylsulfoxide-treated 
control acini at 60 min was set at 100%, to which 
all other values were related. 
Materials. The C-terminal octapeptide of chole-
cystokinin was synthesized by Dr. H.M. Rajh in the 
Department of Organic Chemistry, University of 
Nijmegen. Carbachol was purchased from ACT 
Chemiefarma, Maarsen, The Netherlands. Atropine 
and silica gel 60 HPTLC plates were obtained from 
Merck, Darmstadt, F.R.G.; bovine serum albumin, 
soybean trypsin inhibitor and TPA were from Sig­
ma, St. Louis, MO, U.S.A.; collagenase was from 
Cooper Biomedical Inc., Malvern, PA, U.S.A.; 
hyaluronidase was from Boehringer, Mannheim, 
F.R.G. and ortho[32p]phosphate was from New 
England Nuclear, Boston, MA, U.S.A. All other 
chemicals were of reagent grade. 
RESULTS 
The incoiporalion of orthof'^ pjphosphate in 
pancreatic acinar cell phospholipids was followed 
both under unstimulated (dimethylsulfoxide-treated 
control acini) and stimulated conditions. In the lat­
ter case either CCK-8, at a concentration (10~8 M) 
which nearly maximally stimulates enzyme secre­
tion [10], or the phorbol ester, TPA (IO-5 M), 
known to activate the calcium- and phospholipid-
dependent protein kinase С [7], was present during 
the entire period of labelling. 
As expected, the most dramatic effects of 
CCK-8 were observed on the labelling of PA and 
PI (Fig. 1). At 60 min, the 32P-labelled PA content 
was 2.6-fold the control value and the 32p-]abelled 
PI content 3.6-fold. Of more interest is the observa­
tion that in the presence of CCK-8, 32P-labeUing 
of PIP2 reached equilibrium within 40 min, where­
as in control acini labelling of PIP2 appeared to 
increase nearly linear with time during at least 60 
min. At 60 min, the ^V-\abcì\e4 PIP2 content in 
acini labelled in the presence of CCK-8 was about 
50% the control value. Labelling of PIP appeared 
to be slightly reduced in the presence of CCK-8. 
However, both in control acini and in CCK-8 stim-
ulated acini the 32p.iabeUed PIP content increased 
virtually linear with time. Finally, both in control 
acini and in acini labelled in the presence of 
CCK-8, the rate of incorporation of label in PC was 
relatively low during the first 40 min and increased 
thereafter. 
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Figure I. Effect of CCK-8 on 32P-label]ing of pancreatic acinar cell phospholipids. Rabbit pan­
creatic acini were incubated in the presence of ortho[32p]phosphate and either CCK-8 Ü0"*M) (χ) 
or dimethylsulfoxide ( · ) for 70 min at 370C. Samples for extraction and analysis of ^P-labelled 
phospholipids were removed at the indicated times. After 60 min of labelling, the 
dimethylsulfoxide-tieated acini were stimulated with CCK-8 (10'^M) and the ССК-8-treated acini 
with carbamylcholine (10'^M). In each experiment, for each individual phospholipid, the amount 
of label incoiporated in the drniethylsulfoxide-treated acini at 60 min is set at 100%, to which all 
other values are related. The values presented are the mean ± SE. of three experiments. 
60 90 
TIME (SEC) 
Figure 2. Time-dependence of ССК-8-induced decreases in ^РЛгЬеПеа PIP2 and ^p.iabelkd 
PIP in rabbit pancreatic acini prelabelled with ortho[32p]phosphate. Rabbit pancreatic acini were 
incubated in the presence of ortho[32P]phosphate for 60 min at ЭТ^С. At 60 min the acini were 
stimulated with 10"8M CCK-8. Samples for extraction and analysis of -^P-labelled phospholipids 
were removed at the times indicated. For each phospholipid, the amount of label incorporated at 
60 min is set at 100%, to which all other values are related. The values presented are the means of 
two separate experiments. 
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Figure3. Effects of TPA on 32P-labelling of pancreatic acinar cell phospholipids. Rabbit pancre­
atic acini were incubated in the presence of ortfK>[32P]phosplia!e and either TPA (10-5M) (о) or 
dimethylsulfoxide ( · ) for 70 min at 370C. At 60 min the acini were stimulated with CCK-8 
(10"8M). Details on sampling and calculations are given in the legend of Figure 1. The values pre­
sented are the means ± S.E. of three experiments. 
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At 60 min, ССК-8-treated acini were stimulat­
ed with 10~5 M carbachol and control acini with 
IO"8 M CCK-8. In control acini, already 8 sec after 
the onset of stimulation, a substantial decrease in 
the amount of ^P-lzbelled PIPj was observed 
(Fig. 2). A maximal effect was apparently reached 
within 2 min of stimulation (see also. Fig. 1). At 30 
sec, the ССК-8-induced decrease in the amount of 
labelled PIP2 was nearly 80% of maximal. No 
ССК-8-induced decrease in the amount of 
"p-labelled PIP was observed within 15 sec of 
stimulation. At 30 sec, the decrease was about 50% 
the decrease observed after 2 min. However, the 
latter decrease was apparently not maximal, since 
10 min after the onset of stimulation, the amount of 
labelled PIP was still further decreased (Fig. 1), 
Additional stimulation of CCK-8 stimulated 
acini with carbachol did not change the 
32p-iabelled PIP2 content when measured 10 min 
after the onset of stimulation (Fig. 1). Neither were 
marked effects observed on 32р.і
а
ьеіі^
 0f pip i 
PA or PI. On the other hand, a rapid decrease in the 
amount of 32p.iabelled PIP2 was observed in con­
trol acini as well as rapid increases in labelled PA 
and PI. At 30 sec, the 32P-labelled PIP content was 
hardly affected. Ten minutes after the onset of 
stimulation, the amount of ^Р-ІзЬеиеа PIP2 w a s 
still decreased, whereas a decrease in the 
32p-iabelled PIP content was more obvious now. 
In the presence of TPA, labelling of PIP2 and 
to a lesser extent of PIP and PA appeared to be 
enhanced, whereas labelling of PI was virtually not 
affected (Fig. 3). The most dramatic effect of TPA 
was on the labelling of PC. At 60 min, the 
32P-labelled PC content was about 5.4-fold the 
control value. Preincubation of the acini in the 
presence of the phorbol ester neither affected the 
ССК-8-induced decrease in 32P-labelled PIP2, nor 
the ССК-8-induced increases in 32p_i
a
belled PA 
and PI. However, 32P-labellmg of PIP2 and w p 
appeared to be increased in phorbol ester treated 
acini when measured 10 min after the onset of 
stimulation. 
DISCUSSION 
In unstimulated pancreatic acinar cells synthe­
sis and breakdown of PIP and PIP2 are in balance. 
The main enzymatic reactions involved are de- and 
rephosphorylation reactions. Under unstimulated 
conditions the incorporation of ortho-
[32P]phosphate in PIP and PIP2 occurs by 
(re)phosphorylation and, as was found in the 
present study, did not reach equilibrium during a 
60 min period of labelling. 
Upon cholinergic stimulation or upon stimula­
tion with cholecystokinin, the balance of de- and 
rephosphorylation of the phosphoinositides is dis­
turbed, primarily because of the rapid breakdown 
of PIP2· In acinar cells, prelabelled with 
ortho[32P]phosphate, this rapid secretagogue-
induced breakdown of PIP? ' s reflected by a rapid 
decrease in the amount of 32P-labelled PIP2, which 
in this study was nearly maximal within 30 sec 
after the onset of stimulation. After this initial 
decrease, the amount of 32P-labelled PIP2 hardly 
increased over the next 10 min, indicating that a 
lower steady-state level of PIP2 was established. 
However, it must be taken into account that at the 
time of stimulation, 32P-labelling of PIP2 had not 
reached equilibrium, so that the sustained 
secretagogue-induced decrease in 32P-labelled 
PIP2 is somewhat underestimated because of a 
concommitant increase in specific labelling to 
reach equilibrium. 
When acinar cells were labelled with 
ortho[32P]phosphate under stimulatory conditions, 
the amounts of 32P-labelled PIP2 extracted at 60 
min were significantly less than in unstimulated 
cells. Moreover, 32P-labelling of this polyphospho­
inositide reached equilibrium within 40 min of 
labelling. These observations are in support of a 
lower steady-state level of PIP2 and disagree with 
the hypothesis that in stimulated cells the amount 
of PIP2 increases again to prestimulatory levels [5]. 
Stimulation of pancreatic acini, prelabelled 
with [3H]inositoI, has been shown to result in accu­
mulation of labelled (1,3,4-)ІРз with time [12-14]. 
Since (1,3,4-)ІРз is formed upon dephosphoryla-
lion of (13,4,5-)IP4, the phosphorylation product 
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of (1,4,5-)ІРз, this observation strongly suggests 
that PIP2 breakdown is increased during the entire 
period of stimulation and we provide evidence now 
that this occurs at a lower steady-slate level of 
PIP2· 
In studies dealing with secretagogue-induced 
desensitization [15,16], inhibition of subsequent 
stimulation is most obvious when pancreatic acinar 
cells are treated first with supramaximally stimula­
tory concentrations of secretagogue. When adding 
cholecystokinin together with a cholinergic recep­
tor antagonist to pancreatic acini incubated in the 
presence of a supramaximally stimulatory concen­
tration of carbachol, no increase in free cytosolic 
calcium concentration was observed by Pandel et 
al. [17]. They concluded that this was due to 
carbachol-induced depletion of the intracellular 
calcium store. However, we find now that the rate 
of PIP2 hydrolysis reached with a nearly maximal­
ly stimulatory concentration of 10~8M CCK-8 [10] 
appears to be maximal, since additional stimulation 
with a nearly maximally stimulatory concentration 
of lO'^M carbachol [10] did not result in any fur­
ther decrease in the amount of 32p-labelled PIP2· 
This suggests that the findings of Pandol et al.[17] 
may also be explained by an already maximally 
carbachol-induced decrease in the amount of PIP2· 
Stimulation of rabbit pancreatic acini, prela-
belled with [32P]phosphate, did not result in an ini­
tial fast, but in a sustained slow decrease in the 
amount of 32p-labelled pip, тіш observation is in 
line with the hypothesis that stimulatie» results pri­
marily in the enhanced breakdown of PIP2, leading 
to the formation of (1,4,5-)ІРз, generally accepted 
to be the intracellular messenger mediating the 
release of intracellularly stored calcium [4,5]. 
However, an almost instantaneous and substantial 
decrease in the amount of PIP2. must result in a 
rapid decrease in the rate of dephosphorylation of 
PIP2· Assuming that the rate of phosphorylation of 
PIP remains unaltered, the fact that no rapid 
decrease in 32p-labelled PIP was observed, sug­
gests that the rate of dephosphorylation of PIP2 is 
relatively low compared to the stimulated rate of 
PIP2 hydrolysis to yield diacylglycerol and 
(1,4,5-)ІРз. As a consequence, the rate of phospho­
rylation of PIP has also to be relatively low, which 
means that after an initial large production of 
(1,4,5-)ІРз, the rale of formation of this inosi-
tolphosphate rapidly declines. 
However, the fact that the rapid and substantial 
decrease in the amount of ^p-labelled PIP2 was 
not followed by a rapid decrease in the amount of 
labelled PIP may also be explained by the fact that 
labelling of PIP had not reached equilibrium at the 
time of stimulation. In that case, lower specific 
labelling of PEP compared to PIP2 would result in 
less pronounced secretagogue-induced decreases in 
labelled PIP. 
Interestingly enough, the decrease in the 
amount of labelled PIP, underestimated because of 
the fact that labelling of PIP had not reached equi­
librium at the time of stimulation, appeared to be 
more sustained. This may very well reflect stimu­
lated breakdown of PIP through mechanisms other 
than phosphorylation to yield PIP2· For instance, it 
may be due to an increased phospholipase C-like 
hydrolysis of PIP to yield diacylglycerol and inosi­
tol 1,4-bisphosphate. 
Labelling of PIP under stimulatory condii ions 
did not reach equilibrium during a 60 min period of 
incubation in the presence of ortho[32p]phosphate. 
This observation is not in line with the observation 
that 10 min after the onset of stimulation of prela-
belled cells, the amount of 32P-labelled PIP is 
decreased and also seems to disagree with the 
observation that labelling of PIP2 does reach equi­
librium. However, one explanation may be that 
only part of the 32p.i
a
belled PIP, formed under 
stimulatory conditions, is used for the formation of 
PIP2- If this is the case, compartimentalization may 
be involved. There is some evidence for comparti­
mentalization since the major site of resynlhesis of 
PI, the precursor for PIP, is in the endoplasmic 
reticulum and not in the plasma membrane [18]. 
The receptor-mediated increases in 
32p-iabelling of PA and PI are of course well 
known phenomena, demonstrated first by Hokin 
and Hokin back in 1953 [19] and representing the 
stimulated breakdown and resynlhesis of PI [44]. 
Additional cholinergic stimulation of CCK-8 stim­
ulated acinar cells did not lead to any further 
enhancement of the rates at which both phospho­
lipids were phosphorylated. 
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In the presence of TP A, the accumulation of 
label into PIP2 appeared to be increased. Similar 
observations with phorbol esters have been reached 
in other cell types [20-23]. Increased labelling of 
PIP2 can be explained by inhibition of unstimulat­
ed breakdown of PIP2. by an increase in the rate of 
phosphorylation of PIP, or by increased rates of de-
and re- phosphorylation of PIP2· Whether or not 
the amount of PIP2 is increased in acinar cells, 
incubated in the presence of TPA, cannot be con­
cluded from the present labelling experiments, 
since no equilibrium was reached. Effects of TPA 
on the labelling of PIP and PA were less obvious, 
whereas the labelling of PI was virtually not affect­
ed by the phorbol ester. 
Conform the results presented before [8], the 
ССК-8-mduccd decrease in the amount of 
32P-labeHed PIP2 was not inhibited in TPA-treated 
acini, neither were the CCK-S-induced increases in 
labelled PA and PI. In TPA-treated acini, the 
CCK-S-induced decrease in the amount of 
32p-iabelled PIP, when measured 30 sec after the 
onset of stimulation, was much more pronounced 
than in control acini, which may be in line with a 
TPA-induced increase in the rate of phosphoryla­
tion of PIP. 
It is also noteworthy that 10 min after stimula­
tion of TPA-treated acini, the amounts of 
32P-labelled PIP2 and 32P-labelIed PIP appeared 
to be increased again. This observation may sug­
gest that in TPA-treated cells the sustained, and not 
the initial, secretagogue-induced breakdown of 
PIP2 is inhibited. 
The most remarkable effect of TPA was the 
enhanced labelling of PC. Stimulatory effects of 
phorbol esters on the metabolism of PC have been 
described for a number of cell types [24-29]. It has 
been shown that phorbol esters as well as synthetic 
diacylglycerols induce the translocation of the rate 
limiting enzyme in the synthesis of PC, 
CTP:phosphocholine cytidylyltransferase, from the 
cytosol where it is inactive to the membrane where 
it is active [30,31]. On the other hand, phorbol 
esters also activate the PC specific phospholipase 
C, yielding diacylglycerol and phosphocholine 
[32,33], and the diacylglycerol produced is used for 
the resynthesis of PC [33]. In the latter study it was 
argued that the diacylglycerol produced was not 
used for the synthesis of phosphatidic acid because 
of an inhibitory effect of TPA on diacylglycerol 
kinase activity. In our experiments, however, in 
which acini, labelled in the presence of TPA, were 
stimulated with CCK.-8, no inhibition of 
32p-iabellmg of phosphatidic acid was observed. 
In 3T3 LI cells it has been shown that stimula­
tion with platelet derived growth factor results also 
in the activation of the PC specific phospholipase С 
[32]. In contrast, no stimulatory effect of CCK.-8 on 
the labelling of PC was observed in the present 
investigation. It is not clear whether the lack of 
effect of CCK-8 on the labelling of PC reflects 
inhibitory pathways not activated by the phorbol 
ester alone. 
The data provided in this study show that in 
pancreatic acinar cells, secretagogues of the calci­
um mobilizing type evoke a sustained decrease in 
PIP2 content. Under maximally stimulatory condi­
tions, additional stimulation through a different 
receptor does not lead to any further decrease in the 
amount of 32P-IabeHed PIP2, which may explain 
some aspects of desensitization. The main effect of 
the phorbol ester was the enhanced labelling of PC. 
However, also some interesting but less obvious 
effects were observed on the labelling of the 
polyphosphoinositides, before as well as after stim­
ulation, which certainly need closer examination. 
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Chapter 9 
Secretagogue-induced cyclic AMP formation in rabbit pancreatic acini: 
inhibitory effects of 12-0-tetradecanoylphorbol-13-acetate. 
WILLEMS, P.H.G.M. 
VANNOOIJ,LG.P.and 
DEPONT,JJ.H.H.M. 
Department of Biochemistry, University of Nijmegen, 
P.O. Box 9101,6500 HB Nijmegen, The Netherlands. 
The abbreviations are: CCK-8, cholecystokinin octapeptide; VIP, vasoactive intestinal polypeptide; 
TPA, 12-O-letradecanoylphorbol 13-acetate; IBMX, isobutylmethylxanthine; [Ca2"1"];, free cytosolic cal-
cium concentration; PI, phosphatidylinositol; PIP, phosphatidylinosilol 4-monophosphate; PIP2, phos-
phatidylinositol 4,5-bisphosphate; IP3, inositol 1,4,5-trisphosphate; PC, phosphatidylcholine; PE, phos-
phatidylethanolamine; PA, phosphatidic acid; qum2, 2-((2-(bis((carbonyl)methyl) 
amino)-5-methylphenoxy)-meÜiyl)-6-methoxy-8-((bis(carbonyl)niethyl)amino)quinolme; quin2/AM, 
quin2-tetra(acetoxymethyl)ester. 
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SUMMARY 
It has been demonstrated that the C-terminal octapeptide of cholecystokinin (CCK-8) 
is a potent stimulator of adenylate cyclase activity in broken cell preparations of pancre­
atic exocrine tissue. In the presence of isobutylmethylxanthine (IBMX), an inhibitor of 
cyclic nucleotide phosphodiesterase activity, CCK-8 only slightly increased the acinar cell 
cyclic AMP level. On the other hand, secretin and vasoactive intestinal polypeptide (VIP) 
markedly enhanced cyclic AMP accumulation. 
In contrast to CCK-8, neither VIP nor secretin activated the acinar cell calcium mes­
senger system, since both secretagogues did not induce the breakdown of -'2P-labelled 
phosphatidylinositol 4,5- bisphosphate, the ^P-labelling of phosphatidic acid nor the 
increase in free cytosolk calcium concentration. This leaves the possibility that the simul­
taneous activation of the phosphatidylinositol-calcium pathway by CCK-8 underlies its 
inability to significantly activate the adenylate cyclase in the intact acinar cell. 
To test the possibility that activation of the protein kinase С pathway of the calcium 
messenger system is involved in this process, the effects of TPA on secretagogue-induced 
cyclic AMP formation were investigated. The phorbol ester itself did not significantly 
affect the cellular cyclic AMP concentration in acini incubated in the presence of IBMX. 
The response to relatively low concentrations of CCK-8 and VIP, however, was markedly 
inhibited in TPA-treated acini, whereas cyclic AMP formation in response to relatively 
high concentrations of CCK-8 remained virtually unaffected. 
The observation that the cyclic AMP response to the higher concentrations of VIP 
and CCK-8 was not inhibited in TPA-treated acini indicates that protein kinase С activa­
tion alone cannot account for the relative inability of CCK-8 to activate the adenylate 
cyclase in the intact acinar cell. 
INTRODUCTION cells [10]. Since pertussis toxin is thought to inacti­
vate the inhibitory guanine nucleotide-binding reg­
ulatory protein of the adenylate cyclase system 
An intriguing property of the peptide hormone (Gj), we postulated that activation of this regulato-
cholecystokinin is its ability to activate both the ry protein by some component of the calcium mes-
phosphatidylinositol 4,5-bisphosphate (PIP2) spe- senger system might underlie the inability of chole-
cific phosphodiesterase and the adenylate cyclase cystokinin to significantly activate the adenylate 
in the intact pancreatic acinar cell. But whereas in cyclase in the intact pancreatic acinar cell. 
the intact acinar cell cholecystokinin readily It was the aim of the present investigation to 
increases diacylglycerol [1], inositol test the above hypothesis by examining the effects 
1,4,5-trisphosphate (IP3) [2,3] and free cytosolic of the phorbol ester, 12-O-tetradecanoylphorbol 
calcium [4-7], a suitable inhibitor of cyclic 13-acetate (TPA), known to activate the protein 
nucleotide phosphodiesterase activity has to be kinase С pathway of the calcium messenger system 
present to enable measurement of cholecystokinin- [11], on secretagogue-induced cyclic AMP forma-
induced increases in cyclic AMP [8,9]. tion in rabbit pancreatic acini. In addition we 
Recently we have shown that pretrealment of investigated whether vasoactive intestinal polypep-
rabbit pancreatic acini with pertussis toxin facilitât- tide (VIP) and/or secretin, two potent activators of 
ed cholecystokinin octapeptide (CCK-8)-induced the acinar cell adenylate cyclase, activate the calci-
activation of the adenylate cyclase in intact acinar um messenger system in rabbit pancreatic acini. 
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This because secretin has recently been shown to 
stimulate inositol phosphate production and intra­
cellular calcium mobilization in rat exocrine pan­
creas [12,13]. If this stimulation would also occur 
in the rabbit pancreas, the hypothesis that activa­
tion of this messenger system negatively influences 
activation of the adenylate cyclase could be reject­
ed beforehand. 
The results presented in (his paper do not pro­
vide any evidence for effects of secretin and VIP 
on the calcium-phosphatidylinositol system. They 
moreover, indicate that although phorbol ester 
treatment attenuates secretagogue-induced activa­
tion of the rabbit pancreatic acinar cell adenylate 
cyclase, activation of protein kinase С alone cannot 
account for the inability of cholecystokinin to sig­
nificantly activate the adenylate cyclase in the 
intact cell. 
MATERIALS AND METHODS 
Preparation of rabbit pancreatic acini. Rabbit 
pancreatic acini were prepared as previously 
described [14]. 
Amylase secretion experiments. For amylase secre­
tion experiments, rabbit pancreatic acini, resus­
pended in a Krebs-Ringer bicarbonate medium (pH 
7.4) containing И9 mM NaCl, 3.5 mM KCl, 1.2 
mM КНгГОф 25 mM NaHC0 3, 1.2 mM СаСІг. 
1.2 mM glucose, 1 % bovine serum albumin, an 
amino acid mixture according to Eagle [15] and 0.2 
mg/ml soybean trypsin inhibitor, were preincubated 
in the absence or presence of Ю - 4 M isobutyl-
methylxanthine (IBMX) for 30 min at УІ^С. 
Secretin and CCK-8 were then added and samples 
for measurement of medium amylase activity were 
removed immediately before and 15 min after stim­
ulation. At the beginning of the experiment, an 
aliquot of the suspension was removed and the aci­
ni were homogenized for determination of total 
amylase activity. Amylase activity was measured 
by means of the Phadebas test and medium amy­
lase activity was expressed as percent of total amy­
lase present in the acini at the beginning of incuba­
tion. 
Cyclic AMP measurements. Acini, resuspended in 
the above Krebs-Ringer bicarbonate medium (pH 
7.4), were preincubated in the absence or presence 
of ΙΟ"4 M IBMX and either TPA (IO"6 M) or 
dimethylsulfoxide for 30 min at 370C. Stimulants 
were then added and samples for determination of 
the cyclic AMP concentration were removed at 
appropriate times and immediately mixed with ice-
cold trichloroacetic acid (final concentration, 5 % 
(w/v)). Cyclic AMP was measured as previously 
described [16] and the acinar cell cyclic AMP con­
tent was expressed as pmol cyclic AMP per mg 
protein. Protein concentrations were determined 
by the Lowry method, using bovine serum albumin 
as a standard. 
Quin2 fluorescence measurements. Measurement 
of qum2 fluorescence was performed as previously 
described [6]. 
Analysis of & Ρ-labelled phospholipids. Labelling 
of the acini with ortho[32p]phosphale, extraction 
of the various phospholipids and thin layer chro­
matography was essentially the same as reported 
before [6] with the exception that the extracts were 
devided over two potassium oxalate treated high 
perfoimance thin layer chromatography plates 
(Merck). One plate was developed with 
dichloromethane, methanol and 20% methylamine 
(60: 36:10), separating PIP2, phosphatidylinositol 
4-monophosphate (PIP), phosphatidylcholine (PC) 
and phosphatidylethanolamine (PE) but not phos­
phatidylinositol (PI) from phosphatidk acid (PA). 
The second plate was developed with 
dichloromethane, aceton, methanol, acetic acid and 
water (40 : 15 : 13 : 12 : 8), separating PIP2, PIP, 
PA and PE but not PI from PC. Radioactive spots 
localized by means of autoradiography were 
scraped off and counted as described before [6]. 
The amount of 32P-labelled phospholipid was 
expressed as percent of the amount extracted from 
unstimulated control acini. 
Materials The C-terminal octapeptide of cholecys­
tokinin has been synthesized by Dr. H.M. Rajh in 
the Department of Organic Chemistry, University 
of Nijmegen. The cyclic AMP binding protein was 
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Figure 1. Time-courses for secretagogue-induced cyclic AMP foimation in rabbit pancreatic aci­
ni. Rabbit pancreatic acini were preincubated in the presence of ΙΟ"4 M ШМХ for 30 min at 
370C. CCK-8 (ΙΟ"8 M, ·), secretin (1.5x10"6 Μ. о) or VIP (КГ6 M. •) were then added and sam­
ples for cyclic AMP measurement were removed at the indicated times. The acinar cell cyclic 
AMP concentration measured immediately before stimulation (6.3 pmol/mg protein, S.E. 0.3, n=4) 
is set at 100%, to which all other values are related. ТЪе values presented are the means ± SE., of 
3 experiments. 
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isolated from bovine adrenal cortex as described by 
Brown et al. [17]. Synthetic secretin was a gift 
from Dr. H. Beyerman (Department of Organic 
Chemistry, Technical University, Delft, The 
Netherlands). Carbachol was purchased from ACF 
Chemiefaima, Maarsen, The Netherlands. 
Forskolin was obtained from Calbiochem, La Jolla, 
CA, U.S.A.; ШМХ from Aldrich Chemical Com­
pany, Inc., Milwaukee, WI, U.S.A.; VIP (porcine), 
TPA, bovine serum albumin, quin2/AM and soy­
bean trypsin inhibitor, from Sigma, St. Louis, MO, 
U.SA.; hyaluronidase and cyclic AMP from 
Boehringer, Mannheim, F.R.G.; collagenase from 
Cooper Biomedical Inc., Malvern, PA, U.S.A.; 
[3H]cAMP (15 Ci/mmol) from ICN, Irvine, CA, 
U.S.A.; ortho[32p]phosphate ^
т
 N
e w
 England 
Nuclear, Boston, MA, U.S.A.; Dowex 50W-X8 
from Fluka, Buchs, Switzerland; activated charcoal 
(Norit, SX-1) from Norit, Amersfoort, The Nether­
lands and HPTLC plates silica gel 60, from Merck, 
Darmstadt, F.R.G. The Phadebas test kit was pur­
chased from Pharmacia, Uppsala, Sweden. All oth­
er chemicals were of reagent grade. 
RESULTS 
Effects of CCK-8 and secretin on cyclic AMP for­
mation and amylase secretion. When die acini 
were stimulated with secretin (1.5xl(H> M) and the 
increase in medium amylase activity was measured 
IS min after the onset of stimulation, no stimulato­
ry effect was observed (Table I). Acinar cell cyclic 
AMP levels, however, were significantly increased 
by secretin (5-fold). On the other hand, CCK-8 
(10~° M) clearly stimulated amylase secretion 
(2.4-fold) without altering the acinar cell cyclic 
AMP concentration. 
In the presence of ШМХ, the resting cyclic 
AMP concentration was increased 3.1-fold and 
stimulation with secretin resulted in a 14-fold 
increase in acinar cell cyclic AMP concentration as 
compared to unstimulated acini incubated in the 
absence of IBMX. Despite the substantial increase 
in cyclic AMP level, amylase secretion remained 
unchanged. With CCK-8, the increase in acinar cell 
cyclic AMP concentration, measured in the pres­
ence of IBMX, was less pronounced (6-fold), 
whereas the secretory response was considerably 
potentiated (2.8-fold) as compared to the 
ССК-8-induced response in the absence of IBMX. 
Time-course for secretagogue-induced cyclic AMP 
formation. Rabbit pancreatic acini were preincu-
bated in the presence of ΙΟ-4 M IBMX for 30 min 
and then stimulated with either CCK-8 (IO"8 M), 
VIP ( W 8 M) or secretin (l.SxlO"6 M). Figure 1 
shows the respective time-courses for cyclic AMP 
formation. After 30 min of incubation in the pres­
ence of ΙΟ-4 M IBMX, the acinar cell cyclic AMP 
concentration was 6.3 pmol/mg protein (S.E. 0.3; 
n=4). Both secretin and VIP markedly enhanced 
the acinar cell adenylate cyclase activity and the 
increase in cellular cyclic AMP concentration was 
nearly linear with time during the first 8 min after 
the onset of stimulation. 
We have previously shown, that, in the absence 
of ШМХ, CCK-8 at a concentration of ΙΟ"8 M not 
only maximally stimulates rabbit pancreatic 
enzyme secretion, but also maximally potentiates 
forskolin-induced cyclic AMP formation [16]. 
Hence, a concentration of ΙΟ"8 M was used in this 
investigation to determine the time-dependency for 
the cyclic AMP response to CCK-8. With CCK-8, 
only a small increase in acinar cell cyclic AMP 
concentration was observed and maximal cyclic 
AMP levels were already reached within 2 min of 
stimulation. 
Effects of CCK-8, VIP and secretin on the free 
cytosolic calcium concentration. The effects of 
CCK-8, VIP and secretin on the acinar cell free 
cytosolic calcium concentration ([Ca2+]¡) were 
measured with the quin2 technique. Neither VIP, at 
concentrations of S.IO"10 -ΙΟ"6 M (Fig. 2), пот 
secretin, at a concentration of 1.5x10"^ M (data not 
shown), changed the resting [Ca2+]¡, whereas 
CCK-8, at a concentration of S.IO-10 M, increased 
the free cytosolic calcium concentration within sec-
onds (Fig. 2). 
Effects of CCK-8, VIP and secretin on l32P)-PIP2 
hydrolysis. In agreement with previous findings 
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unstimulated 
a c i n a r c e l l 
amylase s e c r e t i o n cAMP c o n c e n t r a t i o n 
- IBMX + IBMX - IBMX + IBMX 
2.7 ± 0.3 (4) 3.2 i 0.4 (4) 2.7 І 0.4 (6) 8.5 ± 0.3 (6) 
s e c r e t i n (1 .5 χ I O - 6 M) 2.8 Í 0.1 (3) 3.4 ± 0.3 (3) 13.9 І 4.0 (6) 37.8 ± 7.6 (6) 
CCK-8 ( 1 0 ~ 8 M) 6.5 t 1.1 (4) 18.3 ± 3.1 (4) 3.7 t 0.9 (3) 16.2 ± 1.1 (3) 
Table I. Effects of CCK-8 and secretin on amylase secretion and cyclic AMP formation in rabbit 
pancreatic acini. Rabbit pancreatic adni were incubated in the absence or presence of ΙΟ"4 M 
IBMX for 30 min at 370C. The indicated concentrations of CCK-8 and secretin were then added. 
The increase in medium amylase activity and acinar cell cyclic AMP content was measured IS 
min after the onset of stimulation and expressed as percentage of amylase total and as pmol/mg 
protein, respectively. The values presented are the means ±S.E. of the number of experiments giv­
en in parentheses. 
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Figure 2. Effects of VIP and CCK-8 on the free cytosolic calcium concentration in rabbit pancre­
atic adni. Rabbit pancreatic acini resuspended in a Krebs-Ringer bicarbonate medium (pH 7.4), 
were incubated io the presence of quin2/AM (SO μΜ) for 20 min. At 20 min, the suspension was 
diluted 6 times and incubaled for another 30 min. The suspension was then centiifiiged and the 
adni were resuspended in fresh incubation solution. Immediately before fluorescence measure­
ment samples were removed, rapidly centiifuged (Eppendorf minifiige) and resuspended in a 
HEPES/TRIS medium (pH 7.4). Fluorescence measurements were carried out at 370C using a 
spectrofluorometer equipped with a thermostated cuvet bolder and a magnetic stirrer. After S min 
of équilibration, VIP (S.IO"10 - ΙΟ"6 M) or secietin (l.SxlO"6 M, data not shown) and CCK-8 
(S. ΙΟ" 1" M) were added successively. This figure is typical for all concentrations of VIP tested. 
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Figure 4. Effect of TPA on the dose-response curve for VIP-induced cyclic AMP fonnation in 
rabbit pancreatic acini. Rabbit pancreatic acini were preincubated in the presence of ΙΟ-4 M 
IBMX and either dimethylsulfoxide (o) or IO - 6 M TPA ( · ) for 30 min at 370C. The indicated 
concentrations of VIP were added at 30 min and samples for cyclic AMP measurement were 
removed 2 min after the onset of stimulation. The acinar cell cyclic AMP concentration measured 
immediately before stimulation and given in the legend to figure 3 is set at 100%, to which all oth­
er values are related (A). The percentage of inhibition (B) is calculated as described in the legend 
to ligure 3. The values presented are the means ± S.E. of 3 experiments. 
r e l a t i v e acinar ce l l 
CAMP concentration 
uns tinnì La ted 
forskolin (10 M) 
lorekolin (10~5 M) + CCK-8 ( 10~8 M) 
forskolin (I0~5 M) + carbachol ( I0~ 5 M) 
6.5 І 2.3 (5) 
56.0 І 5.6 (5) 
101 .7 ± 9.2 (4) 
100 (5) 
forskolin (ΙΟ - 5 M) + CCK-8 ( 10~8 M) + carbachol ( Ι Ο - 5 M) 113.5 І 15.7 (3) 
forskolin (I0~5 M) + TPA (10 6 M) 61.1 І 9.3 (5) 
Table III. Effects of carbachol, CCK-8 and TPA on forsfcolin-induced cyclic AMP fonnation in 
rabbit pancreatic acini. Rabbit pancreatic acini were incubated in the presence of 10~4 M ШМХ 
for 30 min at 370C. At 30 min, tbe stimulants were added as indicated. Samples for cyclic AMP 
measurement were removed IS min after the onset of stimulation. The acinar cell cyclic AMP 
concentration in acini stimulated with the combination of carbachol and forskolin is set at 100%, 
to which all other values are related. In unstimulated acini tbe cyclic AMP concentration was 7.5 
pmol/mg protein (S.E. 2.7; n=5). The values presented are the means ± S.E. of tbe number of 
experiments given in parentheses. 
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[6], CCK-8 (ΙΟ" 8 M) significantly decreased the 
acinar cell [ 3 2 P]-PIP2 content within 2 min. Table 
II shows that over the same period of time the aci­
nar cell [32p]-pip content also decreased, whereas 
the labelling of PA markedly increased. Labelling 
of the other phospholipids, including PI, P C and P E 
remained unchanged upon stimulation with CCK-8. 
Secretin, however, when added at a concentration 
of 1.5x10"^ M, at which concentration cycl ic A M P 
formation was considerably stimulated (Fig. 1 ), did 
not change the 3 2 p _ i
a
b
e
m
n
g
 0 f the phospholipids 
extracted 2 min after the onset of stimulation. A lso 
when 32p_i
a
tj
e
ii
e
(i acini were stimulated with 10"^ 
M VIP, no changes in [ 3 2 P ] - P I P 2 , [ 3 2 P ] - P I P or 
[32p]-PA were observed. At this concentration 
VIP, in the presence of IBMX, increased the acinar 
cell cyclic AMP level within 2 min to 6 4 0 % (S.E. 
200; n=3) of the control. 
Effects of TPA on secretagogue-induced cyclic 
AMP formation. When acini were preincuba ted in 
the presence of IBMX and T P A ( I O " 6 M ) for 30 
min, the acinar cell cyclic A M P concentration was 
7.1 pmol/mg protein (S.E. 0.4; n = 4 ) , whereas in the 
presence of IBMX and dimethylsulfoxide, the 
cyclic AMP level was 5.9 pmol/mg protein (S.E. 
0.3; n=4). Figure 3 shows that in control acini 
CCK-8 at both IO" 9 and ΙΟ" 8 M increased the aci­
nar cell cyclic A M P level to the same extent. In 
TPA-treated acini, however, cycl ic A M P formation 
induced by I O - 9 and ΙΟ" 8 M CCK-8 was inhibited 
by 70 and 15 %, respectively (Fig. 3 , insertion). 
VIP dose-dependently increased the acinar cell 
cyclic AMP concentration in acini preincubated in 
the presence of IBMX and either dimethylsulfoxide 
or TPA (IO" 6 M) (Fig. 4A). Figure 4 B demon­
strates that in TPA-treated acini only the response 
to the lower concentrations of VIP w a s significant­
ly inhibited, whereas the cyc l ic A M P response to 
the higher concentration of V I P remained virtually 
unaffected. 
Effects of TPA, carbachol and CCKS on forskolin-
induccd cyclic AMP formation. Table III summa­
rizes the effects of T P A ( I O - 6 M ) , carbachol (IO" 5 
M) and CCK-8 (IO" 8 M ) on the forskolin-induced 
increase in cellular cycl ic A M P concentration mea­
sured 15 min after the onset of stimulation. In the 
presence of ШМХ, the phorbol ester alone did not 
affect the cyclic AMP response to forskolin. The 
response to forskolin was almost doubled, how­
ever, when the drug was added in combination with 
either carbachol or CCK-8 or in combination with 
both secretagogues. 
DISCUSSION 
Stimulation of pancreatic acinar cells with 
cholecystokinin or with the cholinergic receptor 
agonist, carbachol, leads within seconds, to the 
enzymatic breakdown of PIP2 [6,18,19], yielding 
diacylglycerol [1], and inositol 1,4,5-trisphosphate 
(IP3) [2,3] and to the mobilization of intracellular 
calcium [4-7]. In addition, cholecystokinin induces 
an increase in the acinar cell cyclic AMP concen­
tration within 30-60 sec after the onset of stimula­
tion (Fig. 1), indicating that not only the PIP2 spe­
cific phosphodiesterase but also the adenylate 
cyclase is rapidly activated by cholecystokinin. 
Cholecystokinin-induced increases in acinar cell 
cyclic AMP concentration, however, can only be 
measured when cyclic AMP phosphodiesterase 
activity is inhibited [8,9 and this publication]. In 
the presence of the cyclic nucleotide phosphodi­
esterase inhibitor, IBMX, CCK-8 stimulated cyclic 
AMP accumulation is only observed during the 
first 2 min, whereas cyclic AMP accumulation in 
response to VIP or secretin continues for at least 8 
min with final cyclic AMP concentrations reached 
far above those for CCK-8 stimulated acini. This 
observation and the fact that in broken cell prepara­
tions of the rabbit pancreas CCK-8 proved to be 
even a better activator of the adenylate cyclase than 
secretin [20], might suggest that after the initial 
activation of the adenylate cyclase by cholecys­
tokinin, a negative feed-back mechanism becomes 
rapidly activated preventing the secretagogue from 
further activation of the adenylate cyclase. 
In addition, our recent observation that pre­
treatment of the acini with pertussis toxin consider­
ably facilitates ССК-8-induced activation of the 
adenylate cyclase [10], may suggest the involve­
ment of the inhibitory guanine nucleotide-binding 
protein (Gj) of the adenylate cyclase system in such 
a negative feed-back mechanism. Our findings with 
pertussis toxin led us to speculate that 
ССК-8-mduced activation of the calcium messen­
ger system might lead to activation of G¡ thus 
inhibiting ССК-8-induced activation of the acinar 
cell adenylate cyclase via the stimulatory G-protein 
(G
s
). In fact, it has been shown by Katada et al. 
[21] that protein kinase С can directly phosphory-
late the a-subunit of Gj. Phorbol esters are gener­
ally believed to exert their biological effects by 
activating protein kinase С in a diacylglycerol-like 
manner [11] and have extensively been used to 
investigate the role of protein kinase С in a wide 
variety of biological systems [22]. We now find 
that upon pretreatment of pancreatic acini with the 
phorbol ester TPA, the cyclic AMP response to the 
lower concentrations of both CCK-8 and VIP is 
inhibited. The response to the higher concentra­
tions of secretagogue, however, is hardly affected 
by pretreatment with the phorbol ester and espe­
cially the finding that VIP-induced cyclic AMP 
formation is not lowered to the levels of 
ССК-8-induced cyclic AMP formation indicates 
that protein kinase С activation alone cannot 
account for the difference observed between 
cholecystokinin- and VIP- or secretin- induced 
activation of the adenylate cyclase in intact acinar 
cells. The fact that TPA pretreatment inhibits the 
cyclic AMP response to the lower concentrations 
of both CCK-8 and VIP indicates that in the pan­
creatic acinar cell protein kinase С can modulate 
secretagogue-induced cyclic AMP formation. One 
possibility is that modulation occurs at the level of 
Gj [21]. Another possibility is that protein kinase С 
acts at the level of the catalytic subunit of the 
adenylate cyclase [25]. TPA-induced desensitiza-
tion of receptor-mediated stimulation of the adeny­
late cyclase has also been found for duck [23] and 
turkey [24] erythrocytes and was shown to be 
accompanied by phosphorylation of the 
ß-adrenergic receptor thus providing a third possi-
bility. 
We have previously shown that under the same 
experimental conditions, employed in the present 
study, TPA also inhibits ССК-8-mduced calcium 
mobilization and amylase secretion [6]. As in the 
present study, only the response to the relatively 
low concentrations of CCK-8 (IO"10 - IO'9 M) was 
inhibited. This may suggest that the same mecha­
nism underlies both the inhibitory action of TPA on 
ССК-8-mduced calcium mobilization and cyclic 
AMP formation. This in tum would mean that the 
inhibitory action of TPA has to occur at the level of 
the CCK receptor and that this receptor is coupled 
both to the PIP2 specific phosphodiesterase and (he 
adenylate cyclase. However, the phorbol ester-
induced inhibition of calcium mobilization was not 
paralleled by inhibition of receptor-mediated 
PIP2-breakdown, suggesting a more distal site of 
action of TPA. We now find that the cyclic AMP 
response to both CCK-8 and VIP is inhibited in 
TPA-treated acini, suggesting that either both 
receptors are desensitized or that inhibition occurs 
more distally as discussed above. 
We have shown before that the dose-response 
curve for ССК-8-induced potentiation of the cyclic 
AMP response to forskolin has the same shape as 
the dose-response curve for ССК-8-induced amy­
lase secretion, with a maximum at 10"8 M CCK-8 
and submaximal potentiation at the higher (supra­
maximal) concentrations of secretagogue [16]. 
This observation together with the present finding 
that the cholinergic receptor agonist carbachol, like 
CCK-8, when given at a concentration which maxi­
mally stimulates amylase secretion [14], potentiates 
the cyclic AMP response to forskolin and that the 
potentiating effects of CCK-8 and carbachol are 
not superimposable, suggests that activation of the 
adenylate cyclase by secretagogues which primari­
ly act by stimulating the phosphatidylinositol-
calcium pathway might be a side-effect of receptor-
mediated activation of the latter pathway. 
Recently it has been reported that secretin, but 
not VIP, stimulated IP3 formation and calcium 
mobilization in rat pancreatic acini, indicating that 
secretin receptors are coupled to the PIP2-specific 
phosphodiesterase [12,13]. In order to test whether 
activation of the calcium messenger system under­
lies the inability of CCK-8 to significantly activate 
the adenylate cyclase in the intact acinar cell, we 
investigated whether secretin and/or VIP stimulat­
ed the phosphatidylinositol-calcium pathway in 
rabbit pancreatic acinar cells. None of the cellular 
responses typical for ССК-8-induced activation of 
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the calcium messenger system: stimulated break- lizing secretagogues is markedly potentiated once 
downof[ 3 2 P]-PIP2. enhanced 32p.i
a
belling of PA the acinar cell cyclic AMP concentration is 
and rapid increases in free cytosolic calcium con- increased [14]. 
centration were observed for secretin and/or VIP, From the results presented, it is concluded (hat 
indicating that at least in rabbit pancreatic acini protein kinase C, or one of its phosphorylated prod-
secretin and VIP do not activate the calcium mes- ucts, can modulate secretagogue-induced activation 
senger system. Moreover, both secretin and VIP, of the acinar cell adenylate cyclase in a negative 
despite significant increases in cellular cyclic AMP sense, but that protein kinase С activation alone 
concentration, do not stimulate amylase secretion cannot account for the inability of CCK-8 to signif-
in the rabbit pancreas, whereas we have shown icantly activate the adenylate cyclase in the intact 
before that the secretory response to calcium mobi- cell. 
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GENERAL DISCUSSION AND SUMMARY 
Pancreatic enzyme secretion is stimulated by 
activating one of two functionally distinct process­
es. Depending on the process which is activated, 
two groups of pancreatic secretagogues are gener­
ally recognized (Gardner, 1979; Jensen and Gard­
ner, 1981; Gardner and Jensen, 1980,1981,1986; 
Schulz and Stolze, 1980). 
Some secretagogues, such as vasoactive intesti­
nal polypeptide (VIP) and secretin, are thought to 
stimulate enzyme secretion by increasing the cellu­
lar cAMP concentration. Binding of these agents to 
their specific receptors on the basolateral surface of 
the acinar cell, initiates a sequence of events 
including, activation of the stimulatory G protein 
(G
s
) of the adenylate cyclase system, activation of 
the cyclase, increases in cellular levels of cAMP, 
activation of protein kinase A, phosphorylation of a 
specific set of cellular proteins and, after a series of 
presently undefined steps, fusion of zymogen gran­
ules with the apical membrane. 
Other secretagogues, such as acetylcholine, 
cholecystokinine, physalaemin, bombesin, litorin, 
eledoisin and the cholecystokinin similar peptides 
gastrin and caenilein, cause increases in the free 
cytosolic calcium concentration. Binding of these 
agents to their specific receptors, initiates a 
sequence of events including, activation of a G pro­
tein (Gp), activation of the PIP2-specific phospho­
diesterase, increases in levels of diacylglycerol and 
(1,4,5-)ІРз, activation of protein kinase С and 
mobilization of intracellular calcium stores, phos­
phorylation of a specific set of cellular proteins by 
kinase С and modulation of the activity of a specif­
ic set of cellular proteins by calcium and, after a 
series of presently undefined steps, discharge of 
zymogens via exocytosis. 
The cAMP messenger system 
In the present study (chapter 9), both secretin 
and VIP are found to increase the cAMP concentra­
tion in the intact rabbit pancreatic acinar cell. This 
indicates that also in the rabbit, secretin and VIP 
bind to receptors which are functionally coupled to 
adenylate cyclase via G
s
. However, in a previous 
study, it was found that secretin did not increase 
the activity of adenylate cyclase in a particulate 
fraction of the rabbit pancreas, whereas it did in rat 
and guinea pig (De Pont et al., 1979). Moreover, it 
was found that CCK-8 stimulated adenylate cyclase 
equally well in all three species and in rat and guin­
ea pig, the stimulatory effect of CCK-8 was com­
parable to the stimulatory effect of secretin. In the 
latter study, no GTT was added to the assay medi­
um and it is now known that the presence of GTP 
is required for hormonal activation of the cyclase 
(Rodbell, 1980,1985; Gilman, 1984,1987; Levitzki, 
1987). It bas been shown in rat, that the apparent 
affinity of the adenylate cyclase system for GTP is 
6-7 -fold higher in the presence of CCK-8 than in 
the presence of secretin (Svoboda et al., 1980). 
Therefore, the inability of secretin to stimulate 
adenylate cyclase in a particulate fraction of the 
rabbit pancreas may be explained by lack of GTP, 
whereas there is enough GTP present to allow acti­
vation of the cyclase by CCK-8. The species differ­
ences observed for secretin-induced activation of 
the cyclase may be explained either by differences 
in the amounts of residual GTP in the different 
preparations or by species-dependent differences in 
apparent affinity of the adenylate cyclase system 
for GTP in the presence of secretin. In addition, it 
has been shown that reducing agents such as dithio-
threitol, added to protect the cyclase against oxyda­
tion of -SH groups, decrease the stimulatory effects 
of secretin and VIP, but not of CCK-8 (Robberecht 
et al., 1984). 
Although secretin and VIP, both in the absence 
and in the presence of the inhibitor of cyclic 
nucleotide phosphodiesterase activity, isobutyl-
methylxanthine (IBMX), significantly increase the 
cAMP concentration in rabbit pancreatic acinar 
cells, enzyme secretion is not enhanced (chapter 
9). Again, species differences seem to be involved 
since both in guinea pig and in rat, secretin and 
VIP stimulate enzyme secretion (Kempen et al., 
1975; Smith and Case, 1975; Gardner and Jackson, 
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1977; Singh, 1979; Gardner et al., 
1979a,1982,1983). However, in both species simi­
lar increases in cellular cAMP concentration 
induced by either VIP or secretin do not lead to 
similar secretory responses (Gardner et al., 1982; 
Vandenneers et al., 1984; Bisonnette et al., 1984). 
In the rat, secretin, acting through the high affinity 
secretin receptor, is much more efficacious as a 
secretory agent than VIP, acting through the high 
affinity VIP receptor (Vandenneers et al., 1984; 
Bisonnette et al., 1984). On the other hand, in guin­
ea pig, VIP already maximally stimulates enzyme 
secretion at concentrations which hardly increase 
the cellular cAMP concentration, whereas secretin 
does not become secretory active before its effect 
on the acinar cell cAMP level is nearly maximal 
(Gardner et al., 1982). Moreover, in guinea pig, 
secrelin-induced enzyme secretion increases still 
dose-dependenlly when the cAMP concentration is 
already maximally elevated. The above observa­
tions for rat and guinea pig have been explained by 
compartimentalization of the cAMP produced 
(Gardner and Jensen, 1986). In case of the guinea 
pig, secretin is thought to stimulate cAMP forma­
tion by activating a secretin-preferring receptor at 
lower concentrations and a VIP-preferring receptor 
at higher concentrations. According to the above 
hypothesis, it is the cAMP produced in response to 
activation of the VlP-prefening receptor which is 
in the appropriate compartment to cause stimula­
tion of enzyme secretion. In the presence of IBMX, 
the secretory response to secretin and VIP is 
markedly augmented in guinea pig (Gardner et al., 
1982), but not in rabbit (chapter 9). 
Similar to secretin and VIP, forskolin-induced 
substantial increases in cellular cAMP concentra­
tion do not lead to enhanced enzyme secretion in 
rabbit (chapter 2). On the other hand, in rat, 
forskolin does stimulate enzyme secretion (Heisler, 
1983; Dehaye et al., 1985). However, the stimula­
tory effect of forskolin is weak and comparable to 
that of VIP. In our opinion, the latter observation 
does not support the hypothesis that the stimulatory 
effect of cAMP on pancreatic enzyme secretion 
depends on the compartment in which it is pro­
duced. There is no indication that forskolin selec­
tively activates adenylate cyclase molecules local­
ized in the immediate vicinity of VIP receptors. 
Neither VIP nor secretin induces the break­
down of 32p_iabelled PIP2 in rabbit pancreatic aci­
ni and no increases in free cytosolic calcium con­
centration are observed in response to these two 
secretagogues (chapter 9). On the other hand, 
secretin, but not VIP, has recently been shown to 
stimulate the formation of (1,4,5-)ІРз and to 
increase the free cytosolic calcium concentration in 
rat pancreatic acini (Trimble et al., 1987a,b). In our 
study and in the studies of Trimble et al., rather 
high concentrations of secretin are used, indicating 
that species differences may be involved. 
In summary, agents such as forskolin and 
IBMX, but also cholera toxin and lipophilic deriva­
tives of cAMP, which all bypass receptor activation 
in increasing the acinar cell cAMP concentration, 
stimulate enzyme secretion in guinea pig and rat 
but not in rabbit. However, compared to secretin in 
rat and to VIP in guinea pig, the secretory effect of 
the above compounds is weak in both species. In 
rabbit, neither secretin nor VIP activates the calci­
um messenger system, whereas in rat secretin, but 
not VIP, activates this messenger system and is 
also more efficacious than VIP as a secretory 
agent. Together, these observations suggest that in 
rat and guinea pig, but not in rabbit, cAMP is a 
weak activator of enzyme secretion and that the 
additional effect of secretin on enzyme secretion in 
rat may be due to its ability to activate the calcium 
messenger system. 
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CCK-8 is a potent activator of adenylate 
cyclase in isolated membranes of exocrine tissue in 
all species tested (Rutten et al., 1972; Kempen et 
al., 1974; Schulz et al., 1974; Bonting et al., 1977; 
Long and Gardner, 1977; Svoboda et al., 1978; De 
Pont et al., 1979). Yet, Stimulation of the intact aci­
nar cell with CCK-8 does not lead to any detectable 
increase in cAMP concentration (chapter 2), unless 
a suitable inhibitor of cyclic nucleotide phosphodi­
esterase activity is present (chapters 3 and 9). 
And, even in the presence of such an inhibitor, the 
effect of CCK-8 is weak compared to the effects 
exerted by secretin or VIP (chapter 9). In the 
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intact acinar cell, ССК-8-induced activation of 
adenylate cyclase is improved by pretreatment with 
pertussis toxin (chapter 3). Effects exerted by this 
toxin are generally ascribed to its ability to modify 
G proteins including the inhibitory G protein of the 
adenylate cyclase system (Gj) (Gilman, 1984; Ui, 
1984; Bokoch et al., 1984). In case of G,, modifi­
cation by pertussis toxin results in inactivation. As 
a consequence, receptor-mediated inhibition of 
adenylate cyclase is abolished in toxin-treated 
cells. Our results with pertussis toxin may suggest 
that CCK-8 not only activates the cyclase via G
s
, 
but also inactivates the cyclase via Gj. Inactivation 
of the cyclase via G¡ is normally the result of 
receptor-mediated activation of Gj. This would 
imply the presence of inhibitory cholecystokinin 
receptors which upon activation interact with G¡. 
In rabbit, CCK-8, but not secretin or VIP, acti-
vates (he calcium messenger system (chapter 9). 
This has led us to put forward the hypothesis that 
CCK-8 activates Gj via some component of the 
activated calcium messenger system. We have used 
the phorbol ester, 12-O-tetradecanoylphorbol 
13-acetate (TPA), which mimicks the stimulatory 
effect of diacylglycerol on protein kinase С 
(Castagna et al., 1982), to test the hypothesis that 
activation of the diacylglycerol/protein kinase С 
pathway underlies the relative inability of CCK-8 
to activate adenylate cyclase in the intact acinar 
cell. Pretreatment of pancreatic acinar cells with 
TPA does not significantly alter basal adenylate 
cyclase activity (chapter 9). On the other hand, 
activation of the cyclase by CCK-8 or by VIP is 
inhibited in phorbol ester-treated cells. However, 
inhibition is only observed at the lower concentra­
tions of secretagogue. This indicates, that activa­
tion of the diacylglycerol/protein kinase С pathway 
alone cannot explain the relative inability of 
CCK-8 to activate adenylate cyclase in the intact 
acinar cell. 
In hepatocytes, glucagon binds to two different 
receptors. One receptor, the GR2 receptor, interacts 
with Gg and activates adenylate cyclase. The other 
receptor, the GR1 receptor, interacts with Gp and 
activates the calcium messenger system. In this tis­
sue, phorbol esters do inhibit glucagon-induced 
activation of the cyclase (Heyworth et al., 1984; 
Murphy et al., 1987). Therefore, in hepatocytes, 
secretagogue-induced activation of protein kinase 
С may underly secretagogue-induced inhibition of 
adenylate cyclase. In addition, inhibitory effects of 
phorbol esters on hormone-sensitive adenylate 
cyclase have been described for human Τ lympho­
cytes (Beckner and Parrar, 1987). At present, it is 
generally believed that the inhibitory effect of 
phorbol esters on hormonal stimulation of adeny­
late cyclase is due to phosphorylation of the recep­
tor by protein kinase C. Evidence for this hypothe­
sis comes from the ß-adrenergic receptor which has 
been shown to be phosphorylated and desensitized 
by phorbol ester treatment of cells bearing this 
receptor (Sibley et al., 1984; Kelleher et al., 1984). 
In other cell types, including frog erythrocytes 
(Sibley et al., 1986), S49 lymphoma cells (Bell et 
al., 1985), rat pinealocytes (Sugden et al., 1983), 
Swiss 3T3 cells (Rozengurt et al., 1987) and 
pheochromocytoma cells (Hollingsworth et al., 
1986), phorbol ester pretreatment results in 
increased agonist-stimulated as well as basal, gua-
nine nucleotide- and fluoride ion- stimulated 
adenylate cyclase activities. In pancreatic acinar 
cells, TPA does not increase basal activity of the 
cyclase (chapter 9). Even in cells pretreated with 
pertussis toxin, TPA has no effect on basal cyclase 
activity (chapter 3). It has been shown that TPA 
produces phosphorylation of the catalytic subunit 
of adenylate cyclase in frog erythrocytes (Yoshi-
masa et al., 1987). This suggests that phosphoryla-
tion of the catalytic subunit of the cyclase by pro-
tein kinase С may be involved in phorbol 
ester-induced enhancement of adenylate cyclase 
activity. In Swiss ЭТЗ cells, forskolin- induced 
cAMP formation is enhanced by receptor-mediated 
as well as phorbol ester-induced activation of pro­
tein kinase С (Rozengurt et al., 1987). In cells pre­
treated with pertussis toxin, the enhancing effect of 
the phorbol ester is lost again. In the pancreatic aci­
nar cell, forskolin- induced cAMP formation is 
enhanced by CCK-8 and by carbachol, but not by 
TPA (chapters 2 and 9). In blood platelets, protein 
kinase С phosphorylates G¡, so reducing the path-
way which inhibits adenylate cyclase (Katada et 
al., 1985; Jakobs et al., 1985; OUanas and Onali, 
1986). Although CCK-8 and carbachol increase 
forskolin-induced cAMP formation in the rabbit 
pancreatic acinar cell, this is apparently not due to 
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protein kinase C-induced phosphorylation of G¡, 
since TPA does not enhance the cAMP response to 
forskolin (chapter 9). 
In summary, compared to secretin or VIP, 
CCK-8 is a weak activator of adenylate cyclase in 
the intact pancreatic acinar cell. The stimulatory 
effect of CCK-8 is apparently not due to activation 
of protein kinase C, since it is not mimicked by 
TPA. Moreover, ССК-8-mduced activation of the 
cyclase is markedly enhanced by pretreatment of 
the acinar cells with pertussis toxin, which may 
suggest that G¡ is involved in preventing CCK-8 
from significantly activating the cyclase. However, 
ССК-8-mduced activation of protein kinase C, 
leading to activation of G¡, cannot explain the rela-
tive inability of CCK-8 to activate the adenylate 
cyclase, since phorbol ester treatment only slightly 
inhibited secretagogue-induced activation of 
adenylate cyclase. Therefore, the best explanation 
may be the presence of three different cholecys-
tokinin recptors on the surface of the acinar cell. 
One receptor which interacts with Gp, a second 
receptor which interacts with Gs and a third recep-
tor which interacts with G¡. 
- o -
Enzyme secretion induced by CCK-8 is sub-
stantially augmented in acinar cells in which the 
с AMP concentration is increased (chapters 2, 3 
and 9). In rabbit, increases in acinar cell cAMP 
concentration alone do not lead to enhanced 
enzyme secretion, whereas in guinea pig and rat the 
stimulatory effect of cAMP is relatively weak. 
These observations strongly suggest that cAMP 
rather is a modulatory agent in pancreatic enzyme 
secretion. 
In acinar cells in which the cAMP concentra­
tion is increased, also the secretory responses to the 
calcium ionophore, A23187, and the phorbol ester, 
TPA, are potentiated (chapters 2 and 3). This sug­
gests that protein kinase A or one of its phosphory-
lated products, acts at or beyond the site of interac­
tion between the (1,4,5-)ІРз/са1сішп limb and the 
diacylglycerol/protein kinase С limb of the bifur­
cating calcium messenger system. To clarify the 
molecular basis of potentiation, detailed informa­
tion is needed on these later steps in the process of 
secretagogue-induced enzyme secretion. 
In summary, pancreatic enzyme secretion 
induced by calcium-mobilizing secretagogues is 
markedly potentiated by cAMP. Normally, 
calcium- mobilizing secretagogues do not increase 
the acinar cell cAMP concentration. Physiological­
ly, substantial increases in acinar cell cAMP con­
centration can be produced by secretin or VIP, 
which in rabbit pancreas do not stimulate enzyme 
secretion. 
- o -
The calcium messenger system 
In all species studied, pancreatic secretagogues 
of the calcium- mobilizing type are much more 
efficacious as a secretory agent than secretagogues 
which increase the cellular cAMP concentration. 
The cholinergic receptor agonist, carbachol, and 
the C-terminal octapeptide of cholecystokinin, are 
among the best studied pancreatic secretagogues of 
the calcium-mobilizing type. 
Upon stimulation with carbachol or CCK-8, the 
free cytosolic calcium concentration ([Ca^+jj) 
increases within seconds, as is judged from pancre­
atic acinar cells loaded with the fluorescent calci­
um indicator, quin2 (chapters 3-6 and 9). This ini­
tial increase in [Ca2+]j is independent of the 
presence of extracellular calcium (chapters 4 and 
6) and is thought to represent the 
(l,4,5-)IP3-induced release of calcium from the 
intracellular calcium store. After having reached its 
maximum height, the [Ca2+]¡ rapidly declines lo a 
poststimulatory level which is maintained as long 
as the receptor remains occupied by the agonist 
(chapter 4). The prestimulatory [Ca^+Jj is calcu-
lated to be 150 nM (chapters 3-6). The poststimu-
latory [Ca2+]i, established after stimulation with 
nearly maximally stimulatory concentrations of 
CCK-8 or carbachol (chapter 5), is calculated to be 
200 nM (chapter 4). The occurrence of 
poststimulatory-elevated calcium levels depends on 
the presence of extracellular calcium (chapter 4). 
This suggests that hormonal stimulation increases 
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the plasma membrane penneability for calcium, 
which leads to the influx of calcium and to elevated 
free cytosolic calcium levels. Similar conclusions 
were drawn from experiments in which the influx 
of 4 5 C a 2 + was found to be stimulated by secreto­
gogues of the calcium-mobilizing type (Koodo and 
Schulz, 1976; Dormer et al., 1981). 
The potent muscle relaxant TMB-8, originally 
shown to inhibit caffeine- induced calcium release 
from isolated sarcoplasmic reticulum (Malagodi 
and Chiou, 1974a,b; Chiou and Malagodi, 1975), 
does not inhibit the ССК-8-mduced, extracellular 
calcium-independent, initial increase in [Ca2+]¡ in 
the pancreatic acinar cell (chapters 4 and 5). This 
suggests that the drug has no effect on the 
secretagogue-induced and (l,4,5-)IP3-mediated 
release of calcium from the intracellular store. On 
the other hand, TMB-8 effectively inhibits 
carbachol-induced increases in [Ca^+jj. The latter 
effect of the drug is most probably due to competi-
tive antagonism at the muscarinic receptor as is 
judged from the rightward shift of the dose-
response curve for carbachol-induced enzyme 
secretion in the presence of TMB-8 (chapter 5). 
Moreover, Tennes et al. (1983) showed that 
TMB-8 inhibited [3H]QNB binding in mouse pan-
creatic acini. 
The presence of TMB-8 prevents CCK-8 from 
establishing poststimulatory- elevated calcium lev-
els. This effect of TMB-8 may be explained by an 
inhibitory effect of the drug on the CCK-8-induced 
increase in plasma membrane permeability for cal-
cium. In the absence of extracellular calcium, 
TMB-8 decreases [Ca2+]¡ to below the prestimula-
tory level in ССК-8-stimulated cells only. This 
observation suggests a stimulatory effect on the 
calcium extrusion mechanism and/or an inhibitory 
effect on the release of calcium from an intracellu­
lar store which plays a role in maintaining [Ca^+Jj 
at the prestimulatory level in cells stimulated in the 
absence of extracellular calcium. TMB-8 has little 
or no effect on [Ca2+]¡ in unstimulated acinar cells 
which suggests that the drug does not affect basal 
calcium influx (chapter 4). The same conclusion is 
reached from the observation that in CCK-8- stim-
ulated acinar cells, the (Gi2 +]¡, decreased by 
TMB-8 to below the prestimulatory level in the 
absence of extracellular calcium, returns to the 
prestimulatory level when calcium is readded to the 
medium. In the latter experiment, [Ca^ +Jj does not 
increase to the poststimulatory-elevated level 
which supports an inhibitory effect on the 
ССК-8-induced increase in plasma membrane per­
meability for calcium. 
TMB-8 has been used in a wide variety of cell 
types to investigate the role of intracellular calcium 
in stimulus-evoked processes. In most tissues, 
inhibitory effects are observed at millimolar con­
centrations of (he drug. In pancreatic acini, 
ССК-8-mduced enzyme secretion is abolished 
completely at 0.5 mM TMB-8 (chapter 5). How­
ever, at this rather high concentration of TMB-8, 
severe side effects are observed. This has led us to 
conclude that inhibitory effects of relatively high 
concentrations of TMB-8 should be treated with 
caution. 
At concentrations between 50 and 100 μΜ, 
TMB-8 potentiates the secretory response to sub-
maximally stimulatory concentrations of CCK-8. 
The drug potentiates also the secretoiy response lo 
A23187 and to TPA. This suggests that TMB-8, 
like cAMP, acts at or beyond the site of interaction 
between the (1,4,5-)ІРз/са1сішп limb and the 
diacylglycerol/protein kinase С limb of the bifur­
cating calcium messenger system. But, whereas 
forskolin potentiates also (he secretoiy response to 
(supra)maxLmany stimulatory concentrations of 
CCK-8 (chapter 2), TMB-8 inhibits enzyme secre­
tion induced by (supramaximal concentrations of 
CCK-8 (chapter 5). Therefore, the mechanism of 
action of TMB-8 differs from the mechanism of 
action of cAMP. 
In summary, calcium-mobilizing secreto­
gogues, increase the permeability for calcium of 
both the intracellular calcium store, leading to a 
rapid but transient increase in [Ca2+]j, and the 
plasma membrane, leading to a sustained but small 
increase in [Ca2+]¡. The putative intracellular cal-
cium antagonist, TMB-8, has no effect on the 
secretagogue-induced release of calcium from the 
intracellular store, but (»events the onset of the 
secretagogue-induced poststimulatory-elevated cal-
cium level. However, the effects of TMB-8 on the 
poststimulatory-elevated calcium level are not sim-
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ply explained by inhibition of the secretagogue-
induced increase in plasma membrane permeability 
for calcium. 
Inhibitory effects of the drug on carbachol-
induced cellular processes are apparently due to 
competitive antagonism at the muscarinic receptor. 
Inhibitory effects by relatively high concentra­
tions of TMB-8 most probably reflect cytotoxic 
activities of the drug. 
At moderate concentrations TMB-8 potentiates 
the secretory response to CCK-8 as well as А2Э187 
and TPA. This suggests that the drug acts at or 
beyond the site of interaction between the two 
limbs of the calcium messenger system. However, 
ТМВ-8-induced potentiation differs from cAMP-
induced potentiation in that cAMP potentiates also 
the secretory response to (supra)maximal concen­
trations of secretagogue. Detailed information on 
cellular processes influenced by protein kinase С 
and/or calcium is needed to elucidate the exact site 
of action of TMB-8. 
- o -
In a number of cell types, including neutrophils 
(Verghese et al., 1985; Bradford and Rubin, 1985), 
leukocytes (Ohta et al., 1985), mast cells (Nakamu-
ra and Ui, 1984) and adipocytes (Moreno et al., 
1983), pertussis toxin inhibits cellular processes 
induced by calcium-mobilizing stimuli. Since the 
toxin is known to modify G proteins (Gilman, 
1984; Ui, 1984; Bokoch et al., 1984), the above 
results were explained by pertussis toxin-induced 
inactivation of Gp. However, pretreatment of pan­
creatic acinar cells with the toxin has no inhibitory 
effect on ССК-8-mduced calcium mobilization and 
enzyme secretion (chapter 3). This observation 
suggests that in the pancreatic acinar cell, as in oth­
er cell types, including hepatocytes (Uhing et al., 
1986) and brown fat cells (Schimmel and Elliott, 
1986), Gp is insensitive to pertussis toxin. Our 
findings support those of Merritt et al. (1986b), 
who reported that in permeabilized rat pancreatic 
acinar cells GTPyS-induced inositol trisphosphate 
formation is not inhibited by pertussis toxin. 
According to Taylor and Merritt (1986), inhibitory 
effects of pertussis toxin on cellular events induced 
by calcium-mobilizing stimuli should be treated 
with caution, since toxin-induced inhibition of G¡ 
might lead to cAMP-dependent inhibition of cellu-
lar responses induced by calcium-mobilizing stim-
uli. Evidence for the existence of Gp in the pancre-
atic acinar cell is recently provided by Williams 
and McChesney (1987), who reported that chole-
cystokinin induced the interaction of its receptor 
with a G protein. 
In summary, preliminary evidence suggests 
that Gp is present in the pancreatic acinar cell. 
However, in the pancreatic acinar cell this G pro-
tein is also insensitive to pertussis toxin. 
- o -
In addition to the stimulatory effect of TPA on 
pancreatic enzyme secretion (De Pont and Fleuren-
Jakobs, 1984; Menitt and Rubin, 1985; Nogochi et 
al., 1985; Pandol et al., 1985a, chapters 3,5 and 6), 
the phorbol ester attenuates ССК-8-mduced 
enzyme secretion (chapter 6; Lee et al., 1987). In 
rabbit, the inhibitory effect of TPA on 
ССК-8-mduced enzyme secretion is paralleled by 
inhibition of ССК-8-mduced increases in free 
cytosolic calcium concentration (chapter 6). 
Inhibitory effects of phorbol esters on 
secretagogue-induced increases in free cytosolic 
calcium concentration are apparently not restricted 
to one type of stimulus, since in rat pancreas it has 
been shown that TPA also inhibits carbachol-
induced increases in free cytosolic calcium concen­
tration (Ansah et al., 1986). Attenuation of agonist-
induced increases in free cytosolic calcium 
concentration by phorbol esters have been observed 
in a wide variety of cell types including, platelets 
(Zavoico et al., 1985; Drummond, 1985), hepato­
cytes (Cooper et al., 1985; Lynch et al., 1985), neu­
trophils (Naccache et al., 1985), smooth muscle 
cells (Brock et al., 1985) and glomerulosa cells 
(Kojima et al., 1986). 
In rabbit pancreatic acini, the inhibitory effect 
of TPA on CCK-8- induced increases in free 
cytosolic calcium concentration is not paralleled by 
inhibition of ССК-8-induced PIP2 breakdown 
(chapter 6). This observation is rather unique, 
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since in an increasing number of tissues pretreat­
ment with phorbol esters is found to lead to inhibi­
tion of agonist-induced hydrolysis of PIP2 
(Zavoico et al., 1985; Brock el al., 1985; Kojima et 
al., 1986). In hepatocytes, phorbol esters inhibit 
PIP2 breakdown and calcium mobilization induced 
by αj-agonists, but not by other calcium-
mobilizing agents such as vasopressin and 
angiotensin Π (Corvera and Garcia-Sainz, 1984; 
Cooper et al., 1985). This selective action of a 
phorbol ester suggests that the diacylglycerol/ 
protein kinase С pathway exerts its negative feed­
back by phosphorylating particular receptors rather 
than Gp or the PIP2-specific phosphodiesterase. 
Evidence for such a mechanism of action of protein 
kinase С is provided by the observation that in 
phorbol ester-treated smooth muscle cells, 
αχ-agonist-induced inhibition of PIP2 hydrolysis is 
paralleled by phosphorylation of the aj-adrenergic 
receptor (Leeb-Lundberg et al., 1985). Recently, 
Lee et al. (1987) reported that in TPA-treated rat 
pancreatic acinar cells, attenuation of 
ССК-8-mduced enzyme secretion is paralleled by a 
reduction in specific binding of !-^I-labelled 
CCK-8. This observation suggests that protein 
kinase С exerts its effect at the receptor level. 
However, the effects of phorbol ester treatment on 
ССК-8-induced PIP2 breakdown were not investi­
gated in this study. 
In rabbit, TPA inhibits both both 
ССК-8-mduced cAMP formation and calcium 
mobilization at the same concentrations of secreta-
gogue (chapters 6 and 9). Assuming that protein 
kinase С acts at the receptor level, as proposed by 
Lee et al. (1987), this observation may suggest that 
the very same cholecystokinin receptor is coupled 
to both Gp and G
s
. It may even be speculated that 
Gp itself has some stimulatory effect on adenylate 
cyclase. 
In some tissues, including GH3 cells (Drum­
mond, 1985) and neutrophils (Rickard and Sheter-
line, 1985), phorbol esters have been shown to 
reduce increases in free cytosolic calcium concen­
tration induced by high potassium or calcium 
ionophores. Observations like these suggest that 
activation of protein kinase С may also lead to acti­
vation of the calcium extrusion mechanism. How­
ever, in TPA-treated pancreatic acinar cells the cal­
cium response to the lower concentrations of 
CCK-8 is abolished completely, which suggests 
that no calcium is released into the cytosol (chapter 
6). 
Another possibility is that TPA does not inhibit 
ССК-8-mduced PIP2 breakdown, but stimulates 
the enzyme that hydrolyses (1,4,5-)ІРз. However, 
it has been reported by Merritt et al. (1986b) that 
in rat pancreatic acini, phorbol ester treatment has 
no effect on caeralein-induced formation of 
(1,4,5-)ІРз. 
In the rabbit pancreatic acinar cell, phorbol 
esters do not affect the ССК-8-induced breakdown 
of PIP2 or the agonist-induced increase in 
(1,4,5-)ІРз but inhibit the (M.SOIPj-induced 
release of calcium in permeabilized cells (chapter 
7). It is generally accepted now that the agonist-
sensitive calcium pool of the cell is the endoplas­
mic reticulum (Streb et al., 1984; Prentki et al., 
1984; CRourke et al., 1985). Accumulation of cal­
cium by the endoplasmic reticulum is ATP-
dependenL At a free calcium concentration of 100 
nM, calcium is rapidly accumulated by this system 
in the permeabilized acinar cell and phorbol ester 
treatment has no effect on the rate at which calcium 
is accumulated. Therefore, the calcium pump of the 
endoplasmic reticulum does not seem to be control­
led by protein kinase С The rapidity and the rela­
tive insensitivity to temperature of the 
(l,4,5-)IP3-induced release of calcium, suggests 
the presence of an (l,4,5-)IP3-operated calcium 
channel in the endoplasmic reticulum (Chueh et al., 
1987). Our observations suggest that activation of 
protein kinase С leads to desensitization of this 
(l,4^-)IP3-operated calcium channel. 
In summary, phorbol ester treatment of pan­
creatic acinar cells results in inhibition of 
ССК-8-induced enzyme secretion. This inhibitory 
action of phorbol esters is paralleled by inhibition 
of ССК-8-mduced increases in free cytosolic calci­
um concentration. Pretreatment with phorbol ester 
has no effect on CCK-8-stìmulated breakdown of 
PIP2, but reduces (l,4,5-)IP3-induced release of 
calcium from the intracellular calcium store. These 
observations suggest that in the pancreatic acinar 
cell the diacylglycerol/protein kinase С pathway 
exerts a negative feedback on the 
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(M^IPycalcium pathway at the level of the 
(l,4,5-)IP3-operated calcium channel of the endo­
plasmic reticulum. 
- o -
Pretreatment of pancreatic acinar cells with 
TPA has no effect on the CCK-8-induced break­
down of 32p_iabelled PIP2 (chapters 6 and 8). On 
the other hand, labelling of PIP2 with 
ortho[32p]phosphate appears to be enhanced in the 
presence of TPA. Similar effects of phorbol esters 
have been observed in other tissues (De Chaffoy de 
Courcelles et al., 1984; Halenda and Feinstein, 
1984; Taylor et al., 1984; Boon et al., 1985). These 
results suggest that protein kinase С may exert a 
positive feedback on inositol lipid metabolism by 
enhancing (he formation of PIP2 (Berridge et al., 
1987a). Additional evidence for this hypothesis is 
provided by the observation that in most cell types, 
preslimulatory levels of PIP2 are restored again, 
soon after their substantial stimulus-induced 
decrease. However, in the pancreatic acinar cell, 
the amount of Э2р-і
а
Ье11еа PIP2 is still maximally 
decreased 10 min after the onset of stimulation 
(chapter 8). Moreover, labelling of acinar cells in 
the presence of a nearly maximally stimulatory 
concentration of CCK-8, results in a substantial 
decrease in the amounts of ^P-labe\led PIP2· 
whereas the rate at which labelling of PIP2 reaches 
equilibrium, is markedly enhanced. This observa­
tion suggests that in the presence of secretagogue 
the preslimulatory level of PIP2 is not restored. 
Additional stimulation of acinar cells labelled in 
the presence of CCK-8 through the cholinergic 
receptor does not lead to any further decrease in the 
amount of ^^P-Hbeüed PIP2. Therefore, reduced 
levels of PIP2, caused by a maximally stimulatory 
concentration of secretagogue, may protect the cell 
against overstimulation and may explain some 
aspects of desensitization. 
Labelling of pancreatic acinar cells in the pres-
ence of TPA results in increased incorporation of 
label in phosphatidylcholine (chapter 8). This 
effect of the phorbol ester has been observed for 
several other tissues (Weinstein, 1981; Pelech and 
Vance, 1984; Hill et al., 1984). In the pre-
adipocyte cell line ЭТЗ-ІЛ (Besterman et al., 1986) 
as well as in Swiss-mouse 3T3 fibroblasts (Takuwa 
et al., 1987), phorbol esters induced the prompt 
increase in diacylglycerol. These observations sug­
gest that phorbol esters activate the 
phosphatidylcholine-specific phospholipase C. No 
increase in ^P-labelled phosphatidylcholine is 
observed in acinar cells labelled in the presence of 
CCK-8. It is not clear whether this lack of effect of 
the secretagogue on the labelling of phosphatidyl­
choline reflects inhibitory pathways not activated 
by the phorbol ester alone. 
In summary, secretagogues of the calcium-
mobilizing type apparently evoke a sustained 
decrease in the amount of PIP2- Under maximally 
stimulatory conditions, additional stimulation 
through a different receptor does not lead to any 
further decrease in the amount of PIP2, which may 
explain some aspects of desensitization. The main 
effect of the phorbol ester is the enhanced labelling 
of phosphatidylcholine. However, it remains to be 
elucidated whether this effect of the phorbol ester 
is caused by activation of protein kinase C, since 
no increased incorporation of label is observed in 
the presence of calcium-mobilizing secretagogues. 
Moreover, it remains to be elucidated whether the 
enhanced incorporation of label in phosphatidyl­
choline also in the pancreatic acinar cell reflects 
increased phospholipase C-like hydrolysis of this 
phospholipid. 
- o -
Perspectives 
Future studies will concentrate on the mecha­
nism of action of protein kinase С in the phorbol 
ester-induced processes described above. Protein 
kinase С has been partially purified from rabbit 
pancreatic tissue by A.G.H. Ederveen in our 
department. It will be investigated whether protein 
kinase С inhibits (l,4,5-)IP3-induced calcium 
release in a microsomal fraction, enriched in endo­
plasmic reticulum membranes. In addition, it will 
be investigated whether protein kinase С enhances 
the formation of the polyphosphoinositides and the 
- 102 -
turnover of phosphatidylcholine in a microsomal 
fraction, enriched in plasma membranes. Finally, 
the protein kinase С preparation will be used in iso­
lated membranes to study the effects of kinase С on 
receptor-mediated hydrolysis of PIP2 and activa­
tion of adenylate cyclase. 
Protein kinase С exerts positive forward as 
well as negative feedback controls over various 
steps of its own and other signaling pathways 
(Nishizuka, 1986; Kikkawa and Nishizuka, 1986; 
Berridge, 1987a,b). Diacylglycerol is the natural 
activator of protein kinase С and future investiga­
tions will concentrate on the metabolism of this 
important intracellular messenger. 
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De alvleesklier of pancreas is een orgaan met 
een tweeledige functie. Enerzijds controleert het 
endocriene deel, dat de hormonen insuline en glu­
cagon afgeeft aan de bloedbaan, de bloedsuiker-
spiegel. Anderzijds is het exocriene deel van de 
pancreas, dat zijn producten afgeeft aan het darm­
kanaal, betrokken bij de spijsvertering. 
Anatomisch gezien bestaat de exocriene pan­
creas uit een zich steeds fijner vertakkend stelsel 
van afvoergangen, wier wanden gevormd worden 
door de ductulaire cellen, en die uiteindelijk uit­
monden in blaasvormige ruimten omzoomd door 
de acineuze cellen. Dergelijke groepjes van acineu­
ze cellen, gelegen aan het begin van de afvoergan­
gen worden acini genoemd en vormen de kleinste 
functionele eenheden van de exocriene pancreas. 
De acineuze cellen staan met elkaar in contact via 
zogenaamde ' gap junctions ', welke een belangrij­
ke rol spelen bij het op elkaar afstemmen van het 
secretoire gedrag van de cellen (Petersen and Iwat-
suki, 1979; Meda el al., 1986,1987; Bmzzone et al., 
1987). 
De bestanddelen van het pancreassap kunnen 
naar afkomst onderscheiden worden in de spijsver­
teringsenzymen (amylase, trypsine, carboxypep-
tidasen, lipasen), welke worden aangemaakt en 
afgegeven door de acineuze cellen, en de bicarbo-
naatrijke vloeistof, wier uiteindelijke samenstelling 
wordt bepaald door de ductulaire cellen (Kuijpers 
en De Pont, 1987) en wier functie vooral is gelegen 
in het neutraliseren van de zure voedselbrij welke 
afkomstig is uit de maag. Dit laatste is nodig willen 
de spijsverteringsenzymen optimaal kunnen func­
tioneren. 
Zodra de zure maaginhoud wordt geleegd in de 
twaalfvingerige darm, geven in de dannwand gele­
gen endocriene cellen een hormoon af aan het 
bloed, het cholecystokinine (vroeger pancreozymi-
ne genaamd), dat de acineuze cellen aanzet tot de 
afgifte van de spijsverteringsenzymen. Een andere 
belangrijke stimulator van de enzymsecretie is de 
neurotransmitter, acetylcholine. 
EN DISCUSSIE 
Om adequaat te kunnen reageren op de in het 
extracellulaire milieu aanwezige stimuli moet de 
cel functionele receptoren bezitten. Naast de recep­
toren voor bovengenoemde stimuli, de cholecysto­
kinine receptor en de muscarine cholinerge recep­
tor, bezit de acineuze cel nog tal van andere 
receptoren (Gardner, 1979; Schulz and Stolze, 
1980; Jensen en Gardner, 1981; Gardner en Jensen, 
1980,1981,1986). De experimenten beschreven in 
dit proefschrift werden uitgevoerd met de choliner­
ge receptor agonist, carbachol, het С-terminale 
octapeptide van cholecystokinine (CCK-8), secreti­
ne en het vasoactieve intestinale polypeptide (VIP). 
Geen van de genoemde stimuli is in staat de cel-
wand (plasmamembraan) te passeren zodat het 
gedeelte van de receptor dat de stimulus herkent, 
buiten de plasmamembraan moet zijn gelegen. 
Geen van deze receptoren behoort tot het type van 
de transmembraanreceptoren dat zelf enzymatisch 
actief is. Andere met de plasmamembraan geasso­
cieerde moleculen zijn daarom nodig om het door 
de receptor opgevangen signaal naar binnen toe 
door te geven. Dit doorgeven geschiedt door de 
vorming van intracellulaire boodschappers welke 
in de cel tal van biochemische processen initiëren, 
uiteindelijk leidend tot het beoogde gedrag van de 
cel. 
Afhankelijk van de weg waarlangs het door de 
receptor opgevangen signaal wordt doorgegeven, 
kunnen stimuli worden onderverdeeld in twee groe-
pen. In geval van cholecystokinine en acetylcholi-
ne leidt receptoractivering uiteindelijk tot de aan-
maak van de intracellulaire boodschappers: 
inositol l,4¿-trisfosfáat (IP¡) (Streb et al., 1985; 
Meiritt et al., 1986a; Trimble et al., 1986.1987a,b; 
Dougney et al., 1987) en diacylglycerol (Bansch-
bach et al., 1974; Pandol en Schoeffield, 1986). Sti-
mulering van acineuze cellen met secretine of VIP 
leidt daarentegen tot de vorming van het adenosine 
(cyclisch) 3'¿'-monophosphate (cAMP) (Rutten et 
al., 1972; Kempen et al., 1977a; Christophe et al., 
1976; Robberecht et al., 1976; Gardner et al., 
1976a,b; Gardner en Rottman, 1979; Gardner en 
Jensen, 1981). 
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Het cyclisch AMP boodschapper systeem 
Langs welke weg receptoractivering leidt tot de 
aanmaak van de intracellulaire boodschapper is in 
meer detail bekend voor het cyclisch AMP sys-
teem. Het membraangeassocieerde enzym dat de 
aanmaak van het cAMP bevordert is het adenylaat-
cyclase en reeds lang is bekend dat de activiteit van 
dit enzym gecontroleerd wordt door twee zoge-
naamde G eiwitten (guanine nucleotide-bindende 
regulaloire eiwitten) (Rodbell, 1980,1985; Gilman, 
1984,1987; Houslay, 1984; lm et al., 1987; Litosch, 
1987; Levitzki, 1987). Activering van het stimule-
rende G-eiwit (Gs) leidt tot een toename van de 
activiteit van het adenylaatcyclase (Smigel et al., 
1985; Gilman, 1986; Pace en Lancet, 1986). Acti-
vering via het stimulerende G-eiwit wordt teniet 
gedaan wanneer het tweede G-eiwit, het remmende 
(Gj), wordt geactiveerd (Northnip et al., 1980; 
Codina et al., 1983; Katada et al., 1984a,b; Jakobs 
et al., 1984). 
Zoals beschreven in hoofdstuk 9 leidt stimule-
ring van acineuze cellen met secretine of VIP tot 
een stijging van de intracellulaire cAMP concentra-
tie. De receptoren voor beide stimuli zijn daarmee 
naar alle waarschijnlijkheid via het stimulerende G 
eiwit gekoppeld aan het adenylaatcyclase. De door 
secretine gestimuleerde cAMP productie blijkt 
geremd te worden door somatostatine (Taparel et 
al., 1985), waarmee de somatostatine receptor 
gekoppeld lijkt aan het remmende G eiwit 
In hoofdstuk 9 is aangetoond dat in intacte aci-
neuze cellen van de konijnepancreas zowel secreti-
ne als VIP het adenylaatcyclase activeren. Dit in 
tegenstelling tot eerdere experimenten waarin de 
stimuleerbaarheid van het adenylaatcyclase door 
secretine werd onderzocht voor geïsoleerde memb-
ranen van onder andere de konijnepancreas (De 
Pont et al., 1979). De aanwezigheid van GTP is een 
vereiste voor hormonale stimulering van het adeny-
laat cyclase. In laatstgenoemde experimenten werd 
geen GTP toegevoegd aan het assaymedium, zodat 
enkel GTP, achtergebleven in het membraanprepa-
raat, aanwezig was in het assaymedium. Bovendien 
is voor geïsoleerde membranen van de rattepancre-
as aangetoond dat de schijnbare affiniteit van het 
adenylaatcyclase systeem voor GTP in aanwezig-
heid van cholecystokinine 6 tot 7 maal hoger was 
dan in aanwezigheid van secretine (Svoboda et al., 
1980). Het wel optreden van activering van het 
cyclase door cholecystokinine, maar niet door 
secretine, zou dan verklaard kunnen worden door 
de aanwezigheid van juist voldoende GTP voor 
activering door het eerste hormoon, maar onvol-
doende voor activering door het tweede hormoon. 
Veelal worden membranen geïsoleerd in aanwezig-
heid van reducerende verbindingen als dithiothrei-
tol, welke oxidatie van -SH groepen van het adeny-
laatcyclase moeten tegengaan. Aangetoond is dat in 
dat geval activering van het cyclase door secretine 
en VIP, maar niet door CCK.-8, sterk geremd wordt 
(Robberecht et al., 1984). 
Een van de criteria voor een rol als intracellu-
laire boodschapper is dat een verhoging van de int-
racellulaire concentratie van het betreffende mole-
cuul leidt tot de respons. Voor de exocriene 
pancreas wordt het onderzoek naar de rol van 
cAMP in stimulus-secretie koppeling sterk 
beïnvloed door speciesverschillen. Terwijl in de 
cavia (Gardner en Jackson, 1977; Gardner et al., 
1979a,1982,1983) en in de rat (Kempen et al., 
1975; Smith en Case, 1975; Singh, 1979), secretine 
en VIP de enzymsecretie stimuleren, blijkt een sti-
mulerend effect in de hond, de kat en de muis twij-
felachtig (Robberecht et al., 1977; De Pont et al., 
1979) en in het konijn afwezig (Hoofdstuk 9 en De 
Pont et al., 1979). In het laatste geval treedt wel 
een significante stijging van de cAMP concentratie 
in de acineuze cellen op (Hoofdstuk 9). Bovendien 
wordt in de rat, bij vergelijkbare cAMP stijgingen, 
de enzymsecretie door secretine aanzienlijk beter 
gestimuleerd dan door VIP (Vandermeers et al., 
1984; Bisonnette et al., 1984). 
Verhoging van de intracellulaire cAMP con-
centratie buiten de receptor om, bijvoorbeeld door 
forskoline, een verbinding die rechtstreeks het ade-
nylaatcyclase activeert (Seamon et al., 1981), leidt 
in de konijnepancreas evenmin tot stimulering van 
de enzymsecretie (Hoofdstuk 2). In de rattepancre-
as wordt daarentegen met forskoline een stimule-
ring van de enzymsecretie gevonden, welke verge-
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lijkbaar is met die voor VIP, maar welke sterk 
achterblijft bij die voor secretine of cholecystokini-
ne (Heisier, 1983; Dehaye et al., 1985). Het niet 
optteden van vergelijkbare secreloire responsen bij 
vergelijkbare verhogingen van de cAMP concen-
tratie, na stimulering met secretine respectievelijk 
VIP, heeft geleid tot het concept van compartimen-
talisarie (Gardner en Jensen, 1986). In de cavia 
leidt een door VIP geïnduceerde, nauwelijks meet-
bare, stijging van de cAMP concentratie reeds tot 
de maximale secreloire respons op dit secretagoog. 
Daarentegen treedt de secreloire respons op secreti-
ne eerst op bij aanzienlijk sterkere stijgingen van 
de cAMP concentratie (Gardner et al., 1982). Het 
cAMP aangemaakt in geval van stimulering met 
VIP, en in de rat met secretine, zou zich dan in het 
juiste compartiment bevinden om de enzymsecretie 
te stimuleren. De waarneming dat in de rattepan-
creas na stimulering met forskoline de enzymsecre-
tie sterk achterblijft bij die na stimulering met 
secretine (Dehaye et al., 1985), is echter niet in 
overeenstemming met bovengenoemde theorie daar 
geen enkele reden bestaat aan te nemen dat forsk-
oline niet hel door secretine stimuleerbare adeny-
laatcyclase zou activeren. 
Recentelijk is aangetoond dat in de rattepancre-
as, secretine, en niet VIP, het calciumsysteem acti-
veert (Trimble et al., 1987a,b). Activering van het 
calciumsysteem leidt in alle species tot enzymse-
cretie. Het is daarom niet ondenkbaar dal hel ver-
mogen van secretme om in de rat de enzymsecretie 
te stimuleren verband houdt met het vermogen van 
dit secretagoog om in dit species het calciumsys-
teem te activeren. In de konijnepancreas induceert 
noch secretme noch VIP de hydrolyse van PIP2 
(Hoofdstuk 9). Evenmin stimuleren beide secreta-
gogen de enzymsecretie. Daarentegen neemt de 
cAMP productie sterk toe na stimulering met secre-
tine of VIP. Het beeld dat ontstaat is, dat in de 
konijnepancreas de verhoging van cAMP onvol-
doende is om de enzymsecretie te stimuleren en dat 
noch secretine noch VIP het calciumsysteem acti-
veren. In de rat is de stijging van cAMP op zich al 
voldoende is om de enzymsecretie te stimuleren en 
secretine geeft een extra stimulering omdat het 
bovendien het calciumsysteem kan activeren. 
Op grond van bovenstaande waarnemingen is 
geconcludeerd dat in ieder geval in de konijnepan-
creas cAMP niet voldoet aan de criteria voor intra-
cellulaire boodschapper. Toch heeft cAMP wel 
degelijk een effect op de enzymsecretie en wel een 
patentierend effect. Wordt namelijk hel 
fosfalidylinositol/calciumsysteem geheel of gedeel-
telijk geactiveerd, hetgeen wel leidt tot stimulering 
van de enzymsecretie, dan blijkt in geval van een 
verhoogde intracellulaire cAMP spiegel de secre-
loire respons aanzienlijk te worden versterkt 
(Deschodt-Lanckman et al., 1975; Collen et al, 
1982; Dehaye et al., 1985; Hoofdstukken 2, 3 en 
9). De conclusie is dat in de exocriene pancreas van 
het konijn de rol van cAMP een modulerende is. 
Een merkwaardig verschijnsel is dat het adeny-
laatcyclase van de acineuze cel van de exocriene 
pancreas geactiveerd kan worden door een sti-
mulus, cholecystokinme, welke primair via het 
fosfatidylinositol/calcium systeem lijkt te werken 
en ook duidelijk wel de enzymsecretie stimuleert 
(Rutten et al., 1972; Kempen et al., 1974; Schulz et 
al., 1974; Bonling et al., 1977; Long en Gardner, 
1977; Svoboda et al., 1978; De Pont et al., 1979; 
Hoofdstukken 3 en 9). Uit hel voorgaande mag 
blijken dat als het cAMP al een rol speelt bij de 
door cholecystokinme gestimuleerde enzymsecre-
tie, er hooguit sprake kan zijn van een modulerende 
rol. Een modulerende rol die duidelijk tot uiting 
komt in de aanzienlijke polentiëring van de door 
cholecystokinme gestimuleerde enzymsecretie 
(Hoofdstukken 2,3 en 9). Onder normale condities 
treedt echter geen meetbare stijging op van de int-
racellulaire cAMP concentratie wanneer gestimu-
leerd wordt met cholecystokinme. Enkel wanneer 
het enzym dat het cAMP afbreekt wordt geremd 
kan een geringe stijging van het cAMP worden 
waargenomen (Kempen et al., 1977a,b; Renckens 
et al., 1980; Gardner et al., 1983; Hoofdstukken 3 
en 9). De door cholecystokinme geïnduceerde stij-
ging van de intracellulaire cAMP spiegel staat ech-
ter in geen verhouding tot die welke geïnduceerd 
wordt door secretine of VIP (Hoofdstuk 9). 
Zoals gezegd spelen twee G eiwitten een sleu-
telrol bij de overdracht van informatie van de 
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receptor naar het adenylaalcyclase. Beide G eiwit-
ten blijken gemodificeerd te kunnen worden door 
bacteriële toxines (Gilman, 1987). Het cholera toxi-
ne modificeert het stimulerende G eiwit zodanig 
dat dit in een blijvend geactiveerde slaat komt. Hel 
gevolg is een aanhoudende stimulering van het 
adenylaalcyclase zonder dat van enige receptoracti-
vering sprake is en de intracellulaire cAMP spiegel 
stijgt sterk (Smith and Case, 197S; Kempen et al., 
1975; Gardner en Rottman, 1979; Gardner en Jen-
sen, 1981). 
Het remmende G eiwit wordt gemodificeerd 
door het pertussis toxine en wel zodanig dat het in 
een blijvend-geinactiveerde toestand komt (Gil-
man, 1984; Ui, 1984; Bokoch et al., 1984). Het 
gevolg is dat de activiteit van het adenylaalcyclase 
niet langer geremd kan worden door stimuli die via 
het remmende G eiwit het adenylaalcyclase contro-
leren. Na behandeling van de acineuze cellen van 
de konijnepancreas met pertussis toxine, blijkt het 
vermogen van CCK-8 om het adenylaalcyclase te 
activeren sterk te zijn toegenomen (Hoofdstuk 3). 
Een mogelijke verklaring zou kunnen zijn dat 
er twee typen cholecystokinine receptoren zijn. Een 
ervan zou dan, door tussenkomst van het stimule-
rende G eiwit, het adenylaalcyclase activeren, ter-
wijl de andere, door tussenkomst van het remmen-
de en door pertussis toxine inactiveerbare G eiwit, 
activering door de eerstgenoemde zou tegengaan. 
Een mogelijke ondersleuning voor deze hypothese 
is dat in membranen van de pancreas, cholecystoki-
nine receptoren, geassocieerd met cholera toxine-
en pertussis toxine-gevoelige eiwitten, konden wor-
den aangetoond (Lambert et al., 1985). 
Een andere mogelijke verklaring voor het feit 
dat het adenylaalcyclase beter geactiveerd wordt 
door CCK-8 in acineuze cellen welke behandeld 
zijn met pertussis toxine, zou kunnen zijn dat acti-
vering van het fosfatidylinositol/calciumsysteem 
door CCK-8 leidt lot activering van het remmende 
G eiwit en daarmee tol remming van de activering 
van het adenylaalcyclase via het stimulerende G 
eiwit. Om deze hypothese te kunnen testen werd de 
diacylglycerol/proteïne kinase С route van het 
fosfatidylinositol/calciumsysteem buiten de recep­
tor om geactiveerd door middel van de forbolester, 
12-O-tetradecanoylforbol 13-acetaat (TPA) 
(Hoofdstuk 9). De stimulering van het adenylaalcy­
clase door zowel CCK-8 als VIP blijkt te zijn 
geremd in cellen welke zijn voorbehandeld met 
forbolester. De mate van remming is echter gering 
en geeft aan dat enkel de activering van de 
diacylglycerol/proteïne kinase С weg onvoldoende 
is om het niet optreden van een significante active­
ring van het adenylaalcyclase door CCK-8 Ie kun­
nen verklaren. 
Een van de eigenschappen van stimuli die via 
het stimulerende G-eiwit het adenylaalcyclase acti­
veren is dat zij de door forskoline gestimuleerde 
с AMP productie potentiëren. In de acineuze cellen 
van de exocriene pancreas blijken zowel cholecys-
tokinine (Hoofdstukken 2 en 9) als de cholinerge 
receptor agonist, carbachol, (Hoofdstuk 9) de door 
forskoline gestimuleerde cAMP productie te verho-
gen. Dat dit potentiërende effect niet het gevolg is 
van activering van de diacylglycerol/proteïne kina-
se С route blijkt uit het feit dat TPA geen effect 
heeft op de door forskoline gestimuleerde cAMP 
productie (Hoofdstuk 9). 
Het fosfatidylinositol/cakiumsysteem. 
Hormonaal geïnduceerde veranderingen in het 
metabolisne van fosfolipiden, in het bijzonder van 
fosfatidylinositol, werden voor het eerst beschreven 
door Hokin en Hokin (1953). Stimulering van pan-
creasweefsel met acetylcholine bleek in aanwezig-
heid van 32pj te teilten tot een verhoogde incorpo-
ratie van label in fosfatidylinositol en fosfatidezuur 
(Hokin en Hokin, 1953,1954,1958). Al snel bleek 
uit prelabelingsexperimenten met [^ HJinositol dat 
er sprake moest zijn van een gestimuleerde afbraak 
van fosfatidylinositol gevolgd door resynthese van 
dit fosfolipide via diacylglycerol en fosfatidezuur 
(Hokin en Hokin, 1964). De hormonaal-
gestimuleerde incorporatie van 32р. щ fosfatidyli­
nositol bleek vervolgens onafhankelijk van de aan­
wezigheid van extracellulair calcium te zijn 
(Hokin, 1966; Parese et al, 1982a,b). 
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Weid gestimuleerd met acetylcholine, dan leid-
de dit bovendien tot afname van de totale hoeveel-
heid fosfatidylinositol (Hokin-Neaverson, 1974) en 
tot toename van de totale hoeveelheden diacylgly-
cerol (Banschbach et al., 1974) en fosfatidezuur 
(Hokin-Neaverson, 1974). Merkwaardig genoeg 
bleken deze stimulus-geïnduceerde veranderingen 
van de totale hoeveelheden fosfatidylinositol en 
fosfatidezuur wel afhankelijk van extracellulair cal-
cium (Parese et al., 1980; 1981a,b; 1982a,b). 
Bovendien werd voor een aantal celtypen, inclusief 
de acineuze cel van de pancreas (Parese et al., 
1980), gevonden dat verhoging van de intracellu-
laire calciumconcentratie, door middel van de cal-
ciumionofoor A23187, eveneens leidde tot veran-
deringen van de totale hoeveelheden 
fosfatidylinositol en fosfatidezuur. Geconcludeerd 
werd dat stimulering van de acineuze cel van de 
rattepancreas met een calciummobilizerend secre-
tagoog leidt tot een calcium-onafhankelijke toena-
me van de turnover van fosfatidylinositol (toename 
van de incorporatie van 32p щ fosfatidylinositol) 
en tot een calcium-afhankelijke afname van de 
totale hoeveelheid fosfatidylinositol (Parese et al., 
1982a,b). 
Recentelijk werd echter aangetoond dat chole­
cystokinine in acineuze cellen van de caviapancre­
as ook in afwezigheid van extracellulair calcium en 
zelfs bij volledige depletie van de intracellulaire 
opslagplaats voor calcium, een daling geeft van de 
totale hoeveelheid fosfatidylinositol (Pandol et al., 
1985b). Depletie van de intracellulaire opslagplaats 
voor calcium heeft tot gevolg dat geen door 
cholecystokinine-geïnduceerde calciumstijging kan 
optreden. De calciumionofoor A23187 bleek daar-
entegen alleen in cakiumhoudend medium een 
afname van de totale hoeveelheid fosfatidylinositol 
te geven. In cakiumhoudend medium veroorzaken 
calciumionoforen, door de inlux van calcium te 
bevorderen, een langdurige en sterke verhoging 
van de intracellulaire calciumconcentratie (Gardner 
et al., 1980). In afwezigheid van extracellulair cal-
cium trad wel stimulering op van de 45(^2+ 
efflux, en daarmee een tijdelijke verhoging van de 
intracellulaire calciumconcentratie, maar geen sti-
mulering van de afbraak van fosfatidylinositol. Een 
tijdelijke verhoging van de intracellulaire calcium-
concentratie lijkt daarmee onvoldoende om de 
afbraak van fosfatidylinositol te stimuleren. Dat 
cholecystokinine in afwezigheid van extracellulair 
calcium in de caviapancreas wel en in de rattepan-
creas niet de totale hoeveelheid fosfatidylinositol 
verlaagt kan zowel liggen aan speciesverschillen 
als aan verschillen in de relatieve snelheden waar-
mee fosfatidylinositol wordt afgebroken en aange-
maakt (Micheli, 1975). 
Het feit dat A23187 alleen in cakiumhoudend 
medium de totale hoeveelheid fosfatidylinositol 
verlaagt en cholecystokinine zelfs wanneer de stij-
ging van de intracellulaire vrije calciumconcentra-
tie volledig wordt geremd, duidt erop dat het effect 
van cakiummobilizerende secretagogen op het 
metabolisme van fosfatidylinositol ten dele onaf-
hankelijk is van de geïnduceerde stijging van de 
cellulaire calciumconcentratie. 
De calcium-afhankelijkheid van de stimulus-
geïnduceerde afbraak van fosfatidylinositol was 
daarom zo belangrijk omdat inmiddels in 1975 
door Micheli was gepostuleerd dat deze afbraak 
een rol zou spelen bij de koppeling van receptorac-
tivering aan veranderingen van de cellulaire calci-
umconcentratie. De wijze waarop was vooralsnog 
onduidelijk maar in 1977 werd door Abdel-Latif et 
al. voor het eerst aangetoond dat receploractivering 
leidt tot de afbraak van het polyfosfoinositide, 
PIP2. Deze afbraak bleek in het gebruikte gladde 
spierweefsel van de iris van hel konijn echter 
afhankelijk te zijn van extracellulair calcium 
(Akhtar en Abdel-Latif, 1978) en geïnduceerd te 
kunnen worden door de calciumionofoor A23187 
(Akhtar en Abdel-Latif, 1980). In de meeste andere 
celtypen (Kirk et al., 1981; Weiss el al., 1982; Bil-
lah en Lapetina, 1982), inclusief de acineuze cel 
van de pancreas (Putney et al., 1983; Orchard et al., 
1984; Pandol et al., 1985b). is echter gebleken dat 
de stimulus-geïnduceerde PIP2 afbraak onafhanke-
lijk is van calcium en inderdaad de schakel vormt 
tussen receptoractivering en calciummobilizering 
(Berridge, 1985,1987a,b). 
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De laatste jaren pas is meer inzicht verkregen 
in het werkingsmechanisme van stimuli, waarvan 
reeds lang bekend was dat zij én de intracellulaire 
vrije calciumconcentratie verhogen én het metabo-
lisme van een van de membraanfosfolipiden, het 
fosfatidylinosilol, stimuleren. Ook nu weer lijken O 
eiwitten betrokken bij de overdracht van het sig-
naal naar het enzym dat de aanmaak van de intra-
cellulaire boodschappers bevordert (Joseph, 1985; 
Cockcroft en Gomperts, 1985; Taylor en Meiritt, 
1986; Litosch en Fain, 1986; Litosch, 1987; Gil-
man, 1987; Berridge, 1987a,b). In tegenstelling tot 
de G eiwitten van het cAMP systeem is tot op 
heden nog geen G eiwit van het fosfatidylinosilol/ 
calciumsysteem geïsoleerd. 
Een sterke aanwijzing voor het bestaan van een 
dergelijk G eiwit is de stimulering door (slecht 
hydrolyseerbare) GTP (analoga) van de PIP2 
afbraak en de (1,4,5)ГРз vorming in gepermeabili-
zeerde cellen, zoals onlangs aangetoond voor aci-
neuze cellen van de rattepancreas door Merritt et 
al. (1986b). 
In een aantal celtypen bleek behandeling met 
het eerder genoemde pertussis toxine te leiden tot 
remming van responsen opgewekt door calcium-
mobilizerende stimuli (Brandt et al., 1985; Krause 
et al., 1985; Nakamura and Ui, 1985; Bradford at 
Rubin, 1985). Door gebruik te maken van tea ver­
binding welke sterker begint te fluoresceren zodra 
zij calcium bindt, het quin2 (Rink en Pozzan, 
1985), kon worden nagegaan dat behandeling van 
acineuze cellen van de exocriene pancreas van het 
konijn met pertussis toxine niet leidt tol een rem­
ming van de door cholecystokinine geïnduceerde 
stijging van de intracellulaire vrije calciumconcen-
tratie (Hoofdstuk 3). Daarmee blijkt in geval van 
de acineuze cel van de exocriene pancreas het G 
eiwit, dat verondersteld wordt receptoren als die 
voor het cholecystokinine en het acetylcholine te 
koppelen aan het PIP2 fosfodiesterase, ongevoelig 
te zijn voor pertussis toxine. 
Het enzym dat in dit systeem de aanmaak van 
de intracellulaire boodschappers bevordert is het 
fosfatidylinositol 4,5-bisfosfaat- specifieke fosfo-
diesterase (PIP2 fosfodiesterase). Het substraat, 
PIP2, wordt door tussenkomst van dit enzym op 
een zodanige wijze afgebroken dat als producten 
het diacylglycerol en het (1,4,5)ІРз ontstaan (Ber­
ridge, 1985,1987a,b). De door cholecystokinine 
gestimuleerde afbraak van PIP2 kan, voor de hoge­
re concentraties van het hormoon, reeds na 8 sec 
gemeten worden en is duidelijk dosis-afhankelijk 
(Hoofdstuk 6). Noch het in deze studies gebruikte 
synthetische secretine noch het VIP stimuleren de 
afbraak van PIP2 (Hoofdstuk 9), hetgeen in over­
eenstemming is met het feit dat zij geen van beiden 
de enzymsecretie stimuleren (Hoofdstuk 9). Recen­
telijk is echter gevonden dat stimulering van aci­
neuze cellen van de rattepancreas met supramaxi­
male concentraties secretine leidt tot een stijging 
van de (1,4,5)ІРз concentratie en de vrije calcium­
concentratie (Trimble et al., 1986, 1987a,b). 
Bovendien is gebleken dat stimulering van acineu­
ze cellen van de rattepancreas met dibutyryl cAMP 
leidt tot een van calcium afhankelijke afbraak van 
fosfatidylinositol (Parese et al., 1981b). 
Hoewel secretine het fosfatidylinositol/calcium 
systeem alleen activeert bij supramaximale concen­
traties, is toch interessant dat VIP dit systeem in de 
rattepancreas niet activeert (Trimble et al., 1986). 
En terwijl beide secretagogen de cAMP productie 
in dezelfde mate stimuleren, is het secretoire effect 
van VIP veel geringer en volledig vergelijkbaar 
met dat van forskoline (Vandermeers et al., 1984; 
Bisonnette et al., 1984). Een mogelijke verklaring 
zou kunnen zijn dat, in de rattepancreas, forskoline 
en VIP de enzymsecretie stimuleren door stimule­
ring van de calcium-afhankelijke afbraak van het 
fosfatidylinositol, terwijl secretine daarnaast de 
cakium-onafhankelijke afbraak van fosfatidylino­
sitol via PIP2 stimuleert en daarmee in veel sterke­
re mate de enzymsecretie. 
De inositolpolyfosfaatlcalcium route 
Binnen enkele seconden na stimulering kan 
reeds een verhoging van de (1,4,5)ІРз concentratie 
worden gemeten (Streb et al., 1985; Merritt et al., 
1986a; Trimble et al., 1987b; Doughney et al., 
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1987). Iets later in de tijd treedt een verhoging op 
van de inositol 1,3,4,5-tetrakisfosfaat ((1,3,4^)0*4) 
concentratie, gevolgd door een stijging van de con­
centratie van het inositol 1,3,4-trisfosfaat 
((1,3,4)ІРз) (Trimble et al., 1987b·, Doughney et 
al., 1987). Inositol 1,3,4,5-tetrakÌsfosfaat wordt 
door fosforylermg gevormd uit (1,3,4)ІРз, waarna 
uit (1,3,4,5)IP4 door defosforylering (1,3,4)ІРз 
wordt gevormd (Berridge, 198S,1987a,b). Inosilol-
trisfosfaten worden achtereenvolgens gedefosfory-
leerd tot inositolbisfosfaat, inositolmonofosfaat en 
inositol. Het gevormde mositol wordt vervolgens 
gebruikt voor de resynthese van fosfatidylinositol. 
Uit fosfatidylinositol wordt dan weer via fosfatidy­
linositol 4-monofosfaat (PIP), PIP2 gevormd (Ber­
ridge, 1985,1987a,b). 
De concentraties van het (1,4,5)ІРз en het 
(1,3,4,5)IP4 bereiken vrij snel na aanvang van sti­
mulering een plateau, terwijl de concentratie van 
(1,3,4)ІРз blijft stijgen in de tijd (Trimble et al., 
1987b; Doughney et al., 1987). Bij aanhoudende 
stimulering blijft de afbraak van PIP2 dus door­
gaan. Een dergelijke verhoogde turnover verklaart 
waarom bij de labeling van PIP2 met 32p eerder 
een evenwicht wordt bereikt in aanwezigheid van 
cholecystokinine (Hoofdstuk 8). 
Van het (1,4,5)ІРз werd in 1983 (Streb el al., 
1983) bekend dat het calcium vrij kan maken uit 
een gesloten, ATP-afhankelijke en niet-
mitochondriële intracellulaire opslagplaats. Thans 
lijkt vrij aannemelijk gemaakt dat deze intracellu-
laire opslagplaats voor calcium het endoplasma-
tisch reticulum is (Streb et al., 1984). Het oorspron-
kelijke experiment van Streb et al. (1983) werd 
uitgevoerd met gepermeabilizeerde acineuze cellen 
van de exocriene pancreas en met gebruik making 
van een zeer gevoelige calcium-selectieve electro-
de. Hoofdstuk 7 beschrijft hetzelfde type experi-
ment, uitgevoerd met gepermeabilizeerde cellen 
van de konijnepancreas. De door (1,4,5)ІРз gesti­
muleerde efflux van calcium werd gemeten met 
behulp van 4^Ca2+. Bij een concentratie van 10 
μΜ blijkt (1,4,5)ІРз in 30 sec ongeveer 35 % van 
het in aanwezigheid van ATP geaccumuleerde cal­
cium vrij te maken. 
De door (1,4,5)ІРз gemedieerde stijging van de 
cytoplasmatische vrije calciumconcenlratie kan 
worden geregistreerd met behulp van quin2, een 
verbinding welke sterker fluoresceert naarmate 
meer calcium wordt gebonden (Rink en Pozzan, 
1985). Wordt deze stof geïntroduceerd in het cyto-
plasme van de cel, dan kan de vrije calciumconcen-
lratie aan de hand van het verkregen fluorescentie-
signaal berekend worden. In de acineuze cel van de 
konijnepancreas blijkt de vrije calciumconcenlratie 
te liggen rond de 150 nM (Hoofdstukken 3-6). 
Zodra gestimuleerd wordt met cholecystokinine of 
carbachol treedt binnen enkele seconden een sterke 
stijging op van de intracellulaire calciumconcenlra-
tie en nadat een dosis-afhankelijk maximum is 
bereikt, daalt de calciumconcentralie weer vrij snel 
(Hoofdstuk 4). De zeer snelle, initiële stijging van 
de vrije calciumconcentralie blijkt onafhankelijk 
van de aanwezigheid van extracellulair calcium 
(Ochs et al., 1984,1985; Pandol et al., 1985a; 
Hoofdstukken 4 en 6) en representeert daarmee de, 
door (1,4,5)ІРз stimuleerbare, afgifte van calcium 
uit de intracellulaire opslagplaats. 
Wordt gestimuleerd met een concentratie van 
cholecystokinine of carbachol welke een bijna 
maximale enzymsecretie geeft, dan keert de intra­
cellulaire calciumspiegel duidelijk niet terug naar 
het prestimulatoire niveau maar naar een niveau 
van om en nabij de 200 nM (Ochs et al., 1985; 
Merritt en Rubin, 1985; Hoofdstuk 4). Dit poststi-
mulatoire niveau wordt na ongeveer 1 min bereikt 
en blijft gehandhaafd voor de duur van de receptor­
activering. Voor het instandhouden van dit poststi-
mulatoire calciumniveau is de aanwezigheid van 
extracellulair calcium vereist, hetgeen duidt op een 
verhoogde influx van calcium. Experimenten met 
45ça2+ foie,, inderdaad zien dat een verhoogde 
influx van calcium optreedt na hormonale stimule-
ring (Kondo en Schulz, 1976; Renckens el al., 
1978; Donna- et al., 1981). Recente waarnemin-
gen aan zeeëgeleieren lijken te wijzen op een geza-
menlijke rol van het (1,4,5)ІРз en het (1,3,4,5)IP4 
bij de hormonaal-geïnduceerde stijging van de 
plasmamembraanpermeabiliteit voor calcium (Irvi-
ne en MOOT, 1986,1987). 
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De veronderstelde remmer van de hormonaal-
gestimuleerde afgifte van calcium uit de intracellu­
laire opslagplaats, TMB-8 (Chiou en Malagodi, 
1975), blijkt geen effect te hebben op de door cho-
lecystokinine gestimuleerde initiële calciumstijging 
(Hoofdstukken 4 en S). Deze verbinding heeft wel 
duidelijke effecten op de poststimulatoire blijvend-
verhoogde calciumspiegel (Hoofdstuk 4). Het niet 
optreden hiervan zou kunnen duiden op remming 
van bovenbeschreven hormonaal-geïnduceerde stij-
ging van de plasmamembraanpermeabiiiteit voor 
calcium. Toediening van TMB-8 aan gestimuleerde 
cellen, leidt, in afwezigheid van extracellulair cal-
cium echter tot een verdere daling van de cytoplas-
malische vrije calciumconcentratie. Dit duidt erop 
dat TMB-8 mogelijk processen beïnvloedt welke 
bijdragen aan handhaving van het calciumniveau in 
cellen gestimuleerd in afwezigheid van extracellu-
lair calcium. Wordt de extracellulaire calciumcon-
centratie weer op peil gebracht, dan stijgt de intra-
cellulaire calciumspiegel weliswaar in 
aanwezigheid van TMB-8, maar niet lot het 
poststimulatoir-verhoogde niveau. Een observatie 
welke weer in in overeenstemming is met een rem-
ming door TMB-8 van de hormonaal-geïnduceerde 
stijging van de plasmamembraanpermeabiiiteit 
voor calcium. Het exacte werkingsmechanisme 
van TMB-8 is vooralsnog echter onbekend. 
Aanwijzingen voor een directe rol van calcium 
in de stimulus-secretie koppeling komen vrijwel 
uitsluitend van werk met calciumionoforen. Calci-
umionoforen als het A23187 en het ionomycine 
verhogen, buiten de receptor om, de intracellulaire 
calciumconcentratie, hetgeen voldoende is om de 
enzymsecretie te stimuleren (Schulz, 1980; Gard-
ner et al., 1980; Ponnappa en Williams, 1980; Pan-
del et al., 1985a; Merritt en Rubin, 1985; Hoofd-
stukken 4 en б). Op een directere wijze hebben 
Knight en Koh (1984) aangetoond dat verhoging 
van de calciumconcentratie van het incubatiemedi-
um leidt tot stimulering van de enzymsecretie door 
gepermeabilizeerde acineuze cellen. Calcium lijkt 
dus te voldoen aan het voor intracellulaire bood­
schappers opgestelde criterium dat enkel een ver­
hoging van de concentratie leidt tot de respons. Een 
ander criterium is dat remming van de hormonaal-
gestimuleerde stijging van de concentratie van de 
boodschapper leidt tot remming van de respons. 
Van de verbinding TMB-8 was beschreven dal 
deze de stijging van de intracellulaire calciumcon­
centratie zou remmen en in die zin zou hel een 
belangrijk hulpmiddel kunnen zijn in hel onderzoek 
naar de betekenis welke de stijging van de vrije 
calciumconcentratie heeft voor de secretoire res­
pons. Uit metingen van de hormonaal-
geïnduceerde veranderingen van de vrije calcium-
concentratie blijkt dat de door carbachol en niet de 
door CCK-8 geïnduceerde calciumstijging door 
TMB-8 wordt geremd (Hoofdstuk 5). Deze rem-
ming treedt reeds op bij micromolair concentraties 
TMB-8 en geconcludeerd is, mede op grond van 
gegevens uit de literatuur betreffende de verdrin-
ging van [3H]QNB door TMB-8 (Termes et al., 
1983), dat TMB-8 een cholinerge receptorantago-
nist is. De door carbachol gestimuleerde enzymse-
cretie wordt reeds bij lage concentraties van 
TMB-8 geremd. De secretoire respons op CCK-8 
wordt daarentegen pas bij veel hogere concentraties 
van TMB-8 geremd, nadat eerst zelfs het stimule-
rende effect van CCK-8 word) gepotentieerd. Inte-
ressant is dat deze potentiëring alleen optreedt bij 
submaximaal stimulerende concentraties secretag-
oog. De wijze waarop TMB-8 zijn potentiërende 
werking uitoefent, is onbekend. De duidelijke rem-
ming van de hormonaal-gestimuleerde enzymsecre-
tie welke optreedt bij de hogere concentraties van 
TMB-8 lijkt gepaard te gaan met cylotoxische 
effecten. Vreemd genoeg echter worden de granula, 
waarin de spijsverteringsenzymen intracellulair 
gelocaliseerd zijn, niet beschadigd. 
De secretoire respons van acineuze cellen van 
de pancreas is bifasisch. Gedurende de eerste 5 
minuten na stimulering is de secretiesnelheid hoog. 
Daarna daalt de secretiesnelheid tot een niveau, 
hoger dan het ongestimuleerde, dat gehandhaafd 
blijft voor de duur van de receptoractivering 
(Schulz, 1980; Campbell, 1983; Pandol el al., 
1985a,b). 
Worden acineuze cellen van de caviapancreas 
gestimuleerd met carbachol en wordt vervolgens 
activering van de cholinerge receptor geblokkeerd 
door middel van een cholinerge receptorantagonist, 
atropine, dan daalt de snelheid waarmee de spijs-
verteringsenzymen afgegeven worden onmiddelijk 
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tot het ongestimuleerde niveau (Pandol et al., 
1985a). Wordt nu gelijktijdig met atropine, chole-
cyslokinine toegevoegd, dan wordt de enzymsecre-
tie wel gestimuleerd. De initiële fase van de secre-
toire respons, welke gekenmerkt wordt door de 
hoge secretiesnelheid, treedt echter niet op. Onder 
dezelfde condities leidt stimulering met cholecysto-
kinine niet tot verhoging van de intracellulaire cal-
ciumconcentratie en geconcludeerd wordt dal de 
initiële calciumstijging van belang is voor de, 
gedurende de eerste S min na stimulering optreden-
de, hoge secretiesnelheid. Het niet optreden van 
een door cholecystokinine geïnduceerde calcium-
stijging wordt, als eerder beschreven door Stolze en 
Schulz (1980), toegeschreven aan depletie van de 
intracellulaire opslagplaats ten gevolge van de 
voorafgaande stimulering met carbachol. 
Dat de honnonaal-geïnduceerde stijging van de 
intracellulaire calciumconcentratie inderdaad een 
rol speelt bij de secretoire respons blijkt ook uit het 
feit dat de respons duidelijk geremd is in cellen die 
opgeladen zijn met het calcium-bindende quin2 
(Ochs et al., 1985), of in cellen waarin door middel 
van osmotische zwelling andere calciumchelatoren 
zijn geïntroduceerd (Donner, 1984). 
Terwijl bovengenoemde initiële fase van de 
secretoire respons afhankelijk is van de aanwezig-
heid van calcium in de intracellulaire opslagplaats, 
is de daaropvolgende fase van de respons, geken-
merkt door de geringere maar nog steeds verhoog-
de secreliesnelheid, wel afhankelijk van extracellu-
lair calcium (Gardner el al., 1979b,1980; Williams, 
1980; Schulz, 1980; Argent et al., 1982). De secre-
toire respons op forbolesters lijkt daarentegen, of 
veel minder (Günther, 1981), of nauwelijks (Мет-
ritt en Rubin, 1985) afhankelijk van extracellulair 
calcium. Dit duidt erop dat calcium, maar nu van 
extracellulaire origine, ook een rol speelt geduren­
de de fase van de geringere secretiesnelheid 
(Schreurs et al., 1976; Petersen en Ueda, 1976). In 
dit verband is het interessant dat het potentiërende 
effect van TMB-8 bij die concentraties waarbij het 
remmende effect op de poststimulatoir-verhoogde 
calciumspiegel zichtbaar wordt, begint af te nemen 
en overgaat in een remmend effect (Hoofdstukken 
4 en 5). 
De diacylglycerollproteïne kinase С route 
Behalve lot de vorming van (1,4^)0*3, leidt de 
hormonaal gestimuleerde afbraak van PIP2 ook tol 
de vorming van het diacylglycerol. 
In 1977 werd door de groep van Nishizuka een 
proteïne kinase beschreven dat enkel proteolytisch 
(door een calcium-afhankelijk thiol protease) geac-
tiveerd kon worden (Inoue et al, 1977). Het niet 
proteolytisch geactiveerde enzym bleek vervolgens 
toch geactiveerd te kunnen worden door de combi-
natie van calcium en fosfolipiden (Takai et al., 
1979a). Vervolgens bleek dat wel de calcium-
afbankelijkheid, maar niet de fosfolipide-
afhankelijkheid, sterk afnam in aanwezigheid van 
diacylglycerol (Takai et al, 1979b). Tenslotte werd 
gevonden dat de tumor-bevorderende forbolesters, 
welke qua moleculaire structuur sterke gelijkenis 
vertonen met diacylglycerolen, eveneens de 
calcium-afhankelijkheid van het proteïne kinase С, 
zoals het enzym inmiddels genoemd werd, verlaag­
den (Castagna et al., 1982). Sindsdien zijn forbo­
lesters, zoals het 12-O-tetradecanoylforbol 
13-acetaat (TPA) overal waar mogelijk gebruikt 
om de rol van proteïne kinase С le bestuderen 
(Ashendel, 1985; Nishizuka, 1986; Kikkawa en 
Nishizuka, 1986). Onlangs nog is door Nishizuka 
(1986) een overzicht gepubliceerd betreffende de 
processen welke door proteïne kinase С beïnvloed 
worden. 
Wanneer acineuze cellen van de exocriene pan-
creas gestimuleerd worden mei forbolesters, dan 
leidt dit tot toename van de enzymsecretie (De Pont 
en Fleuren-Jakobs, 1984; Merritt en Rubin, 1985; 
Pandol et al., 1985a; Bumham et al., 1986; Ansah 
et al., 1986; Hoofdstukken 3, 5 en 6). Net als bij 
cAMP lijkt ook bij forbolesters de mate waarin de 
enzymsecretie gestimuleerd wordt afhankelijk van 
het species. In het konijn wordl de enzymsecretie 
door zowel TPA alleen, als door de calciumiono-
foor, А2Э187, alleen, relatief slecht gestimuleerd 
indien vergeleken met maximaal effectieve concen­
traties van carbachol of cholecystokinine (De Pont 
en Fleuren-Jakobs, 1984 en Hoofdstuk 5). De com­
binatie van beiden geeft echter een maximale sti­
mulering van de enzymsecretie (De Pont en 
Fleuren-Jakobs, 1984). In de cavia verschilt de 
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maximale respons op TP A nauwelijks van die op 
cholecystokmine (Pandol et al., 1985a) en toevoe­
ging van A23187 heeft in dat geval nauwelijks nog 
extra effect (φ de enzymsecretie. Het synergistisch 
effect van forbolesters en calciumionoforen zoals 
dat waargenomen wordt in de exocriene pancreas 
(De Pont en Fleuren-Jakobs, 1984; Merritt en 
Rubin, 1985) blijkt op te treden in tal van celtypen 
en ondersteunt de hypothese dat slechts de geza­
menlijke activering van zowel de inositolfosfaat/ 
calcium route als de diacylglycerol/proteïne kinase 
С route, leidt tot een volledige respons (Nishizuka, 
1983). 
Wanneer acineuze cellen van de pancreas wor­
den gestimuleerd met cholecystokmine, vervolgens 
verschillende malen gewassen en daarna opnieuw 
gestimuleerd, dan blijkt de respons aanzienlijk 
geremd (Abdelmoumene en Gardner, 1980). De 
mate van desentizering blijkt toe te nemen met de 
concentratie van het cholecystokmine tijdens de 
eerste incubatie. Bovendien wordt niet alleen de 
respons op cholecystokinine maar ook die op ande­
re calciummobilizerende hormonen geremd. De 
respons op secretagogen welke cAMP verhogen 
wordt daarentegen niet geremd (Gardner en Jensen, 
1981). 
De mogelijkheid dat activering van de 
diacylglycerol/proteïne kinase С route een rol 
speelt bij desentizering werd onderzocht door aci­
neuze cellen van de konijnepancreas voor te behan­
delen met TPA, te wassen en vervolgens te stimu­
leren met cholecystokinine (Hoofdstuk 6). 
Voorbehandeling met TPA blijkt, zoals verwacht, 
te leiden tot stimulering van de enzymsecretie 
(activering van de diacylglycerol/proteïne kinase С 
route). Wordt vervolgens gestimuleerd met chole­
cystokinine dan blijkt een verdere verhoging van 
de TPA-gestimuleerde enzymsecretie eerst op te 
treden bij relatief hoge concentraties van het hor­
moon. Het onvermogen van de lagere hormooncon­
centraties om de TPA-gestimuleerde secretie ver­
der te verhogen blijkt samen te vallen met een 
remming van het vermogen van het hormoon om 
bij deze lagere concentraties de intracellulaire vrije 
cale iumconcen trat ie te verhogen (zie ook: Ansah et 
al., 1986). Een mogelijke verklaring zou kunnen 
zijn dat voorbehandeling met forbolester leidt tot 
stimulering van het calciumextrusiemechanisme en 
zo een hoimonaal-geïnduceerde calciumslijging 
teniet doet (Berridge, 1987a). Hiertegen spreekt 
echter dat de door cholecystokmine geïnduceerde 
cakiumstijging volledig wordt geremd. 
Remming van stimulus-geïnduceerde stijgin-
gen van de vrije calciumconcentratie door forboles-
ters is ook gevonden voor andere celtypen (Zavoi-
co et al., 1985; Sagi-Eisenberg et al., 1985; 
Mclntyre et al., 1985; Kojima et al., 1986) en blijkt 
in tal van celtypen gepaard te gaan met remming 
van de stimulus-geïnduceerde afbraak van PIP2 
(Watson en Lapetina, 1985; Orellana et al., 1985; 
Vicentini et al., 1985; Drummond, 1985). Voor 
enkele celtypen is bovendien aangetoond dat 
behandeling met forbolesters leidt tot fosforylering 
van de aj-adrenerge receptor en langs die route tot 
ontkoppeling van de receptor van de 
fosfatidylinositol/calcium route (Leeb-Lundberg et 
al., 1985). In hepatocyten is gebleken dat 
forbolester-geïnduceerde remming van de 
hormonaal-geslimuleerde afbraak van PIP2 wel 
optreedt voor de aj-receptor maar nauwelijks of 
niet voor de Vasopressine of angiotensme-2 recep-
tor (Cooper et al., 1985; Corvera en Garcia-Sainz, 
1984), hetgeen erop zou kunnen duiden dat het 
remmende effect van forbolesters optreedt op 
receptorniveau en niet op het niveau van het G 
eiwit of het PIP2 fosfodiesterase (Berridge, 1987a). 
In het licht van de bovenbeschreven observa-
ties is het tamelijk exceptioneel dat in acineuze cel-
len van de konijnepancreas voorbehandeld met 
TPA, de cholecystokinine-geïnduceerde afbraak 
van [32P]PIP2 niet wordt geremd (Hoofdstuk 6). 
Dit betekent dat de hormonaal-geïnduceerde pro-
ductie van (1,4,5)ІРз niet geremd is in acineuze 
cellen voorbehandeld met forbolester, hetgeen 
overeenstemt met de observatie van Merritt et al. 
(1986a). De observatie van Merritt el al. (1986a) 
betekent bovendien dat een verhoogd metabolisme 
van (1,4,5)ІРз (Molina y Vedia en Lapetina, 1986; 
Connolly et al., 1986) niet de oorzaak zou Zijn van 
remming van de door cholecystokinine 
geïnduceerde cakiumstijging. Recentelijk is echter 
gevonden dat TPA-voorbehandeling van acini van 
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de rattepancreas wel leidt tot remming van de 
honnonaal- geïnduceerde (1,4,5)ІРз stijging (Bniz-
zone en Wollheim, 1987). 
Remming van de honnonaal-gestimuleerde cal-
ciumstijging zonder remming van de hormonaal-
geïnduceerde PIP2 afbraak kan behalve uit een ver-
hoogd metabolisme van de, voor stimulering van 
de calciumafgifte in aanmerking komende polyino-
sitolfosfaten, ook verklaard worden uit een desen-
tizering van de intracellulaire calciumopslagplaats 
voor deze inositolpolyfosfaten. Wanneer acineuze 
cellen van de konijnepancreas worden voorbehan-
deld met TPA en vervolgens gepermeabilizeerd 
met saponine dan blijkt de ATP-afhankelijke opna-
me van Ca2+ niet beïnvloed, terwijl de 
(1,4,5)ІРз-gestimuleerde afgifte van calcium, 
ondanks grote verschillen in stimuleerbaarheid van 
de verschillende celpreparaten, significant is 
geremd (Hoofdstuk 7). Gemiddeld over alle 
(1,4,5)ІРэ concentraties blijft ongeveer 5,5% meer 
calcium achter in de met forbolester behandelde 
cellen. De dose-respons curve is daannee naar 
rechts verschoven ten opzichte van die voor de 
onbehandelde cellen, hetgeen betekent dat de affi­
niteit voor (1,4,5)ІРз verlaagd is. In dat geval leidt 
activering van de diacylglycerol/proteïne kinase С 
route tot desentizering van de intracellulaire calci­
umopslagplaats, met als gevolg remming van de 
door cholecystokinine gestimuleerde afgifte van 
calcium. 
Worden acineuze cellen van de pancreas gela­
beld met 32p in aanwezigheid van een cakiummo-
büizerend secretagoog zoals cholecystokinine, dan 
treedt, als reeds uitvoerig beschreven, een sterke 
incorporatie van label op in fosfatidylinositol en 
fosfatidezuur (Hoofdstukken 8 en 9). De incorpo-
ratie van label in PIP2 blijft echter sterk achter bij 
die in controle cellen terwijl evenwichtslabeling 
duidelijk eerder wordt bereikt, hetgeen, zoals reeds 
ter sprake is gekomen, verklaard zou kunnen wor-
den uit de verhoogde turnover van dit polyfosfoi-
nositide bij een gedaalde totale hoeveelheid. De 
bevinding dat de totale hoeveelheid PIP2 verlaagd 
is in gestimuleerde cellen is nieuw. Berridge 
(1987a) concludeert namelijk uit de toename van 
de hoeveelheid 32p_pn>2, welke optreedt na de 
stimulus-geïnduceerde snelle en sterke daling, dat 
in gestimuleerde cellen de totale hoeveelheid PIP2 
na stimulering eerst af- en dan toeneemt en soms 
zelfs het prestimulatoire niveau overschrijdt. Op 
grond van het feit dat forbolesters de labeling van 
PIP2 met 32p bevorderen (De Chaffoy de Courcel-
les et al., 1984; Halenda en Feinstem, 1984; Taylor 
et al., 1984; Boon et al., 1985), zoals ook gevonden 
is voor de konijnepancreas (Hoofdstuk 8), wordt 
een positief feedback effect van het geactiveerde 
proteïne kinase С gesuggereerd. 
Vreemd genoeg bereikt de labeling van PIP 
geen evenwicht, terwijl de turnover toch verhoogd 
moet zijn om het benodigde PIP2 te kunnen leve­
ren. Een mogelijke verklaring zou kunnen zijn dat 
het PIP dat gelabeld wordt in aanwezigheid van 
secretagoog niet de precursor is voor hel 
secretagoog-gevoelige PIP2- Dit zou ook kunnen 
verklaren waarom stimulering niet in alle gevallen 
leidt tot een duidelijke afname van de hoeveelheid 
32p.pip (puiney et al., 1983; Orchard et al., 1984; 
Pandolci al., 1985b). 
Wordt gelabeld in aanwezigheid van TPA, dan 
blijkt vooral de incorporatie van 32p ¡n PIP2 gesti-
muleerd. Een dergelijke door forbolester 
geïnduceerde verhoogde incorporatie van label in 
PIP2 is, als boven beschreven, eerder gevonden 
voor andere celtypen en is mogelijk het gevolg van 
een verhoogde de- en/of refosforylering van PIP2 
en PIP. Een zelfde effect op de labeling van PIP is 
minder duidelijk, terwijl de labeling van fosfatidy-
linositol nauwelijks beïnvloed lijkt. Opvallend is 
dat stimulering van acineuze cellen gelabeld in 
aanwezigheid van forbolester wel leidt tot een dui-
delijke en snelle daling van de hoeveelheid 
32p.pip
 e n z o a i s reeds eerder vermeld is de 
afbraak van 32p.piP2 niet geremd. Bovendien lijkt 
in aanwezigheid van TPA de hoeveelheid 32p.piP2 
na de stimulus-geïnduceerde daling wel toe te 
nemen. 
Het meest opvallend is echter dat in aanwezig-
heid van forbolester de labeling van fosfatidylcho-
line zeer sterk wordt gestimuleerd, een effect dat 
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niet optreed) in aanwezigheid van cholecystokini-
ne. Het stimulerende effect van forbolesters op het 
métabolisme van fosfatidylcholine is beschreven 
voor tal van celtypen en is in verband gebracht met 
de tumor- bevorderende werking van deze verbin-
dingen (Weinstein, 1981; Pelech en Vance, 1984). 
Het CTPifosfocholine cytidylyltransferase 
katalyseert de snelheidsbepalende stap in de syn-
these van fosfatidylcholine. Bevindt dit enzym zich 
in het cytosol dan is het inactief. Membraangebon-
den daarentegen is het enzym wel actief. Vetzuren 
(Cornell en Vance, 1987), diacylglycerol (Wright 
et al., 1985) en forbolesters (Pelech et al., 1984) 
bevorderen de translocatie van dit enzym en stimu-
leren daarmee mogelijk de synthese van fosfatidyl-
choline. Forbolesters stimuleren ook de hydrolyse 
van fosfatidylcholine. Het enzym dat wordt geacti-
veerd is het fosfalidylcholine-specifïeke fosfolipase 
С en de producten zijn fosfocholine en diacylglyce­
rol (Daniel el al, 1986; Besterman et al., 1986). Er 
bestaat echter verschil tussen het effect van forbo­
lesters en dat van synthetische diacylglycerolen als 
het ІД-dioctanoylglycerol of het 
l-oleoyl-2-acetylglycerol. De laatsten stimuleren 
de hydrolyse van fosfatidylcholine op fosfolipase 
A2-achtige wijze met als producten lysofosfatidyl-
choline en arachidonzuur (Kolesnick en Paley, 
1987). 
In 3T3 LI cellen werd gevonden dat niet alleen 
forbolesters, maar ook stimuli als de platelet deri­
ved growth factor (PDGF), het fosfatidylcholine-
specifieke fosfolipase С activeren, gemeten aan de 
toename van fosfo[3H]choline. Downregulatie van 
proteïne kinase С door langdurige voorbehandeling 
met forbolester bleek vervolgens wel de respons op 
foibolester, maar in veel mindere mate die op 
PDGF, te remmen. Hieruit werd geconcludeerd dat 
PDGF niet alleai door activering van de 
diacylglycerol/proteïne kinase С route van het 
fosfatidylinositol/calciumsysteem, maar ook langs 
een van proteïne kinase С onafhankelijke route het 
fosfalidylcholine-specifïeke fosfolipase С activeert 
(Besterman et al., 1986). 
Werden 3T3 cellen gestimuleerd met forboles­
ter dan bleek de totale hoeveelheid fosfatidylcholi­
ne niet te veranderen. Dit ondanks een verhoogde 
turnover van dit fosfolipide. Ook de totale hoeveel­
heid fosfatidezuur veranderde niet. Wel echter 
bleek de hoeveelheid diacylglycerol aanzienlijk 
toegenomen en geconcludeerd werd dat de forbo­
lester het diacylglycerol-kinase remt (Takuwa et 
al., 1987). 
In acineuze cellen van de konijnepancreas 
wordt de labeling van fosfatidylcholine niet of nau­
welijks beïnvloed door stimulering met cholecysto-
kinine, terwijl de labeling van fosfatidezuur en fos-
fatidylinositol sterk is toegenomen. Dit duidt erop 
dat het gevormde diacylglycerol in hormonaal-
gestimuleerde cellen niet het substraat is voor het 
CDP-choline-diacylglycerol-transferase maar voor 
het diacylglycerol-kinase. Voor cellen gestimuleerd 
in aanwezigheid van forbolester is het beeld precies 
omgekeerd. De forbolester heeft geen effect op de 
labeling van fosfatidylinositol, terwijl die van fos-
fatidylcholine significant is toegenomen, hetgeen 
aangeeft dat het diacylglycerol nu substraat is voor 
het CDP-choline-diacylglycerol-transferase. 
Aangezien zowel diacylglycerol als forboles-
ters de translocatie van het CTP:fosfocholine cyti-
dylyltransferase stimuleren, moet het verschil in 
effect later optreden. Een mogelijkheid is dat for-
bolesters inderdaad het diacylglycerol-kinase rem-
men (Takuwa et al., 1987). Dit lijkt echter in geval 
van de acineuze cel niet waarschijnlijk daar na sti-
mulering met cholecystokinine in aanwezigheid 
van forbolester de incorporatie van label in fosfati-
dezuur niet is geremd. Eea andere verklaring zou 
kunnen zijn dat de velzuursamenstelling van het uit 
PIP2 gevormde diacylglycerol zodanig verschilt 
van het uit fosfatidylcholine gevormde diacylglyce-
rol dat dit bepalend is voor de wijze waarop het 
wordt gemetabolizeerd. 
Bij de behandeling van het cAMP systeem is 
reeds ter sprake gekomen dat activering van de 
diacylglycerol/proteïne kinase С route ook leidt tot 
een remming van het vermogen van cholecystoki­
nine (en VIP) om hel adenylaatcydase te activeren 
en de intracellulaire cAMP-spiegel te doen stijgen. 
Ook in dit geval treedt de remming enkel op voor 
de relatief lage concentraties van het cholecystoki­
nine (Hoofdstuk 9). Een dergelijke observatie doet 
vermoeden dal een en dezelfde, door de 
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forbolesler- geïnduceerde, modificering ten grond-
slag ligt aan de remming van zowel de door chole-
cystokinìne geïnduceerde activering van het cAMP 
systeem als de door cholecystokinìne geïnduceerde 
activering van het fosfatidylinositol/ 
cakiumsysteem. In dat geval is voor de band lig-
gend dat remming optreedt op het niveau van de 
receptor, hetgeen betekent dat dezelfde receptor 
gekoppeld is aan beide systemen. Hiertegen spreekt 
echter dat voorbehandeling met TPA niet leidt tot 
remming van de door cholecystokinìne gestimu-
leerde afbraak van PIP2 (Hoofdstuk 6). Op welk 
niveau de forbolesler de hormonaal- gestimuleerde 
aanmaak van cAMP remt is onduidelijk. In geval 
van hepatocyten bleek TPA activering van het ade-
nylaatcyclase door glucagon te remmen zonder de 
binding van glucagon te beïnvloeden (Heyworth et 
al., 1984), terwijl in erylhrocyten van de kalkoen 
de door forbolesler geïnduceerde desentizering van 
de ß-adrenerge receptor gepaard gaat met fosfory-
lering van de receptor (Kelleher et al., 1984). In 
weer andere celtypen, zoals pinealocyten, potentië-
ren forbolesters juist de hormonaal-gestimuleerde 
cAMP productie (Sugden et al., 1985). Aangetoond 
is verder dat proteïne kinase С zowel het remmen­
de G eiwit van het adenylaatcyclase systeem als de 
katalytische subunit van dat enzym kan fosforyle-
ren (Yoshimasa et al., 1987). 
Conclusies 
In het voorgaande is uitvoerig ingegaan op het 
werkingsmechanisme van die hormonen en neuro­
transmitters welke, omdat zij niet in staat zijn de 
plasmamembraan te passeren, extracellulair binden 
aan hun specifieke receptoren. In het onderzoek 
naar de wijze waarop het signaal vanaf het recep­
tormolecuul naar het inwendige van de cel wordt 
doorgegeven speelde en speelt de geïsoleerde aci-
neuze cel van de exocriene pancreas een belangrij-
ke rol. De redenen biervoor zijn onder andere dat 
functionele acineuze cellen relatief gemakkelijk en 
in grote aantallen te isoleren zijn. 
Het hormoon cholecystokinìne (CCK) en de 
neurotransmitter acetylcholine stimuleren de 
enzymsecretie primair door activering van het cal-
ciumsysteem. Het C-terminale octapeptide van 
cholecystokinìne (CCK-8) en de cholinerge recep-
tor agonist carbachol induceren dalingen van de 
hoeveelheid PIP2 en stijgingen van de hoeveelheid 
(1,4,5-)ІРз welke voldoende snel zijn om vooraf te 
kunnen gaan aan de stijging van de cytoplasmati· 
sehe vrije calciumconcentratie. Bovendien bestaan 
nu sterke aanwijzingen dat (1,4,5-)ІРз de lang 
gezochte schakel vormt tussen de gestimuleerde 
afbraak van fosfoinositiden en de gestimuleerde 
afgifte van calcium vanuit een intracellulaire 
opslagplaats. Het metabolisme van de inositolfosfa-
ten staat in het middelpunt van de belangstelling en 
mogelijk speelt het (1,3,4,5-)IP4 een rol bij de 
receptor-geïnduceerde verhoging van de plasma-
membraanpenneabilileit voor calcium. Wij hebben 
aangetoond dat na stimulering met CCK-8 of car-
bachol, de plasmamembraanpermeabiliteit voor 
calcium blijvend verhoogd is in aanwezigheid van 
het secretagoog. De vrije calciumconcentratie, 150 
nM in de ongestimuleerde cel, wordt daarbij 
gehandhaafd op 200 nM, mits extracellulair calci-
um aanwezig is. De veronderstelde intracellulaire 
Calciumantagonist TMB-8, remt niet de door 
CCK-8 geïnduceerde afgifte van calcium uit de int-
racellulaire calciumopslagplaats maar wel de door 
CCK-8 geïnduceerde langdurig- verhoogde vrije 
calciumconcentratie. Remming door TMB-8 van de 
door CCK-8 geïnduceerde stijging van de plasma-
membraanpermeabiliteit voor calcium kan onze 
waarnemingen niet volledig verklaren en toekom-
stig onderzoek moet uitwijzen op welk niveau 
TMB-8 exact aangrijpt. 
Het tweede product dat ontstaat bij de receptor-
gestimuleerde afbraak van PIP2 is het diacylglyce-
rol. Deze verbinding blijft in de plasmamembraan 
en activeert daar het proteïne kinase С, een naar het 
lijkt cruciaal enzym in de regulatie van cellulaire 
processen. Belangrijke hulpmiddelen bij de bestu­
dering van dit enzym in de intacte cel zijn de forbo­
lesters welke, zonder tussenkomst van receptoracti­
vering, het kinase activeren. Wij hebben de 
forbolesler 12-O-tetradecanoylphorbol 13-acetaat 
(TPA) gebruikt om de rol van proteïne kinase С in 
de acineuze cel van de pancreas nader te bestude-
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ren. De forbolester stimuleert de enzymsecretie. 
Activering van proteïne kinase С lijkt daarmee vol­
doende om de acineuze cel aan te zetten tot secre-
toire activiteit. Hel maximale effect van TPA blijft 
echter sterk achter bij dat van CCK-8 of carbachol. 
Pas in combinatie met een calciumionofoor, welke 
buiten de receptor om de intracellulaire calcium-
concentratie verhoogt en waarvan het maximale sti­
mulerende effect ook duidelijk achterblijft bij dat 
van CCK-8 of carbachol, treedt een stimulering op 
van de enzyrasecreiie welke vergelijkbaar is met 
die van CCK-8 of carbachol. Het effect van de for­
bolester en de calciumionofoor is additief. Dit addi-
tieve effect wordt algemeen beschouwd als bewijs 
voor een synergistische werking van de 
(1,4,5-)ІРз/са1сішп route en de diacylglycerol/ 
proteïne kinase С route bij het tot stand komen van 
de uiteindelijke respons. Dit synergistisch effect 
blijkt ondermeer nog uit onze waarneming dat 
CCK-8 in acineuze cellen, welke zijn voorbehan-
deld met forbolester, de door de forbolester gesti­
muleerde enzymsecretie pas bij die concentraties 
verder doet toenemen welke een stijging geven van 
de vrije calciumconcentratie. 
Activering van de enzymsecretie bleek echter 
niet het enige effect van de forbolester. Voorbehan­
deling van acineuze cellen met TPA leidde name­
lijk ook tot remming van de door CCK-8 
geïnduceerde stijging van de cytoplasmatische cal-
ciumconcentratie en daarmee van de door de forbo-
lester gestimuleerde enzymsecretie. Deze remming 
bleek niet op te treden op het niveau van de door 
CCK-8 geïnduceerde afbraak van PIP2. Wel echter 
kon worden aangetoond dat de voorbehandeling 
met TPA leidde tot remming van de door 
(1,4,5-)ІРз geïnduceerde afgifte van ATP-
afhankelijk opgeslagen calcium in gepenneabili-
zeerde acineuze cellen. De voorlopige werkhypo-
these zal zijn dat het in het endoplasmatisch 
reticulum aanwezige (l,4,5-)IP3-gevoelige calci-
umkanaal door proteïne kinase С zelf wordt gefos-
foryleerd. Bovendien is gevonden dat voorbehan­
deling met carbachol een zo mogelijk nog sterkere 
remming geeft van de door (1,4,5-)ІРз 
geïnduceerde afgifte van ATP-afhankelijk opgesla-
gen calcium in gepenneabilizeerde cellen. 
Op ons laboratorium is inmiddels een steile 
gezuiverd proteïne kinase С preparaat verkregen 
uit exocrien pancreasweefsel (A.G.H. Ederveen). 
Een volgende stap zal dan ook zijn een aan endop­
lasmatisch reticulum verrijkte membraanfractie te 
preïncuberen met gezuiverd proteïne kinase С en te 
onderzoeken of de door (1,4,5-)ІРз geïnduceerde 
afgifte van ATP-afhankelijk opgeslagen calcium 
opnieuw geremd is. 
Voorbehandeling met forbolester leidt ook tot 
veranderingen in het metabolisme van fosfolipiden. 
De meest in het oog springende verandering is wel 
de sterk verhoogde incorporatie van 32p¡ in fosfati-
dylcholine. Deze verhoogde incorporatie van label 
in fosfatidylcholine treedt niet op in aanwezigheid 
van CCK-8. De vraag rijst dan ook of dit effect van 
TPA al dan niet het gevolg is van activering van 
proteïne kinase С. Zo ja, welk mechanisme voor­
komt dan dat activering van proteïne kinase С door 
CCK-8 niet leidt tot dit effect. Bovendien is tot nu 
toe in een celtype gevonden dat activering van het 
metabolisme van fosfatidylcholine door forboles-
ters leidt tot een aanzienlijke verhoging van de hoe­
veelheid diacylglycerol. Hoe verstrekkend een der­
gelijke werking van forbolesters is, is op het 
moment nog onduidelijk maar verdient zeker in 
verband met het tumorbevorderende karakter van 
deze verbindingen nader onderzoek. 
De incorporatie van label in de polyfosfoinosi-
tiden, in het bijzonder in PIP2· 'Ü t^ eveneens gesti-
muleerd door TPA. De forbolester heeft geen effect 
op de zeer snelle door CCK-8 of carbachol gesti-
muleerde daling van de hoeveelheid gelabeld PIP2. 
Na deze hormonaal- geïnduceerde daling lijkt in 
aanwezigheid van forbolester de hoeveelheid gela-
beld PIP2 weer toe te nemen, terwijl dat niet het 
geval is in controle cellen. Een correcte interpreta-
tie van bovengenoemde waarnemingen wordt ech-
ter bemoeilijkt door het feit dat op het moment van 
stimulering geen evenwicht was bereikt met betrek-
king tot de labeling van de beide polyfosfoinositi-
den. Een langere labelingsduur is daarom noodza-
kelijk. Dit laatste is zeker het geval wanneer 
gelabeld wordt met verbindingen als inositol, ara-
chidonzuur of glycerol. Het zal daarom nodig zijn 
om te zoeken naar een manier om de vers 
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geïsoleerde acineuze cellen langer in leven te hou-
den. Het alternatief is te gaan werken met een cel-
lijn. 
Wordt gelabeld in aanwezigheid van een hoe-
veelheid CCK-8 welke de enzymsecretie maximaal 
stimuleert, dan blijkt de labeling van PIP2 wel tot 
evenwicht Ie komen. De hoeveelheid gelabeld PIP2 
is echter aanzienlijk verlaagd ten opzichte van cel-
len gelabeld in afwezigheid van secretagoog. Wor-
den eerstgenoemde cellen vervolgens maximaal 
gestimuleerd met carbachol, dan treedt geen verde-
re daling op van de hoeveelheid PIP2· Deze obser-
vatie geeft aan dat zolang een maximaal effectieve 
stimulus aanwezig is een tweede stimulus geen 
effect kan hebben omdat de hydrolyse van PIP2 al 
maximaal geactiveerd is en kan mede ten grondslag 
liggen aan bet verschijnsel van desentizering. 
Voorbehandeling met forbolester blijkt geen 
effect te hebben op de basale activiteit van het ade-
nylaatcyclase. Toch wordt het cAMP systeem 
beïnvloed door TPA. Zowel de door CCK-8 als de 
door VIP geïnduceerde stijging van de intracellu-
laire cAMP concentratie is geremd in cellen welke 
zijn voorbehandeld met TPA. Remming treedt ech-
ter alleen op wanneer gestimuleerd wordt met lage 
concentraties van de betreffende secretagogen. 
Toekomstig onderzoek zal moeten uitwijzen op 
welk niveau remming optreedt. Een mogelijkheid 
biedt de geïsoleerde membraanfractie. Deze fractie 
kan zowel gebruikt worden om het effect van voor-
behandeling met forbolester als het effect van 
preïncubatie gezuiverd proteïne kinase С op de 
hormonale stimuleerbaarheid van het adenylaatcy-
clase te bestuderen. 
Stimulering van het cAMP systeem leidt in de 
exocriene pancreas van het konijn niet tot enzym­
secretie. Wel wordt bij verhoogde intracellulaire 
cAMP concentraties de door calciummobilizerende 
secretagogen gestimuleerde secretie aanzienlijk 
versterkt De rol van cAMP lijkt daarmee een meer 
modulerende te zijn. Omdat cAMP ook de secretoi-
re respons op calciumionoforen en forbolesters ver­
sterkt, is geconcludeerd dat het niveau waarop 
cAMP aangrijpt gelegen moet zijn na het punt waar 
гіе(1,4,5-)ІРз/са1сіит route en de diacylglycerol/ 
proteïne kinase С route bij elkaar komen. Een 
eerste aanzet om deze hypothese te onderzoeken is 
na te gaan of mogelijk een van de substraateiwitten 
voor proteïne kinase С ook gefosforyleerd wordt 
door een cAMP-afhankelijk kinase. 
Gezien de belangrijke rol die proteïne kinase С 
speelt in de regulatie van de cellulaire activiteit is, 
behalve de isolatie en karakterisatie van dit enzym 
en het gebruik van gezuiverd enzym om na te gaan 
wat voor effecten het heeft op tal van intracellulaire 
processen, van belang het metabolisme van de cel­
lulaire activator van proteïne kinase С, het diacyl­
glycerol, te onderzoeken. Dit laatste zal dan ook 
het hoofddoel zijn van het vervolgonderzoek. 
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STELLINGEN 
I · 
De hypothese van Gardnçr en Jensen dat het venchil in secretoire activiteit tussen VIP en secretine berust 
op compartimenialisaUe van het gevonnde cyclisch AMP. wordt niet ondersteund door de bevinding van 
Dehaye et al., dal fprakollne de enzymsecretie slechts in geringe mate stimuleert. 
Gardner, J.D, and Jensen, R,T, (1986) Ann. Rev. Physiol. 48, ¡03-117 
Dehaye, J.-P., GHIard, M„ Роіосгек, P., Stievenart, M., Wìnand, J. <md Christophe, J. (1985) J. Cycl. 
Nucl. Prot. Phosph. Res. 10,269*280 
Π 
Dal hel netto stimulerende effect van cholecystokinine geringer is in acini die voorbehandeld zijn met for-
bol ester, bewijst niet dat het aantal receptoren voor het betreffende honnoon is afgenomen, maar dient 
veeleer verklaart te worden uit het feit dat een van beide routes waarlangs het honnoon de çnzymsecrelie 
stimuleert reeds door de forbol ester is geactiveerd. 
Lee, P.C., Leung, YJC„ Srimaruta, N.. Cumella, J. and Rossi, T. (1987) Biochim. Biophys. Acta 931, 
101,109 
Willems, РЯ.СМ., Van NooiJ, I.GP.. Haenen, HEM.G. and De Pont, JJJiMM. (1987) Biochim. Bio­
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